INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA
ÉVORA, JUNHO DE 2017
ORIENTADORES: Professora Doutora Joana Margarida Ferreira da Costa Reis Professor Doutor José Alberto Caeiro Potes
Tese apresentada à Universidade de Évora
para obtenção do Grau de Doutor em Ciências Veterinárias
Maria Teresa Carvalho Oliveira
Development of a large animal model for percutaneous vertebroplasty for in vivo
evaluation of a new injectable cement
Para ser grande, sê inteiro: nada
Teu exagera ou exclui.
Sê todo em cada coisa. Põe quanto és
No mínimo que fazes.
Assim em cada lago a lua toda
Brilha, porque alta vive.
Ricardo Reis
À memória dos meus avós
Aos meus amores
À minha família
v
Agradecimentos
O desenvolvimento e a execução deste trabalho não teriam sido possíveis sem o auxílio precioso
de algumas pessoas e instituições. A todos, desde já, o meu muito obrigada.
O meu mais profundo agradecimento à minha orientadora, Professora Doutora Joana Reis, pela
confiança que depositou continuamente em mim, até quando a mesma em mim teimava em
falhar. Pela motivação e orientação constantes ao longo destes anos, dando-me sempre asas
para voar.
Ao meu orientador, Professor Doutor José Potes, por toda a generosa e filantropa transmissão
de conhecimentos, quer no âmbito deste projeto, quer no restante da minha actividade
profissional, enquanto médica veterinária.
O meu agradecimento à Universidade de Évora, que apoiou financeiramente o meu trabalho
através de uma bolsa individual de doutoramento, por sua vez suportada pela Comissão
Europeia, ao abrigo do Sétimo Programa-Quadro, através do projeto RESTORATION –
RESORBABLE CERAMIC BIOCOMPOSITES FOR ORTHOPAEDIC AND
MAXILLOFACIAL APPLICATIONS–, ao abrigo da ação “SME-targeted Collaborative
project”, grant agreement NMP.2011.2.1-1.
Agradeço à Professora Doutora Maria Cristina Queiroga a ajuda preciosa nos trabalhos
decorrentes do projeto, quer fosse nas cirurgias, quer no tratamento das ovelhas internadas no
Hospital Veterinário. Mais agradeço todo o auxílio prestado na correção dos artigos publicados,
uma e outra vez.
Ao Professor Doutor José Lopes de Castro agradeço toda a inestimável amizade e
companheirismo demonstrados desde os primeiros dias de convivência. Muito obrigada pela
sua entusiástica disponibilidade para todas as tarefas que lhe propúnhamos, mesmo quando se
vi
afiguravam fora da sua área técnica. Obrigada ainda pela partilha de saberes e sabores da alma,
uma constante ao longo destes anos.
Ao Professor Doutor Alfredo Franco Pereira, o meu muito obrigada por todo o auxílio prestado
e transmissão de conhecimentos no tratamento e bem-querer das nossas “amigas”, ao longo de
todo este projeto. Não tenho qualquer dúvida que o seu trabalho, conjuntamente com o trabalho
do Professor Lopes de Castro, foi fundamental para o sucesso inolvidável deste projeto.
Ao Professor Doutor Kenneth Dalgarno, da Universidade de Newcastle, e à Doutora Sarrawat
Rehman, da JRI Orthopaedics, pela pronta disponibilidade que demonstraram para nos auxiliar
nos testes mecânicos efetuados no decorrer do estudo ex vivo, tendo que, para isso, abandonar
o conforto dos seus lares e famílias e vir até Portugal.
À Professora Doutora Chiara Vitale-Brovarone, do Politécnico de Turim, e ao Doutor Antonio
Manca, da Unidade Radiológica do Instituto Oncológico Candiolo de Turim, pela amabilidade
que tiveram em corrigir em tempo recorde o artigo “Novel mesoporous bioactive glass/calcium
sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study”, só assim
tornando possível a entrega desta tese “a tempo e horas”.
Ao Professor Doutor António Ramos, na representação do TEMA, da Universidade de Aveiro,
por se ter disponibilizado para nos auxiliar na execução dos testes mecânicos das vértebras,
abrindo-nos a porta da sua “casa” e acompanhando-me nesta minha aprendizagem.
Ao Professor Doutor António Completo, o meu agradecimento pelo convite dirigido à
Professora Doutora Joana Reis e, posteriormente, estendido à minha pessoa, para a submissão
do capítulo “Bone: functions, structure and physiology”, inserido num livro, neste momento em
fase de edição, intitulado de “The bone tissue computational mechanics - Biologic behaviour,
remodelling algorithms and numerical applications”.
vii
O meu agradecimento também ao Pedro Pinto, pelos “rabiscos” perfeitos com que brindou este
trabalho. Fê-los de maneira tão eficaz e célere que até se afigurou fácil.
À Dra. Sónia Lucena, por toda a amizade e companheirismo demonstrados no início desta
aventura.
Aos colegas do Hospital Veterinário da Universidade de Évora e alunos que se encontravam
em atividades hospitalares/ complementares, o meu muito obrigada por todo o auxílio prestado
nas cirurgias e tratamentos dos animais.
À Leonor Pinho e à Margarida Costa, o meu eterno obrigada. Nunca me esquecerei dos nossos
anos no HVUÉ, das nossas estórias, das nossas alegrias e tristezas, convivências e divergências,
e todos os ingredientes que constroem relações duradouras.
O meu desmedido agradecimento ao João Fragoso e à Ana Bota por toda a amizade,
companheirismo, motivação e ajuda disponibilizados desde sempre, quer no âmbito do projeto,
quer fora dele. Vocês fazem parte da minha família de Évora.
O meu eterno obrigada às minhas amigas de coração, que mesmo longe estão perto, sempre à
distância de um telefonema, e que são sempre as primeiras a quem recorro nos momentos mais
difíceis. À Susana, minha companheira de viagem, obrigada pela paciência para ouvires os
meus dilemas quando por vezes os teus se afiguram gigantes. À Ana Isabel, minha amiga desde
sempre, que admiro enquanto mãe e profissional, e que continua a ser uma das minhas
referências quando volto à minha terra-mãe. À minha prima Marta, pelo exemplo de força de
mulher que é e dá. Todas lutamos e almejamos por vidas melhores, mais justas e plenas.
À minha família, de sangue e de coração, que em tempos de necessidade são os primeiros a
acudir.
viii
Aos meus pais, que fizeram de mim quem eu sou, e cujo apoio familiar foi imprescindível para
me dar a serenidade de espírito suficiente e permitir abraçar uma empreitada deste tamanho.
Sem eles, nada disto era possível.
À minha amada irmã, por toda a paciência e ajuda na correção de boa parte destes escritos.
Aos meus amores pequeninos, que sem quererem ou pedirem, se viram privados da mãe, mais
do que, por vezes, a própria desejava. Amo-vos daqui até à Lua e voltar.
Ao Artur, o meu porto seguro, desde sempre e para sempre.
ix
Nota: O conteúdo da presente tese foi parcialmente publicado ou submetido para publicação.
Como tal, os capítulos 2, 3, 4, 5 e 6 encontram-se formatados de acordo com as normas de
formatação e de referenciação bibliográfica das respetivas publicações. A indexação das
secções, figuras e tabelas dos capítulos supracitados aparece de acordo com a ordem original,
precedida pelo número do capítulo correspondente.
xi
Index
Agradecimentos v
Index xi
List of figures xv
List of tables xix
Abbreviations xxi
Abstract xxv
Sumário xxvii
Chapter 1 1
1. Introduction 3
1.1. Context and Objectives 3
1.2. References 8
Chapter 2 11
2. Bone: functions, structure and physiology 13
2.1. Introduction 13
2.2. And yet it moves 14
2.2.1. Bone functions 14
2.2.2. Regulations of bone metabolism (modelling/
remodelling)
16
2.2.2.1. Parathormone (PTH), Vitamin D and
calcitonin
16
2.2.2.2. Growth hormone (GH) 17
2.2.2.3. Sexual hormones and steroids (oestrogen
and testosterone)
18
2.2.2.4. Thyroid hormones 18
2.2.2.5. Leptin (“satiety” hormone) 19
2.2.2.6. Bone Morphogenetic Proteins (BMPs) 19
2.2.2.7. Insulin and insulin-like growth factors
(IGF-1 and IGF-2)
19
2.2.3. Bone structure and mechanical properties 20
2.2.4. The bone matrix 24
2.2.5. Bone cell population 26
2.2.5.1. Osteoblasts 26
2.2.5.2. Osteocytes 26
2.2.5.3. Osteoclasts 28
2.2.6. Bone remodelling and cell interplay 30
2.2.7. Bone mechanotransduction 31
2.2.7.1. The membrane elements, ECM-cell and
cell-cell adhesions
31
2.2.7.2. Primary cilia 34
2.2.7.3. The cytoskeleton 35
2.2.8. Mechanotransduction mechanisms 37
2.2.8.1. Strain, frequency and loading duration 37
2.2.8.2. Bone piezoelectricity 38
xii
2.3.References 39
Chapter 3 59
3. Analgesia em Modelo Animal 61
3.1 Resumo 61
3.2. Introdução 61
3.3. Experimental 64
3.4. Discussão 65
3.5. Conclusões 66
3.6. Agradecimentos 66
3.7. Referências 66
Chapter 4 67
4. Ex vivo Model For Percutaneous Vertebroplasty 69
4.1. Abstract 69
4.2. Introduction 69
4.3. Experimental 70
4.4. Results and Discussion 71
4.5. Conclusions 73
4.6. Acknowledgements 73
4.7.References 74
4.8.DOI References 75
Chapter 5 77
5. Percutaneous vertebroplasty: a new animal model 79
5.1. Abstract 79
5.2. Introduction 80
5.3. Materials and methods 80
5.3.1. Ex vivo model development 80
5.3.1.1. Animal Model 80
5.3.1.2. Micro-CT assessment 80
5.3.1.3. Bone defect creation 80
5.3.1.4. Cement injection 81
5.3.1.5. Mechanical testing 81
5.3.1.6. Statistical analysis 81
5.3.2. In vivo model application 81
5.3.2.1. Animal model 81
5.3.2.2. Anesthetic protocol 81
5.3.2.3. Surgery 82
5.3.2.4. Biomaterial injection 82
5.3.2.5. Post-surgery 82
5.4. Results and discussion 83
5.4.1. Ex vivo model 83
5.4.2. In vivo model 85
5.5. Conclusions 85
5.6. Acknowledgments 87
5.7. Supplementary material 87
5.8. References 87
xiii
Chapter 6 89
6. Novel mesoporous bioactive glass/calcium sulphate cement for
percutaneous vertebroplasty and kyphoplasty: in vivo study
91
6.1. Abstract 92
6.2. Introduction 93
6.3. Materials and methods 95
6.3.1. Cement development and characterization 95
6.3.2. In vivo large model development 95
6.3.3. Assessment of tissue regeneration 96
6.3.3.1. Macrocospic inspection 96
6.3.3.2. Micro-CT assessment 97
6.3.3.3. Histology 98
6.3.3.3.1. Undecalcified histology 98
6.3.3.3.2. Decalcified histology 99
6.3.4. Statistical analysis 100
6.4. Results 100
6.4.1. Cement development and characterization 100
6.4.2. In vivo findings 101
6.4.3. Assessment of tissue regeneration 102
6.4.3.1. Macroscopic 102
6.4.3.2. Micro-CT assessment 103
6.4.3.3. Histology 105
6.4.3.3.1. Undecalcified histology 105
6.4.3.3.2. Decalcified histology 108
6.5. Discussiom 110
6.6. Conclusions 113
6.7. Acknowledgements 113
6.8. Conflicts of interest 113
6.9. References 114
Chapter 7 119
7. Discussion 121
7.1. Analgesia in animal models 121
7.2. Ex vivo model development 124
7.3. In vivo study 127
7.4. References 134
Chapter 8 145
8. Conclusions and Future Perspectives 147
8.1. Conclusions 147
8.2. Future Perspectives 148
8.3. References 150
xv
List of figures
Figure 2.1. Illustration of a long bone structure, showing the distribution of two
different types of lamellar bone: cancellous and cortical compact bone.
21
Figure 2.2. Microphotograph of cortical bone in vertebrae (undecalcified bone
section of sheep vertebra, Giemsa-Eosin, 20x magnification; slide digitalized
using Nanozoomer SQ, Hamamatsu Photonics, Portugal). Haversian systems
are evident, along with organized fibrils. Osteocytes are visible in their lacunae,
in between lamellae.
22
Figure 2.3. Image of vertebral trabecular bone (undecalcified bone section of
sheep lumbar vertebra, Giemsa-Eosin, 1.25x magnification; slide digitalized
using Nanozoomer SQ, Hamamatsu Photonics, Portugal). The picture
illustrates the sponge-like structure of cancellous bone.
23
Figure 2.4. Osteoblasts are round cells that when actively deposing matrix on
bone surfaces show prominent Golgi complexes (on the left, microphotograph,
undecalcified bone section, Giemsa Eosin, magnification 100x). When
quiescent, osteoblasts appear as flat bone lining cells.
26
Figure 2.5. Microphotograph of undecalcified bone section of sheep vertebra,
Giemsa-Eosin, on the left, showing osteocytes (Giemsa-Eosin, 24x
magnification; slide digitalized using Nanozoomer SQ, Hamamatsu Photonics,
Portugal). Some of the canaliculi where cell processes run are evident. The
image on the right illustrates the resulting three-dimensional syncytium.
27
Figure 2.6. On top, microphotograph of TRAP positive osteoclasts in cutting
cone; on bottom, a schematic detail of the ruffled border membrane in direct
contact with bone. This is the resorbing organelle; along its enlarged ruffled
contact surface, proton pumps lower the local pH, dissolving hydroxyapatite.
29
Figure 3.1. Vertebroplastia percutânea com fluoroscopia. 64
Figure 3.2. Vertebroplastia em ovino com monitorização anestésica adequada. 65
Figure 3.3. Ovinos intervencionados em pasto. 65
Figure 4.1. 3D partial reconstructed L4 showing major anatomical landmarks
and PVP access point, with the advocated access angle (large arrow).
71
Figure 4.2. Scan image of a ovine lumbar vertebra showing the wide nutritional
foramen (white arrow).
72
Figure 4.3. 3D partial reconstructed L4 showing the interconnected defect
(white arrow).
72
Figure 4.4. MicroCT scan image of a L4 showing the disrupted vertebral
foramen (white arrow)
73
xvi
Figure 4.5. MicroCT scan image of a L4 showing the artefact caused by
Cerament®.
73
Figure 4.6. Stiffness of vertebrae (groups A-C). 73
Figure 5.1. Three-dimensional (3D) partially reconstructed L4 showing the
instruments’ orientation regarding a transverse plane.
81
Figure 5.2. Three-dimensional (3D) partially reconstructed L4 showing the
instruments’ orientation regarding a frontal plane.
81
Figure 5.3. Anesthetized sheep, with the surgical location (over the lumbar
vertebrae) already clipped and sheep’s position supported with foam wedges.
82
Figure 5.4. Anesthetic monitor providing data from the sheep. 82
Figure 5.5. C-Arm image showing an L4 with an interconnected defect, in a
dorsoventral projection.
82
Figure 5.6. C-Arm image showing Cerament filling the interconnected defects
(in vivo study), in a dorsoventral projection.
83
Figure 5.7. Scan image of an ovine lumbar vertebra showing the wide
nutritional foramen (white arrow).
83
Figure 5.8. 3D partial reconstructed L4 showing the interconnected defect
(white arrow).
83
Figure 5.9. Defect volume of interest (VOI)’s values distribution shown in a
histogram with normal curve (SPSS 22 graph).
84
Figure 5.10. Micro-computed tomography (micro-CT) scan image of an L4
showing the disrupted vertebral foramen (white arrow).
84
Figure 5.11. C-Arm image showing an L4 with defect injected with Cerament
in a dorsoventral projection.
84
Figure 5.12. Micro-computed tomography (micro-CT) scan image of an L4
showing the artefact caused by Cerament.
85
Figure 5.13. (Top) Compression testing of vertebra with Cerament-filled
defect. (Middle) Vertebrae stiffness (Groups A-D) (SPSS 22 graph). (Bottom)
Vertebrae normalized stiffness (Groups A-D) (SPSS 22 graph).
86
Figure 5.14. Micro-Computed tomography (micro-CT) scan image injected
with Cerament, from the in vivo study, showing cement resorption, new bone
formation, and no artefact.
87
Figure 5.15. Micro-Computed tomography (micro-CT) scan image of an L4
injected with Cerament, from the in vivo study, showing a potential cortical
disruption of the vertebral foramen (white arrow).
87
xvii
Figure 5.16. [Video 1] C-Arm image showing Cerament filling the
interconnected defects (in vivo study) in a dorsoventral projection.
87
Figure 6.0. Graphical abstract. Testing a new bioactive composite – Spine-
Ghost – for percutaneous vertebroplasty/kyphoplasty. From the sheep to the
slide.
92
Figure 6.1. Histomorphometric study. Giemsa staining, 0.55x magnification;
the circles are limiting the two areas of interest: A) newly formed trabecular
bone within the defect; B) mature trabecular bone outside the defect. Scale bar
on image.
99
Figure 6.2. Cement characterization. A) Syringe after the injection of Spine-
Ghost, coupled with a 13-gauge vertebroplasty needle and Spine-Ghost cement
extruded on a paper sheet to prove its injectability; B) Spine-Ghost radiopacity
assessment C) FE-SEM micrograph of precipitated HAp on Spine-Ghost after
7 days of immersion in SBF and relative EDS spectrum.
101
Figure 6.3. Macroscopic assessment. A) Instrumentation entry point with a pink
discoloration pointed by the cannula; B) hemivertebra, after sagittal cut, with
cement still evident (large white arrow) and adjoining newly formed bone
(small white arrow); C) macroscopic evidence of cortical disruption of the
vertebral canal.
102
Figure 6.4. Clustered stacked chart presenting micro-CT qualitative evaluation.
Data obtained from the injected vertebrae: group A (n=7) – Cerament™ –, and
group B (n=8) – Spine-Ghost. Legend: ND – not disrupted; D – disrupted.
103
Figure 6.5. Micro-CT post-mortem assessment. Here it can be seen the
reconstructed cross-section images and the 3D rendered models of 2 injected
vertebrae – one from each group –, explanted from the sheep closest to the
mean, when it comes to the trabecular bone mineral densities of the intact
caudal hemivertebrae (BMDCHv): 1) vertebra injected with Spine-Ghost, with a
BMDCHv of 0.45 gcm-3; 2) vertebra injected with Cerament™, with a BMDCHv
of 0.50 gcm-3; a) cross-section image of CHv; b) 3D rendered image of 30
cross-sections of VOICHv; c) cross-section image of the defect; d) 3D rendered
image of 30 cross-sections of VOIDefect.
105
Figure 6.6. Undecalcified Technovitt 9100 sections of two vertebrae. A)
Cerament™ augmented vertebra section (magnification 0.55x) with areas of
lighter pink stain where bone was more recently mineralized (black arrows); B)
Spine-Ghost augmented vertebra section (magnification 0.54x) showing the
affinity of Giemsa to the biomaterial, which stains in shades of blue (white
arrowheads). Both defect areas are fulfilled with an intricate network of
trabeculae, with multiple directions, surrounding and penetrating the remains
of the cements. In contrast, is evidenced the trabecular structure of intact tissue,
mostly parallel to the long axis of the vertebrae. C) Cerament™ augmented
vertebrae section (magnification 0.55x) where empty areas with some cement
present may be seen; it’s also visible the disruption of the cortex of the vertebral
canal (black arrow). This section belongs to same vertebra shown above in
Figure 3. D) Spine-Ghost augmented vertebra section (magnification 0.55x)
where an empty area with some cement present may be seen. This was the only
106
xviii
section from this group where the defect cavity wasn’t filled with trabeculae.
Scale bar on images.
Figure 6.7. Spine-Ghost augmented vertebra section. A) double fluorochrome
labelling obvious, with the calcein green line placed closer to material (large
arrow) than alizarin complexone (small arrow); B) double fluorochrome
marking showing different patterns of bone apposition and bone remodeling,
with alizarin complexone (small arrow) encircling a trabecula. Scale bar on
images.
108
Figure 6.8. Sections of decalcified histology with Mallory and Masson
trichromes staining. A) Spine-Ghost augmented vertebra demineralized section
(Masson Trichrome with aniline blue), 0.5x magnification, showing the
intricated net of trabecular bone within the defect area; B ) and D) Spine-Ghost
and Cerament™ augmented vertebrae demineralized sections, respectively
(Mallory’s trichrome), 10x magnification, showing biomaterial integration into
the trabecular bone structure (arrowheads), blue staining of collagen fibres
(small arrows); C) Cerament™ augmented vertebra demineralized section
(Masson Trichrome with aniline blue), 0.58x magnification. Scale bar on
images.
109
Figure 6.9. Sections of immunohistochemistry of Spine-Ghost augmented
vertebra demineralized sections. A) 100x magnification, anti-osteopontin
antibody, showing DAB stained biomaterial (large arrow); osteocytes, bone
lining cells and cells within bone marrow are also positive (arrowheads). B)
1000x magnification, anti-TRAP antibody. The image shows an area of
cement/bone interface. Scale bar on images.
110
xix
List of tables
Table 4.1. Descriptive analysis for vertebrae groups (n=18) 72
Figure 5.1. Descriptive statistics analysis for vertebrae groups (n=24) 84
Table 6.1. Descriptive analysis of the 3D structural parameters 104
Table 6.2. Descriptive analysis of the Histomorphometric Parameters 107
xxi
Abbreviations
ADHR Autosomal dominant hypophosphatemic rickets
ALP Alkaline phosphatase
AOI Area of interest
ASBMR American Society for Bone and Mineral Research
BAr Bone area
BCIS Bone cement implantation syndrome
BMC Bone mineral content
BMD Bone mineral density
BMP Bone morphogenetic protein
BMU Basic multicellular unit
BRU Bone remodelling unit
BSP Bone sialoprotein
BS/BV Specific surface
BTM Bone turnover marker
BV/TV Relative bone volume
Ca2+ Calcium ions
CaS Calcium sulphate
CHv Caudal hemivertebra
CNS Central nervous system
COX-2 Cyclooxygenase-2
CSR Calcium-sensing receptor
CSH α-Calcium sulphate hemihydrate
CTGF Connective tissue growth factor
DAB Diaminobenzidine
DGAV Direcção Geral de Alimentação e Veterinária
ECG Electrocardiograma
ECM Extracellular matrix
EISA Evaporation-induced self-assembly
FELASA Federation of European Laboratory Animal Science
Associations
FGF23 Fibroblast Growth Factor 23
GABA Gamma-aminobutyric acid
xxii
GH Growth hormone
HA Hydroxyapatite
HVUE Hospital veterinário da Universidade de Évora
IGF Insulin-like growth factor
KP Kyphoplasty
MAR Mineral apposition rate
MBG Mesoporous bioactive glass
M-CSF-1 Macrophage colony stimulating factor-1
Micro-CT Micro-computed tomography
MSC Mesenchymal stem cells
NSAID Non-steroidal anti-inflamatory drug
NO Nitric oxide
ODF Osteoclast differentiation factor
OPG Osteoprotegerin
OPN Osteopontin
PFF Pulsating fluid flow
PG Proteoglycan
PGE2 Prostaglandin E2
Pi Phosphorus ions
PMMA Polymethylmethacrylate
PKP Percutaneous kyphoplasty
PTH Parathormone
PVP Percutaneous vertebroplasty
RANK Receptor activator of nuclear factor-κB
RANKL Receptor activator of nuclear factor κB ligand
RESTORATION Resorbable Ceramic Biocomposites for Orthopaedic and
Maxillofacial Applications
ROI Region of interest
Rt-PCR Reverse transcription-polymerase chain reaction
Runx2 Runt-related transcription factor 2
SBF Simulated body fluid
SMC Smooth muscle cell
SPARC Secreted protein acidic and rich in cysteine
TbN Trabecular number
xxiii
TbSp Trabecular separation
TbTh Trabecular thickness
TGF Transforming growth factor
TIO Tumour-induced osteomalacia
TIVA Total intravenous anaesthesia
TRAP Tartrate-resistant acid phosphatase
TSH Thyroid stimulating hormone
TV Tissue volume
T3 Triiodothyronine
T4 Thyroxine
VBH Vertebral body height
VCF Vertebral compression fracture
VOI Volume of interest
[1,25(OH)2D] 1,25 dihydroxyvitamin D3 [1,25(OH)2D3]
2D Two-dimensional
3D Three-dimensional
xxv
Abstract
The present work aimed to test in vivo a new biomaterial for vertebral augmentation.
Vertebral compression fractures not healing with conservative management are treated
through minimally invasive surgical techniques. Presently, most of the cements used in
percutaneous bone interventions are based on a polymeric non-resorbable matrix. However,
they can present some complications. Calcium suphate-based cements are effective bone
substitutes. Disadvantages include their limited shear and compressive strength.
To go beyond the state of the art, a new bioactive calcium sulphate-based cement was
developed – Spine-Ghost. To test the suitability of the injectable cement for percutaneous
vertebroplasty, a preclinical study was mandatory.
A new large animal model for percutaneous vertebroplasty was developed in sheep. In
the ex vivo model, bone defects were created in the cranial hemivertebrae through a bilateral
modified parapedicular approach, and mechanical tests were performed. The ex vivo model is
reproducible, and safe under physiological loads.
In the in vivo study, two groups of Merino sheep were defined (n=8): a) the control group,
injected with a commercial ceramic cement; and b) the experimental group, injected with Spine-
Ghost. Of the first interventioned animals, two presented cardiorespiratory distress during the
cement injection, and one had mild neurologic deficits in the hindlimbs. All sheep survived and
completed the 6-month implantation period.
After sacrifice, the samples were assessed by micro-computed tomography, histological,
histomorphometric, and immunohistological studies. There was no evidence of cement leakage
into the vertebral foramen. No signs of infection or inflammation were observed. Most
importantly, there was cement resorption and new trabecular bone formation in the bone defects
of all sheep.
The model of percutaneous vertebroplasty is considered suitable for preclinical in vivo
studies, mimicking clinical application.
Spine-Ghost proved to be an adequate material for percutaneous vertebroplasty, with a
biological response identical, if not superior, to the one elicited by the available commercial
control.
xxvii
Desenvolvimento de modelo animal superior para vertebroplastia
percutânea para avaliação in vivo de um novo cimento injetável.
Sumário
O trabalho aqui apresentado teve por objetivo a avaliação in vivo de um novo biomaterial
injetável para vertebroplastia a cifoplastia percutâneas.
As fraturas de compressão vertebral com indicação cirúrgica são tratadas com recurso a
técnicas minimamente invasivas. Presentemente, a maioria dos cimentos utilizados baseiam-se
numa matriz polimérica não reabsorvível. Podem, no entanto, causar algumas complicações.
Os cimentos à base de sulfato de cálcio são substitutos ósseos eficazes, cujas desvantagens
incluem resistência limitada a esforços de corte e compressão.
Um novo cimento bioativo de sulfato de cálcio – Spine-Ghost – foi desenvolvido. Para
testar a sua aplicabilidade na vertebroplastia percutânea, tornou-se imperativo um estudo pré-
clínico.
Para o efeito, um novo modelo animal para vertebroplastia percutânea foi desenvolvido
em ovinos e sujeito a ensaios mecânicos. No modelo ex vivo, foram criados bilateralmente dois
defeitos ósseos interligados, nas hemivértebras craniais, através de uma abordagem
parapedicular modificada. O modelo ex vivo é reprodutível e seguro sob cargas fisiológicas.
No estudo in vivo, definiram-se dois grupos de ovelhas Merino (n=8): a) grupo controlo,
injetado com cimento comercial de base cerâmica; b) grupo experimental, injetado com Spine-
Ghost. Nos primeiros animais intervencionados, dois apresentaram alterações
cardiorrespiratórias durante a injeção de cimento, e um défices neurológicos ligeiros nos
membros pélvicos. Todos os animais sobreviveram e completaram o período de implantação
de 6 meses.
Após a ocisão, as amostras foram avaliadas por microtomografia computorizada,
histologia, histomorfometria e imunohistoquímica. Não se observou derrame de cimento para
o canal vertebral, nem sinais de infeção ou inflamação. Ademais, verificou-se a reabsorção do
cimento e a neoformação de tecido ósseo trabecular no interior dos defeitos ósseos, em todos
os animais.
O modelo de vertebroplastia percutânea é considerado adequado para estudos pré-
clínicos, mimetizando a aplicação clínica.
xxviii
O Spine-Ghost demonstrou ser um biomaterial adequado para vertebroplastia percutânea,
com uma resposta biológica idêntica, se não superior, à elicitada pelo controlo comercial.
Chapter 1
Introduction
Introduction
3
1. Introduction
1.1. Context and objectives
Presently, it’s reasonable to discuss biomedical research in an integrated,
transdisciplinary way. The contemporary “One medicine – One health” concept implies that
multidisciplinary teams of medical doctors, veterinarians, engineers, biologists, among other
experts (Cook & Bal, 2014), share the responsibilities and synchronise local and global
activities to address health problems at the animal-human-environment interfaces, either these
problems concern the whole population or the individual, since a better understanding and a
more adequate control of animal health (often through environmental management) potentially
lead to less human risks (Kaplan et al., 2008). The collaboration between the specialists from
the different scientific areas is the vital key that will result in a better health for humans and
animals in a near future.
The improvement of the living conditions and the aging of the world population, along
with the evolution of medicine, led to the necessity of new approaches to pathologies and the
development of novel therapeutics. Likewise, the evolution of animal healthcare and welfare
and the subsequent raise of the life span of our pets and domestic animals triggered the increase
of disorders commonly associated with geriatrics. These diseases occasionally can be compared
with some human conditions, considering the interspecies similarities. Conditions like cancer,
diabetes, asthma, orthopaedic disorders – like osteoarthritis and osteoporosis –, cardiovascular
diseases, and neurologic diseases – like dementia – are thoroughly studied in companion
animals, as well as in other species. These studies can be of benefit to both animal and human
health, in the sense that they can generate longer, healthier lives for all species.
The testing of innovative biomaterials – for clinical application in orthopaedic surgery
and other areas – in living and sentient animal models in direct benefit to the human race, must
be the subject of careful planning and consideration, given the ethical conflict that arises. There
are several currents of thought within the international scientific community, either for or
against the use of animals. For example, the "Medical Research Modernization Committee"
believes that animal testing is mainly driven by economic interests. Moreover, it says that
animal testing should not be considered a valid method for medical research due to the
anatomical, physiological and pathological differences between human and non-human
(Anderegg, 2002). Bearing this in mind, in order to deepen the knowledge in bone structure and
physiology, and responding to an invitation made by Professor Joana Reis, Chapter 2 was
written. Nonetheless, numerous evidences show that animal testing is inexorable and an
Introduction
4
important way to advance in science, by allowing the observation of the in vivo processes that
otherwise would not be evaluated (Paul, 2001). This theme is succinctly approached in Chapter
3, in a small paper that was presented orally and published in the Proceedings of the “VI
Congresso Nacional de Biomecânica”.
In accordance to the previous insights, the present doctoral research work was integrated
in a multidisciplinary European project – Resorbable Ceramic Biocomposites for Orthopaedic
and Maxillofacial Applications [RESTORATION] – led by the University of Newcastle Upon
Tyne, United Kingdom. This project involved several consortium partners, each with different
tasks – from the development of the biomaterials, through the in vitro testing and the in vivo
testing in the small animal model, until the in vivo testing in the large animal model.
The project’s research team from the University of Évora, coordinated by Professor Joana
Reis, was responsible for the development and application of the large animal models and
ulterior biomaterials testing. Encompassing the different models, a total of 40 Merino sheep
were intervened. All animals were daily assessed and taken care by members of the research
team, for over 6 months. After the sacrifice of the animals, the samples were collected and
processed for ulterior analysis. This work is the result of multiple tasks, such as sheep handling
and care, surgery planning and performance, postoperative animal care, and bone samples
processing and evaluation. For confidentiality reasons imposed on the Consortium partners, in
this thesis the only shown data are those relative to vertebroplasty, even though this was just
one of the models developed. Nevertheless, other surgical models were implemented and
biomaterials assessed.
The entire project was designed and developed respecting the prevailing European
legislation for the protection of animals used for scientific purposes – Directive 2010/63/EU
(Official Journal of the European Union, 2010) –, and the Federation of European Laboratory
Animal Science Associations [FELASA] guidelines (Mähler et al., 2014), which follows the
3R’s recommendations of replacement, reducing and refinement of animals. Consortium
partners’ local laws were also respected; hence, the work regarding the large animal models
was developed under the Portuguese law decree – Decreto-Lei nº 113/2013 (Diário da
República, 2013).
Accordingly, researchers are advised to minimize the use of animals through
Replacement – e.g. with computational models, in vitro studies, studies in invertebrates –;
Reducing – e.g. with proper study’s experimental design, pilot tests, ex vivo studies, and the use
of non-invasive techniques of diagnostic, like ultrasonography, fluoroscopy, radiology and
Introduction
5
fluorochromes, which allows the collection of data from the same animal at different
experimental time points –; and methodology Refinement, in such a way that the pain, suffer
and anxiety inflicted to the animals are reduced to minimum levels. At this time, it is important
to refer the responsibility of all the team researchers, as well as their experience and technical
knowledge as imperative requisites to be able to recognize the distinct behaviours of each
chosen experimental species and to prevent and minimize the negative impact over the
individuals, not only acting when the distress or pain are installed, but also assuming a proactive
attitude and avoiding unnecessary noxious stimulus or manipulations.
In consideration of the foregoing, it is within the 3R’s concepts that the veterinarian role
assumes utmost importance in basic science’s research, through the development of new better
models and other refinement techniques, in a synergy with the other researchers – e.g.
physicians, engineers, and biologists –, which help to minimize the animal usage. This way, in
addition to contribute to the progress of medicine, the veterinarian guarantees the best health
care to the experimental animals. Therefore, it is of utter importance the investment in
veterinary science as a mean to a general medical benefit, diminishing the gap between animal
models and clinical trials and profiting every species (Cook et al., 2010; Vainio, 2012; Baird et
al., 2013).
Finally, the ultimate purpose of the project was to evaluate, in a controlled in vivo study,
the bone response to a novel resorbable calcium sulphate injectable bone cement, developed by
one of the consortium partners for application in percutaneous vertebroplasty. As in the clinical
context, the biomaterial was to be injected in a vertebral body defect through a minimally
invasive procedure. Considering the difficulties and limitations found in previous techniques
and studies (Zhu et al., 2011; Galovich et al., 2011; Benneker et al., 2012; Verron et al., 2014),
the development of a new reproducible and feasible preclinical model for percutaneous
vertebroplasty in sheep was mandatory. The use of sheep is largely accepted due to its
translational features regarding the human species, besides its availability, low cost, easy
handling and good homogeneity when selected for age, race and gender. In addition, sheep are
considered a good model for orthopaedic research due to its anatomical similarities when
compared to the human model, when it comes to the size, weight, skeletal structure, bone
remodelling and biomechanical behaviour of the bone, also consenting the use of some of the
same prosthetic material (Alini et al., 2008; Li et al., 2015; Wancket et al., 2015). Chapter 4
presents an article describing the development of the ex vivo model and chapter 5 the in vivo
application of the previously developed model for the novel biomaterial testing.
Introduction
6
In the past two decades, the development of bone fillers and cements as bone substitutes
for trauma and orthopaedic surgery saw an exponential growth due to the overall gratifying
results (Kopylov et al., 1996; Goodman et al., 1998; Wolfe et al., 1999; Jubel et al., 2004;
Cassidy et al., 2003; Poitout, 2016).
Up to date, most of the cements used in orthopaedic surgery are based on a polymeric
matrix – polymethylmethacrylate (PMMA) (Magnan, 2013; Puoci, 2015). These cements have
been thoroughly used and investigated over the years, mainly for its immediate effect and
safety, but they also present some limitations, such as high polymerization temperatures, low
bioactivity, bioinertia, absence of resorbability, and high elastic modulus. These properties are
related to the – relatively rare – complications that have been documented with the use of
PMMA. For instance, the high polymerization temperatures potentially induce inflammation
and/or necrosis of the neighbour structures; likewise, the formation of new healthy tissue is
hindered by the cement’s the low bioactivity. Another syndrome, known as Bone Cement
Implantation Syndrome (BCIS), is described as a possible complication of PMMA injection
during total hip arthroplasty and vertebroplasty/kyphoplasty. It occurs around the cement
injection, secondary to medullary fat embolism, and is characterized by hypoxia and/ or
hypotension, with or without unexpected loss of consciousness and ultimately death. Finally,
subsequent fractures of the contiguous vertebrae are also described as complications, due to the
cement’s high elastic modulus (Becker et al., 2014; Puoci, 2015).
Synthetic ceramics are widely known and are proved to be safe and effective in bone
substitution, since they are highly biocompatible, resorbable, and osteoconductive, displaying
mechanical properties similar to those of the cancellous bone, with reduced Young’s Modulus,
and a low risk of infection or donor site morbidity (Campana et al., 2014). They also present
low setting temperatures and short setting times. Some disadvantages include their limited shear
and compressive strength, when compared to those of the normal bone (Campana et al., 2014;
Gupta et al., 2015). To overcome these limitations, ceramics are most of the times combined
with other composites (Campana et al., 2014). Numerous different formulations are
commercially available, like different-sized granules, blocks, and injectable pastes.
Furthermore, currently there is an investment in developing new composites that can act as
delivery vehicles for cells, growth factors and antibiotics into fractures (Waselau et al., 2007;
Larsson et al., 2011; Campana et al., 2014).
Calcium sulphate-based injectable ceramics present themselves as good alternatives to
PMMA, concerning vertebroplasty/kyphoplasty. Calcium sulphate offers an effective, low cost
gap filler, by allowing vascular ingrowth and by being resorbable, thus allowing new bone
Introduction
7
formation (Kumar et al., 2013); it’s also known for being osteoconductive and osteoinductive.
Disadvantages include the – sometimes – too fast resorption (6-8 weeks) and secondary
inflammatory reaction (Larsson et al., 2011; Kumar et al., 2013; Campana et al. 2014).
Subsequently calcium sulphate, like other ceramics, is widely used mixed with other
biomaterials.
To progress beyond the state of the art in terms of available calcium sulphate cements for
percutaneous vertebroplasty, a novel bioactive injectable cement for percutaneous
vertebroplasty was developed – Spine-Ghost (Vitale-Brovarone et al., 2015). Spine-Ghost was
implanted into a sheep vertebral defect model. The performance was compared to a commercial
biphasic cement – Cerament™|Spine Support. Cerament™’s application for vertebral
compression fractures (VCFs) has been well documented (Marcia et al., 2014). Spine-Ghost
supported new bone formation into the vertebral body defect, while slowly biodegraded,
suggesting it allows a safe and unpainful medical recovery, thus reducing pain and morbidity.
Chapter 6 presents the final in vivo study and the biological response to the biomaterial.
Introduction
8
1.2. References
Anderegg, C. (2002). “A critical look at animal experimentation”, Medical Research
Modernization Committee.
Baird, A. W., Rathbone, M. J., & Brayden, D. J. (2013). Human: Veterinary Technology Cross
Over. In Long Acting Animal Health Drug Products (pp. 359-375). Springer US.
Benneker, L. M., Gisep, A., Krebs, J., Boger, A., Heini, P. F., & Boner, V. (2012). Development
of an in vivo experimental model for percutaneous vertebroplasty in sheep. Veterinary
and Comparative. Orthopaedics and Traumatololy V.C.O.T., 25 (3), 173-177.
Cassidy, C., Jupiter, J. B., Cohen, M., Delli-Santi, M., Fennell, C., Leinberry, C., Husband, J.,
Ladd, A., Seitz, W. R., & Constanz, B. (2003). Norian SRS cement compared with
conventional fixation in distal radial fractures. A randomized study. Journal of Bone and
Joint Surgery. American volume, 85(11), 2127–2137.
Cook, J. L., Kuroki, K., Visco, D., Pelletier, J. P., Schulz, L., & Lafeber, F. P. J. G. (2010). The
OARSI histopathology initiative–recommendations for histological assessments of
osteoarthritis in the dog. Osteoarthritis and cartilage, 18, S66-S79.
Cook, J. L., & Bal, B. S. (2014). The Clinical Biomedical Research Advances Achievable
Utilizing One Health Principles. In Confronting Emerging Zoonoses (pp. 233-239).
Springer Japan.
Decreto-Lei nº 113/2013, de 7 de Agosto. Diário da República, 1.ª série — N.º 151. Ministério
da Agricultura, do mar, do ambiente e do ordenamento do território, Lisboa.
Directive 2010/63/EU. (2010). Official Journal of the European Union, L276/33-79, ISSN
1725-2601.
Galovich, L. A., Perez-Higueras, A., Altonaga, J. R., Gonzalo Orden, J. M., Barba, M. M., &
Morillo, M. C. (2011). Biomechanical, histological and histomorphometric analyses of
calcium phosphate cement compared to PMMA for vertebral augmentation in a validated
animal model. European Spine Journal, 20(3), 376-382.
Goodman, S. B., Bauer, T. W., Carter, D., Casteleyn, P. P., Goldstein, S. A., Kyle, R. F.,
Larsson, S., Stankewich, C. J., Swiontkowski, M. F., Tencer, A. F., Yetkinler, D. N., &
Introduction
9
Poser, R. D. (1998). Norian SRS cement augmentation in hip fracture treatment.
Laboratory and initial clinical results. Clinic Orthopaedics and Related Research, 348,
42–50.
Gupta, A., Kukkar, N., Sharif, K., Main, B. J., Main, B. J., Albers, C. E., & El-Amin Iii, S. F.
(2015). Bone graft substitutes for spine fusion: A brief review, World Journal of
Orthopaedics, 6(6), 449-456.
Jubel, A., Andermahr, J., Mairhofer, J., Prokop, A., Hahn, U., & Rehm, K. E. (2004). Use of
the injectable bone cement Norian SRS for tibial plateau fractures. Results of a
prospective 30-month follow-up study. Der Orthopäde, 33(8), 919–927.
Kaplan, B., Kahn, L. H., & Monath, T. P. (2008). The brewing storm. Veterinaria italiana,
45(1), 9-18.
Kopylov, P., Jonsson, K., Thorngren, K. G., & Aspenberg, P. (1996). Injectable calcium
phosphate in the treatment of distal radial fractures. The Journal of hand surgery (British
and European Volume), 21(6):768–771.
Larsson, S., & Hannink, G. (2011). Injectable bone-graft substitutes: current products, their
characteristics and indications, and new developments. Injury, 42, S30-S34.
Li, Y., Chen, S. K., Li, L., Qin, L., Wang, X. L., & Lai, Y. X. (2015). Bone defect animal
models for testing efficacy of bone substitute biomaterials. Journal of Orthopaedic
Translation, 3(3), 95-104.
Kumar, C. Y., Nalini, K. B., Jagdish Menon, D. K. P., & Banerji, B. H. (2013). Calcium sulfate
as bone graft substitute in the treatment of osseous bone defects, a prospective study.
Journal of clinical and diagnostic research: JCDR, 7(12), 2926-2928.
Magnan, B., Bondi, M., Maluta, T., Samaila, E., Schirru, L., & Dall’Oca, C. (2013). Acrylic
bone cement: current concept review. Musculoskeletal surgery, 97(2), 93-100.
Mähler, M., Berard, M., Feinstein, R., Gallagher, A., Illgen-Wilcke, B, Pritchett-Corning K,
Raspa M (2014). FELASA recommendations for the health monitoring of mouse, rat,
hamster, guinea pig and rabbit colonies in breeding and experimental units. Laboratory
Animals, 0023677213516312.
Introduction
10
Marcia, S., Boi, C., Dragani, M., Marini, S., Marras, A., Piras, E., Anselmetti, G., & Masala, S.
(2012). Effectiveness of a bone substitute (CERAMENTTM) as an alternative to PMMA
in percutaneous vertebroplasty: 1-year follow-up on clinical outcome, European Spine
Journal, 21(1), 112–118.
Paul, E.F., Paul, J. (eds.) (2001). “Why Animal Experimentation Matters: The Use of Animals
in Medical Research”, Transaction Publishers.
Vainio, O. (2012). Translational animal models using veterinary patients–An example of canine
osteoarthritis (OA). Scandinavian Journal of Pain, 3(2), 84-89.
Verron, E., Pissonnier, M. L., Lesoeur, J., Schnitzler, V., Fellah, B. H., Pascal-Moussellard, H.,
Pilet, P., Gauthier, O., & Bouler, J. M. (2014). Vertebroplasty using bisphosphonate-
loaded calcium phosphate cement in a standardized vertebral body bone defect in an
osteoporotic sheep model. Acta biomaterialia, 10(11), 4887-4895.
Vitale-Brovarone C., Pontiroli L., Novajra G., Tcacencu I., Reis J., Manca A. (2015). Spine-
Ghost: a new bioactive Cement for Vertebroplasty. Key Eng Mat, 631, 43-47.
Wancket, L. M. (2015). Animal Models for Evaluation of Bone Implants and Devices
Comparative Bone Structure and Common Model Uses. Veterinary pathology, 52(5),
842-850.
Waselau, M., Samii, V. F., Weisbrode, S. E., Litsky, A. S., & Bertone, A. L. (2007). Effects of
a magnesium adhesive cement on bone stability and healing following a metatarsal
osteotomy in horses. American Journal of Veterinary Research, 68(4), 370-378.
Wolfe, S. W., Pike, L., Slade, J. F. III, & Katz, L. D. (1999). Augmentation of distal radius
fracture fixation with coralline hydroxyapatite bone graft substitute. The Journal of hand
surgery, 24(4):816–827.
Zhu, X.S., Zhang, Z.M., Mao, H.Q., Geng, D.C., Zou, J., Wang, G. L., Zhang, Z. G., Wang, J.
H., Chen, L., & Yang, H. L. (2011). A novel sheep vertebral bone defect model for
injectable bioactive vertebral augmentation materials. Journal of Materials Science:
Materials in Medicine 22(1), 159-164.
Chapter 2
Bone: functions, structure and physiology
Accepted for publication in July 2016 as a chapter of the book “The bone tissue computational
mechanics - Biologic behaviour, remodelling algorithms and numerical applications”, in the book series
entitled: Lecture Notes in Computational Vision and Biomechanics, Springer.
Bone: functions, structure and physiology
13
Bone: functions, structure and physiology
Maria Teresa Oliveira1 and Joana da Costa Reis2
Abstract The bone is reviewed regarding its functions, regulation, morphological
structure and physiology; addressing how complex, how responsive to external and
internal stimuli, and how intimately intertwined with other organs it is. From
embryogenesis to endocrine regulation and bone remodelling, an overall view is
presented. Special emphasis is given to how cell structure and tissue organization
contribute to the response to mechanical stimuli.
1. Introduction
Bones are dynamic structures. They vary in shape, size and number, and are divided
in axial and appendicular skeleton. Through life they are subjected to loads and
strains that induce their shape, with old matrices being replaced by newly formed
ones. This process is important for maintaining bone volume and strength. In the
case of fractures, bones are capable of healing, as long as stability and alignment
are assured.
It is the entanglement of environment, cell-to-cell interactions and cell-extracellular
matrix interactions that direct and model osteogenesis, bone repair and remodelling.
Mechanical forces are essential in early embryonic development. There is evidence
that morphogenesis is regulated through fluid flow mechanisms and by cellular
contractility. Cells generate tensional forces through contraction of actin-myosin
cytoskeleton filaments, which are transmitted through cadherin-mediated adhesion
sites to neighbour structures, these being either cells or extracellular matrix.
Cohesivity determines morula contraction and the definition of multiple layers -
with the development of endoderm, mesoderm and ectoderm in the blastula - and
thus early embryo shaping (Oster et al., 1983; Takeichi, 1988; de Vries et al., 2004;
1 Maria Teresa Oliveira
Universidade de Évora, Largo dos Colegiais, Évora, email: [email protected] 2 Joana da Costa Reis
Universidade de Évora, Largo dos Colegiais, Évora, email: [email protected]
Bone: functions, structure and physiology
14
Ingber, 2006). The stress-dependent changes in cytoskeletal conformation and cell
shape act locally to regulate cell phenotype, of utter importance are interactions with
the extracellular matrix (Ingber, 2006). Unidirectional fluid flow, dependent on the
specialized motor protein complex dynein, determines organ lateralization and
asymmetry, by causing differences in key molecules expression (such as the TGF-
family signalling molecules) (Collignon et al., 1996, Okada et al., 1999; Cartwright
et al., 2004, Nakamura et al., 2006). Lateralization may also depend on fluid shear,
in the embryo, by acting on a group of non-motile cilia, coupled to calcium
channels; fluid shear may cause the intracellular calcium concentrations to rise and
initiate the cascade of events responsible for lateralization (McGrath et al., 2003).
The mechanical environment is also determinant for vasculogenesis, angiogenesis
(Schmidt et al., 2007; le Noble et al., 2008; Patwari and Lee, 2008), and neuronal
development (Bray, 1979; Dennerll et al., 1989; Anava et al., 2009).
The embryo mesoderm is constituted by spindle or star-shaped cells called
mesenchymal stem cells (MSCs). MSCs are the most pluripotential cells in the
organism, giving rise to different tissues such as the connective tissue, muscle,
cardiovascular tissue and the entire skeletal system. Bone, cartilage, tendons and
ligaments develop through mechanisms of proliferation, migration and
differentiation, but also apoptosis (Carter and Beaupré, 2001).
For a long time, bone was generally regarded as a less interesting organ, but we are
only now starting to address how complex it is in its functions, its responsiveness
to external and internal stimuli, and its intimate intertwining with other organs.
2. And yet it moves
2.1 Bone functions
Bone or osseous tissue is the most rigid and resilient tissue of the body. Constituted
by dense connective tissue, it’s the primary tissue of the skeleton, thus providing
structure, support, and protection to vital organs, like the brain (skull), the spinal
cord (vertebrae), and the heart and lungs (ribs and sternum). Moreover, the vertebrae
participate in the spine shock absorbance – providing adequate load cushioning for
the intervertebral disks (fibrocartilaginous joints) –, whilst long bones, along with
the joints, enable body movement – providing levers for the muscles.
Additionally, bones act as the major source of blood, since haematopoiesis occurs
in their medullary cavity. In infants, the bone marrow of all long bones is capable
of this synthesis. As a person gets older, part of the red marrow turns into yellow
fatty marrow, no longer capable of haematopoiesis. Functional red marrow in adults
is restricted to the vertebrae and the extremities of femur and tibia.
Bone: functions, structure and physiology
15
Bones also have an important role as:
• Mineral storage: mostly calcium (Ca2+), phosphate (Pi), and magnesium;
it plays an important metabolic role, regulating mineral homeostasis
(Bélanger et al., 1968; Zallone et al., 1983; Teti & Zallone, 2009), a
process mediated by many hormones.
• Growth factor storage: insulin like growth factors 1 and 2 (IGF-1 and IGF-
2), transforming growth factor-beta (TGF-β), acidic and basic fibroblast
growth factor, platelet-derived growth factor, and bone morphogenetic
proteins have been isolated from bone matrix (Mohan & Baylink, 1991).
Osteoblasts have been shown to produce many of these growth factors and
their production is regulated by systemic hormones and local mechanical
stress (Baylink et al., 1993).
• Adipose tissue storage (yellow bone marrow as a fatty acid/ energy
reserve) (Rosen et al., 2009; Krings et al., 2012; Suchacki et al., 2016).
• Acid-base balance, as it buffers the blood against excessive pH changes by
absorbing or releasing alkaline salts (Green & Kleeman, 1991; Arnett et
al., 2003; Bushinsky & Krieger, 2015).
• Heavy metal and other foreign elements storage, after detoxification from
the blood, that are, later on, excreted (Roelofs-Iverson et al., 1984; Sharma
et al., 2014).
• Endocrine organ, as it produces two known circulating hormones:
a. Fibroblast Growth Factor 23 (FGF23): produced mainly by
osteocytes (Rhee et al., 2011), but also by osteoblasts (Masuyama et
al., 2006), acts on the kidney to inhibit 1α-hydroxylation of vitamin
D and promote phosphorus excretion in urine (Shimada et al., 2004;
Fukumoto & Martin, 2009; Haussler et al., 2012). FGF23 also inhibits
phosphorus absorption in the intestine, thus regulating inorganic
phosphate metabolism and mineralization (Feng et al., 2006). It is
now acknowledged that the serum calcium concentration regulates
FGF23 production (David et al., 2013), thus making FGF23 into a
calcium-phosphorus regulatory hormone (Lopez et al., 2011;
Rodriguez-Ortiz et al., 2012). Hence, FGF23 excess or deficiency
results in several abnormalities of phosphate metabolism. Excess
FGF23 inhibits renal phosphate reabsorption and 1,25
dihydroxyvitamin D3 [1,25(OH)2D] production, leading to
hypophosphatemia and suppression of circulating 1,25(OH)2D levels
and, ultimately, rachitic changes in bone (Fukumoto & Yamashita,
2007), such as happens in autosomal dominant hypophosphatemic
rickets and osteomalacia (ADHR) and in the paraneoplastic syndrome
called tumour-induced osteomalacia (TIO). In contrast, reductions in
FGF23 cause the syndrome of tumoral calcinosis (Shimada et al.,
2001), characterized by hyperphosphatemia, increased 1,25(OH)2D
and soft tissue calcifications (Lyles et al., 1988; Fukumoto &
Yamashita, 2007). An obligate FGF23 coreceptor was identified –
Klotho– (Urakawa et al., 2006). Klotho is required to activate FGF
Bone: functions, structure and physiology
16
receptors and their signalling molecules. Secreted Klotho suppresses,
by itself, activity of insulin, insulin-like growth factor-1 (IGF-1)
(Kurosu et al., 2005), Wnt (Liu et al., 2007), and TGF-β1 (Doi et al.,
2011) by interacting with these growth factors or their receptors. The
resulting FGF23-Klotho axis represents a specialized system
responsible for the external and internal Ca2+ e Pi balance in the bone,
intestine and kidney. FGF23-Klotho axis works under parathormone
regulation, since parathormone directly promotes FGF23 expression
by osteocytes (Quarles et al., 2012), whereas balance is sought by
FGF23 inhibiting action on parathyroid glands (Ben-Dov et al., 2007;
Krajisnik et al., 2007).
b. Osteocalcin: a protein produced by osteoblasts in bone, major
regulator of insulin secretion by direct action over the pancreatic β-
cell, and increasing sensitivity of peripheral tissues, e.g. muscles and
liver, enhancing glucose uptake and energy expenditure, thus
intervening in glycaemia regulation (Lee & Karsenty, 2008; Ferron
et al., 2008; Ferron et al., 2010; Fulzele et al., 2010); it also acts on
adipocytes to increase adiponectin, thus reducing fat deposition
(Ribot et al., 1987; Reid et al., 1992). Furthermore, studies on clinical
diabetes have shown that blood osteocalcin levels are significantly
lower in diabetics, when compared to non-diabetic controls, and that
these levels are inversely related to fat mass and blood glucose
(Kindblom et al., 2009; Pittas et al., 2009). Lastly, osteocalcin shows
some influence in male fertility, by enhancing testosterone
production by Leydig cells in the testes (Oury et al., 2011).
2.2 Regulation of bone metabolism (modelling/ remodelling)
Bone functions, like (re)modelling and fracture repair, are accomplished by four
types of cells: osteoblasts, bone lining cells, osteocytes and osteoclasts. These
processes are regulated locally by cytokines and growth factors, and systemically
by hormones, neuropeptides and other mediators (Harada and Rodan, 2003;
Karsenty et al., 2009).
2.2.1 Parathormone (PTH), Vitamin D and calcitonin:
The regulation of the bone mineral metabolism (calcium and phosphorus) results
from the interplay between parathormone (PTH), calcitonin, FGF23 and vitamin D.
PTH is released from the parathyroid glands in response to low levels of
extracellular ionized calcium, through the presence of specific cell-surface calcium-
sensing receptor (CSR) on the glands. High levels of PTH cause the increase of the
number of osteoclasts, and resorption of bone matrix, with consequent release of
calcium phosphate and increasing calcaemia. Inversely, low levels of PTH cause
the elevation of osteoblast numbers. It also acts over osteoblasts’ receptors, thus
stimulating osteoblasts to stop synthetizing collagen, and to inhibit the secretion of
stimulating factor by osteoclasts (Calvi et al., 2003). At renal level PTH, stimulated
Bone: functions, structure and physiology
17
by low plasma calcium, inhibits phosphate reabsorption and accelerates its
excretion, stimulates calcium reabsorption, and upregulates a hydroxylase enzyme
(CYP27B1), thus stimulating the final step of 1,25(OH)2 vitamin D3 synthesis
(Murayama et al., 1998).
Circulating hormonal metabolite, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3)
originates an activated complex that enhances several physiological functions,
including intestinal calcium and phosphate absorption, bone phosphate and calcium
resorption, and renal calcium and phosphate reabsorption, which results in a rise in
the blood calcium and phosphate, required for bone passive mineralization of
unmineralized bone matrix to occur (Haussler et al., 1998; Saini et al., 2013).
Additionally, 1,25(OH)2D3 stimulates differentiation of osteoblasts and the
expression of several bone proteins, like bone-specific alkaline phosphatase,
osteocalcin, osteonectin, osteoprotegerin, and other cytokines; and influences the
proliferation and apoptosis of other skeletal cells, including hypertrophic
chondrocytes (Clarke, 2008).
Calcitonin is produced by parafollicular cells of the thyroid, in direct relationship to
extracellular calcium, through the same sensor that regulates the production of PTH.
It inhibits matrix resorption, promotes calcium and phosphate excretion, thus
reducing calcium and phosphate serum levels; calcitonin has an inhibiting effect
over osteoclast mobility and over the secretion of proteolytic enzymes through its
receptor on osteoclasts (Boissy et al., 2002; Hadjidakis & Androulakis, 2006).
2.2.2 Growth hormone (GH):
Growth hormone, or somatotropin, is produced in the anterior hypophysis,
stimulates growth in general, particularly over the epiphyseal cartilage (Isaksson et
al., 1982). It stimulates certain organs, as the liver and the skeleton, to synthetize
somatomedins that have effect over growth, like insulin-like growth factor 1 (IGF-
1) and 2 (IGF-2). Thus, GH stimulates bone formation in two ways: 1) via a direct
interaction with GH receptors on osteoblasts and 2) via an induction of endocrine
and autocrine/paracrine IGF-1 (Ohlsson et al., 1998).
According to Ohlsson et al. (1998), GH action in bone remodelling follows a
“biphasic model”: initially it increases bone resorption with a concomitant bone
loss, which is followed by a phase of increased bone formation. When bone
formation is stimulated more than bone resorption (transition point), bone mass is
increased. A net increase of bone mass will be seen after 12–18 months of GH
treatment in GH deficient adults.
Moreover, a recent study developed in rats showed that GH increased bone growth,
by increasing both periosteal and endocortical bone formation, bone mineral content
(BMC) and bone mineral density (BMD), and that the administration of GH along
with PTH increases bone growth and bone formation, decreases bone resorption,
and has a synergistic effect on increasing bone density and bone mass (Guevarra et
al., 2010).
Bone: functions, structure and physiology
18
2.2.3 Sexual hormones and steroids (oestrogen and testosterone):
Oestrogen is an important regulator of skeletal development and homeostasis, both
via direct and indirect effects over the skeleton (Turner et al., 1994; Prince et al.,
1994). Indirectly it influences, for example, the calcium intestinal absorption (Liel
et al., 1999; ten Bolscher et al., 1999) and secretion (Draper et al., 1997), and the
calcium renal excretion; oestrogen also influences the secretion of PTH (Väänänen
et al., 2005; Robinson et al., 2009). On the other hand, the mechanisms by which
oestrogen acts directly on bone tissue are not completely understood. Nevertheless,
it’s now acknowledged that oestrogen maintains bone homeostasis by inhibiting
osteoblast and osteocyte apoptosis (Tomkinson et al., 1997; Kousteni et al., 2002;
Emerton et al., 2010). Moreover, oestrogen inhibits the osteoclast formation and
activity as well as induces osteoclast apoptosis, thus indirectly preventing excessive
bone resorption (Hughes et al., 1996; Rodan & Martin, 2000; Faloni et al., 2007;
Faloni et al., 2012; Khosla et al., 2012).
Androgens are also important to bone homeostasis, in both sexes. It has been shown
that they stimulate bone formation in the periosteum, through several effects on
osteoblasts and osteoclasts, and by influencing the differentiation of pluripotent
stem cells toward distinct lineages (Wiren & Marcus, 2010). Similarly, to the loss
of oestrogen, the loss of androgen influences the rate of bone remodelling by
removing restraining effects on osteoblastogenesis and osteoclastogenesis, and
creates an imbalance between resorption and formation, as it prolongs the lifespan
of osteoclasts and shortens the lifespan of osteoblasts. Likewise, androgens
maintain cancellous bone mass and integrity, regardless of age or gender (Compston
et al., 2001; Vanderschueren et al., 2004).
2.2.4 Thyroid hormones:
Thyroid hormones (T3 and T4) levels influence bone growth during early
development as well as adult bone turnover and maintenance. They act both
indirectly, by enhancing the effects of growth hormone over tissues, and directly,
by stimulating bone resorption and formation. Hypothyroidism causes impaired
bone formation and growth retardation; inversely, thyrotoxicosis is an established
cause of secondary osteoporosis. Osteoclastic receptors for thyroid hormone have
been demonstrated (Abu et al., 1997). Thus, bone turnover is increased by thyroid
hormones, which is confirmed by increased biochemical markers of bone turnover,
such as osteocalcin and bone-specific alkaline phosphatase (Harvey et al., 1991; El
Hadidy et al., 2011; Waring et al., 2013), and therefore bone loss can occur (Britto
et al., 1994; Hadjidakis & Androulakis, 2006). Recent studies also suggest a
potential direct effect of thyroid stimulating hormone (TSH) on bone (Abe et al.,
2003) and TSH receptors have been found on osteoblasts and osteoclasts.
Furthermore, recombinant TSH showed antiresorptive effects in ovariectomized
rats (Abe et al., 2003; Sun et al., 2008) and lower TSH levels – with no apparent
association with free T4 levels – have been related with hip fracture risk, supporting
the idea that TSH effect on the skeleton may be independent from free T4 (Waring
et al., 2013). Finally, abnormal thyroid hormone signalling has been recognized as
an osteoarthritis’ risk factor (Bassett & Williams, 2016).
Bone: functions, structure and physiology
19
2.2.5 Leptin (“satiety” hormone):
Leptin is produced mainly in adipose tissue, influences bone metabolism via direct
signalling from the central nervous system (CNS). It inhibits osteoclast generation
(Holloway et al., 2002), promotes the decrease in cancellous bone and increase in
cortical bone, thus enhancing bone enlargement (Ducy et al., 2000; Elefteriou et al.,
2004; Hamrick & Ferrari, 2008); it also increases osteoblast number and activity,
acting primarily through the peripheral pathways (Turner et al., 2013). Another
study showed that leptin increases bone mineral content and density, especially at
the lumbar spine (Mantzoros et al., 2011). Leptin also increases the expression of
IGF-1 receptor and IGF-1 receptor messenger RNA (mRNA) within the
chondrocytes and the progenitor cell population, thus acting as a skeletal growth
factor with a direct peripheral effect on skeletal growth centre; it also induces
chondrocytes proliferation and differentiation through specific leptin binding sites
(Maor et al., 2002). Leptin is also a key up regulator of FGF23 secretion (Tsuji et
al., 2010) and it has recently been described as a direct enhancer of parathormone
secretion (Lopez et al., 2016).
2.2.6 Bone Morphogenetic Proteins (BMPs):
BMPs are group of 15 growth factors also known by cytokines, which belong to the
transforming growth factor β (TGF-β) superfamily, with the ability to induce the
formation of bone (Urist et al., 1965) and cartilage (Kobayashi et al., 2005). Bone
formation is a very complex process wherein BMPs play the major role in the
regulation of osteoblast lineage-specific differentiation and later bone formation
(Beederman et al., 2013). Alterations in BMPs activity are often associated to a
great variety of clinical pathologies, like skeletal and extra-skeletal anomalies,
autoimmune, cancer, and cardiovascular diseases (Rahman et al., 2015). BMPs
crosstalk with several other major signalling pathways, e.g. Wnt, Akt/mTOR,
miRNA, among others, having Runx2 as a key integrator (Lin & Hankenson, 2011;
Rahman et al., 2015). Among all BMPs, several authors refer to BMP9 as one of
the most potent BMPs in inducing osteogenic differentiation of MSCs, both in vitro
and in vivo (Kang et al., 2004; Kang et al., 2007; Beederman et al., 2013); moreover,
TGF-β and GH are known to act synergistically with BMP9 to enhance bone
formation (Li et al., 2012; Huang et al., 2012; Rahman et al., 2015). In addition to
BMP9, other BMPs also have shown the ability to induce osteogenesis in vivo, such
as BMP2, BMP6 and BMP7 (Franceschi et al., 2000; Jane et al., 2002; Cheng et al.,
2003), with recombinant human-BMP2 and -BMP7 already being commercialized
with the purpose of enhancing bone healing (Carreira et al., 2014). Contrariwise,
BMP3 is known to be a negative regulator of bone formation (Kang et al., 2004).
2.2.7 Insulin and insulin-like growth factors (IGF-1 and IGF-2):
IGF-1 stimulates chondrocyte proliferation in the growth plate, thus playing a
crucial role in longitudinal bone growth (Lupu et al., 2001). It is also involved in
the formation of trabecular bone, which is essential to bone mineralization (Zhang
et al., 2002). Insulin and IGF-1 have shown to be anabolic agents in osteoblast and
bone development, mainly through the activation of Akt and ERK signalling
Bone: functions, structure and physiology
20
pathways; also, IGF-1, but not insulin, was capable of inducing osteoblasts in vivo
proliferation (Zhang et al., 2012). IGF-1 inhibits the gene expression of osteocalcin,
a marker for differentiating osteoblasts, whilst insulin enhances it. Furthermore,
insulin indirectly enhances Runx2 expression, which is a regulator of osteoblast
differentiation, by inhibiting the expression of Runx2 inhibitor Twist2 (Fulzele et
al., 2010; Zhang et al., 2012). A study with insulin-deficient type I diabetic mice
showed that these mice presented a decreased expression of Runx2 and the Runx2-
regulated genes, like osteocalcin and collagen type I, and a secondary decrease in
bone formation. Bone loss was restored after insulin treatment, which increased
Runx2 expression and the expression of related genes (Fowlkes et al., 2008).
Likewise, IGF-2 potentiates BMP-9-induced osteogenic differentiation and bone
formation (Chen et al., 2010) through PI3K/AKT signalling. Moreover, a recent
study in mice aortas showed that IGF-2 induces the expression of miR-30e, in a
feedback loop, which is a major down-regulator of osteogenic differentiation in
MSCs and smooth muscle cells (SMCs) (Ding et al., 2015).
2.3 Bone structure and mechanical properties
Bone mechanical properties depend on mineralization degree, porosity,
composition and organization of solid matrix. Therefore, the mechanical behaviour
of a whole bone is highly dependent on its properties at a microscale (Rho et al.,
1998).
Bone is composed of 70% inorganic component (of which 95% is hydroxyapatite
and 5% are impurities impregnated in hydroxyapatite), 22% to 25% of organic
component (of which 94-98% is mainly collagen type I and other non-collagen
proteins and 2%-6% are cells) and 5 to 8% is water (Sommerfeldt & Rubin, 2001).
Mature, lamellar bone is morphologically classified in two different types: cortical
or compact and cancellous bone. Cortical and cancellous bone types differ in
structure and functional properties.
The typical structure of a long bone such as the femur or the humerus comprises the
shaft, or diaphysis, and the extremities, or epiphysis (Fig. 1). The diaphysis consists
of a cylinder of compact bone surrounding the central medullary cavity, lined by a
thin layer of connective tissue, the endosteum.
Bone: functions, structure and physiology
21
Fig. 1 Illustration of a long bone structure, showing
the distribution of two different types of lamellar bone:
cancellous and cortical compact bone.
The epiphysis consists of cancellous bone surrounded by a layer of cortical bone.
Within the porous chambers of cancellous bone lays red bone marrow. A layer of
dense connective tissue called periosteum covers the outer surface of the bone,
except for the areas of articulation, covered with hyaline cartilage. The periosteum
is highly vascular and is responsible for appositional bone growth (Van De Graaff,
2001).
Cortical bone (Fig. 2) is a porous mineralized tissue and accounts for approximately
80% of the skeletal mass. It is formed by tightly packed collagen fibrils, forming
concentric lamellae. Each lamella is 2 – 3 μm thick and is arranged in several
discrete layers of parallel fibrils, each layer having a different orientation of fibrils
(Weiner et al., 1999). Apatite crystals (mainly carbonated apatite) are deposited
within and around these fibrils. The lamellae form cylinders containing a hollow
central tube wherein blood vessels and nerves run. The ensemble is called Haversian
system or osteon and it is the microstructural unit of cortical bone. Blood vessels
form a three-dimensional network, from the centre of the osteon (Haversian canals)
and penetrating the cortical bone layer perpendicularly (Volkman’s channels)
(Meyer & Wiesmann, 2006). In between the osteons are remnants of incomplete
osteons, known as interstitial systems or interstitial bone.
Articular
cartilage
Cortical
bone Diaphysis
Epiphysis
Cancellous
bone
Bone: functions, structure and physiology
22
Fig. 2 Microphotograph of cortical bone in vertebrae (undecalcified bone section
of sheep vertebra, Giemsa-Eosin, 20x magnification; slide digitalized using
Nanozoomer SQ, Hamamatsu Photonics, Portugal). Haversian systems are
evident, along with organized fibrils. Osteocytes are visible in their lacunae, in
between lamellae.
Cancellous (or trabecular) bone has a more loosely organized structure and higher
porosity. The lamellae are organized in a parallel manner, forming trabeculae in a
flattened and spongy-like network (Fig. 3). Trabeculae are covered by osteoblasts
and bone-lining cells. Osteoblasts actively depose extracellular matrix (ECM) and
bone-lining cells are in an inactive state.
The metabolic rate of trabecular bone is higher than that of cortical bone, and so are
the remodelling phenomena. The trabecular network is a light structure, of uttermost
importance for load transfer through the bone. This can be clearly seen in epiphyses
and metaphysis of long bones, but also in vertebrae and ribs; trabeculae are
orientated according to routine load bearing direction (Carter & Beaupré, 2001;
Currey, 2003).
Bone: functions, structure and physiology
23
Fig. 3 Image of vertebral trabecular bone (undecalcified bone section of sheep
lumbar vertebra, Giemsa-Eosin, 1.25x magnification; slide digitalized using
Nanozoomer SQ, Hamamatsu Photonics, Portugal). The picture illustrates the
sponge-like structure of cancellous bone.
The bone exhibits a stress-strain response of sequential elastic and plastic responses.
The slope of the elastic region is called the elastic or Young’s modulus, and is a
measure of the intrinsic stiffness of the material.
Bone can withstand a maximum level of stress, corresponding to a maximum strain,
before a fracture occurs. In its elastic region, no permanent damage is caused to the
bone structure; if the stress increases, a gradual transition to a plastic response
occurs. Elastic and plastic regions of the stress-strain curve are separated by the
yield point. Post-yield deformations are permanent and may include lesions at
cement lines, cracks and trabecular fractures. Crack formation and growth is a mean
to dissipate energy. In the elastic phase of the curve energy builds up, whilst in the
plastic region the energy levels are lowered by damage to the bone structure, and
ultimately, by fracture. Generally speaking, the higher bone mineral density, the
higher the stiffness. However, a higher Young’s modulus corresponds to less
ductility and higher brittleness (Turner, 2006). Long bones, as other natural
composite tubular structures, combine great strength and fatigue resistance against
axial compression forces with minimum weight. However, much of the strain
measured in bone is due also to bending moments (Sommerfeldt et al., 2001).
Normal loading of long bones combines compressive and bending efforts, causing
in humans a large variation of strains, up to 400 to 2000 μstrains or even as high as
4000 μstrains (Duncan & Turner, 1995; Burr et al., 1996; Sommerfeldt et al., 2001).
Strains are local deformations and 1 μstrain corresponds to 1 μm deformation per
meter of length (Duncan & Turner, 1995).
Bone: functions, structure and physiology
24
However, due to difficulties to measure bone mechanical properties at a
microstructural level, in the various possible directions, further knowledge about
the actual strains bone cells are subjected to and able to sense in vivo is necessary.
Both cancellous and compact bone show anisotropic behaviour, i.e. the Young’s
modulus depends on the direction of the load, due to the deliberate direction of
lamellae (Heinonen et al., 1995; Carter & Beaupré, 2001). In long bones,
fundamental for load bearing and leverage, stiffness along the long axis was
favoured. Vertebral bodies function like shock absorbers and flexibility was
preferred and achieved through the cancellous porous architecture (Carbonare et al.,
2005).
Woven or primary bone is present in growth, fracture healing and in certain diseases
(like Paget’s disease). Cells and ECM are laid randomly. During intramembranous,
endochondral or rapid appositional bone growth, woven bone is formed. In large
animals (whether reptiles, birds or mammals), woven bone with large vascular
canals is rapidly deposited in the subperiosteal region. The canals are lined with
osteoblasts that slowly will deposit lamellae, until the canal has a reduced diameter;
the resulting structure is a primary Haversian system or osteon. The random
distribution of its components explains woven bone’s isotropy.
2.4 The bone matrix
The mineral phase comprises most of bone mass, but the organic component is
essential for normal function. The collagen network is coated by hydroxyapatite
crystals.
Structure and biomechanical properties of the bone depend on collagen. Three long
peptide sequences, arranged helicoidally, constitute the collagen I molecule.
Collagen goes through several enzymatic modifications whilst still within the
osteoblast (Young, 2003). Further cross-linking within and between collagen
molecules occurs after leaving the cell. Diseases such as osteogenesis imperfecta
are caused by collagen chain mutations (Young, 2003; Bodian et al., 2009). As
reviewed ahead in this chapter, the triple tropocollagen units are aligned in fibrils,
displaying a permanent dipole moment. Therefore, collagen acts as a piezoelectric
and pyroelectric material, and as an electromechanical transducer (Fukada &
Yasuda, 1964; Noris-Suárez et al., 2007). The piezoelectric properties of collagen
and the native polarity of the molecules are associated with the mineralization
process. Under compression, negative charges on the collagen surface become
uncovered and entice calcium cations, which are followed by phosphate ions (Noris-
Suárez et al., 2007; Ferreira et al., 2009).
Non-collagenous proteins, present in much smaller quantities, are also paramount
for normal bone function and properties. Some of these proteins are shortly
introduced: osteopontin, fibronectin, osteonectin and bone sialoprotein.
Bone: functions, structure and physiology
25
Osteopontin (OPN) is a non-collagenous secreted glycoprotein, present in bone
matrix, where it binds both to cell surface and to hydroxyapatite. It is mainly
produced by proliferating pre-osteoblasts, osteoblasts and osteocytes, but also by
fibroblasts, osteoclasts and macrophages (Ashizawa et al., 1996; Perrien et al.,
2002). OPN intervenes in cell migration, adhesion, and survival in many cell types.
OPN production is known to be increased in association with mechanical loading
(Harter et al., 1995; Perrien et al., 2002), and its deficiency significantly diminishes
bone fracture toughness and causes anomalous mineral distribution (Fisher et al.,
2001; Thurner et al., 2010).
Fibronectin mediates a large number of cellular interactions with the ECM, also
playing an important part in cell adhesion, migration, growth and differentiation. It
is vital for vertebrate development and is mainly synthesized by osteoblast
precursors and mature bone cells, but can also be produced at distant sites (such as
the liver), and enter systemic circulation. Some studies suggested that only
circulating fibronectin exerts effects on the bone matrix (Young, 2003; Bentmann
et al., 2010). Fibronectin binds to collagen and may act as an extracellular scaffold
that binds and facilitates interactions of BMP1 with substrates that include
procollagen and biglycan (Huang et al., 2009). Fibronectin may also be vital for
MSC differentiation into osteoblastic lineage (Linsley et al., 2013).
Osteonectin or SPARC (secreted protein acidic and rich in cysteine) is one of the
most abundant non-collagenous protein present in bone matrix. It has a strong
affinity to collagen and mineral content; osteonectin knockout mice suffer from
osteopenia in consequence of low bone turn-over, and osteoblasts and osteoclasts
defective function. Changes in osteonectin encoding gene have also been linked to
idiopathic osteoporosis and osteogenesis imperfecta (Rosset & Bradshaw, 2016).
Thrombospondin-2 is another matricellular protein that also exerts its effects on
osteoblast proliferation and function, being involved in MSCs adhesion and
migration; it has also influence on angiogenesis and tumour growth (Delany et al.,
2000; Delany & Hankenson, 2009).
Bone sialoprotein (BSP) is a highly glycosylated and sulphated phosphoprotein that
is found almost exclusively in mineralized connective tissues (Ganss et al., 1999).
BSP knockout mice present reduced amounts of cortical bone and higher trabecular
bone mass with very low turn-over. BSP defective mice maintain unloading bone
response, as opposite to OPN knockout mice (Malaval et al., 2008).
Proteoglycan (PG) encoding genes are expressed both in skeletal and non-skeletal
tissues but with stronger expression in bone, joints and liver; in bone PG encoding
PrG4 gene expression is under PTH control (Novince et al., 2012); structure and
localization is varied and PG perform a large number of biological functions. PGs
help structuring the bone tissue by regulating collagen secretion and fibril
organization. PGs also modulate cytokines and growth factors biological activity in
bone (Lamoureux et al., 2007).
Bone: functions, structure and physiology
26
2.5 Bone cell population
Mature bone comprises three main types of cells: osteoblasts, osteocytes and
osteoclasts.
2.5.1 Osteoblasts
Osteoblasts derive from MSCs, sharing a common background with chondrocytes,
myoblasts and fibroblasts. Osteoblasts differentiate under the influence of a variety
of hormones and cytokines and the local mechanical environment (Nakamura,
2007). These cells, when active, are characteristically round, with specific features
consistent with their secretory role (Fig. 4).
Fig. 4 Osteoblasts are round cells that when actively deposing matrix on bone surfaces show
prominent Golgi complexes (on the left, microphotograph, undecalcified bone section, Giemsa Eosin,
magnification 100x). When quiescent, osteoblasts appear as flat bone lining cells.
These cells present very evident Golgi complexes and endoplasmic reticulum (with
multiple vesicles and vacuoles) especially ostensive during matrix secretion and
early stages of mineralization (Palumbo, 1986).
Osteoblasts can also remain on inactive bone surfaces as flat bone lining cells, with
scarce cell organelles evident. Increased levels of expression of pro-collagen,
osteopontin and osteocalcin are present during osteoblast maturation process; bone
sialoprotein seems to be more strongly expressed at intermediate phases of
differentiation (Bellows et al., 1999; Bellows & Herschel, 2001). Osteoblast
differentiation is impaired when gap junctions are inhibited, suggesting
communication to neighbouring cells is essential for differentiation (Schiller et al.,
2001). Osteoblasts produce non-mineralized matrix – osteoid – that becomes
gradually mineralized, wherein they become trapped and some differentiate into
osteocytes. Osteoblast differentiation is influenced by 1,25(OH)2D3 and mechanical
stimuli, amongst other factors (van der Meijden et al., 2016).
2.5.2 Osteocytes
Osteocytes are the most abundant cells of bone by far, comprising more than 90%
of the osteoblast lineage and contributing to both bone formation and resorption
(van Bezooijen et al., 2004; Bonewald et al., 2007). They are fully differentiated
osteoblasts embedded in mineralized matrix, sitting in the osteocytic lacunae.
Bone: functions, structure and physiology
27
Lacunae are located between adjacent lamellae and are interconnected to
surrounding lacunae by a canalicular system (Fig. 5). Osteocytes’ long cell
processes lay within the canaliculi. The extremities of the dendritic processes
connect osteocytes amongst themselves, also establishing contact with osteoblasts
and bone lining cells (Carter & Beaupré, 2001; Knothe Tate et al., 2004; Jiang et
al., 2007). The resulting functional syncytium shares a common environment
(Knothe Tate, 2003).
Osteocytes have no matrix secretion functions; however, they are responsible for
sensing changes in the bone structure and commanding bone remodelling.
Pre-osteoblasts and osteoblasts are less responsive to fluid shear stress than
osteocytes. Mechanosensitivity seems to increase during differentiation although it
is now known that osteoblasts are able to modulate response to mechanical stimulate
in function of its intensity (Sommerfeldt et al., 2001; Kringelbach et al., 2015).
Osteocyte functions include maintaining bone matrix and mechanosensing (Burger
& Klein-Nulend, 1999; Mullender et al., 2004). Sensation of electrical signals may
be one of the functions of osteocytes, and electrical signals mediated by osteocytes
may regulate the cell behaviour in bone tissue (Huang et al., 2008). The same
mechanical stimulus may cause a different response in osteocytes according to their
cell body shape (van Oers et al., 2015).
Osteocytes early response to mechanical loading results in vesicular ATP release
by exocytosis, tuned according to the magnitude of the stimulus (Kringelbach et al.,
2015).
Osteocytes also respond to mechanical stimuli by producing various messengers’
molecules such as nitric oxide and prostaglandins, in particular prostaglandin E2
Fig. 5 Microphotograph of undecalcified bone section of sheep vertebra, Giemsa-Eosin, on the left,
showing osteocytes (Giemsa-Eosin, 24x magnification; slide digitalized using Nanozoomer SQ, Hamamatsu Photonics, Portugal). Some of the canaliculi where cell processes run are evident. The
image on the right illustrates the resulting three-dimensional syncytium.
Bone: functions, structure and physiology
28
(PGE2) (Klein-Nulend et al., 1998; Cherian et al., 2003; Mullender et al., 2004).
This response is dependent on function of stretch-activated calcium channels
(Rawlinson et al., 1996). PGE2 has anabolic effects, stimulating osteoblast activity
and new bone formation (Jee et al., 1990). Nitric oxide inhibits bone resorption, by
suppressing osteoclast formation and increasing the expression of osteoprotegerin
(Kasten et al., 1994; Fan et al., 2004).
The life span of osteocytes is highly variable but is probably associated with the rate
of bone remodelling, depending on mechanical and environmental factors such as
hormones; osteocytes apoptosis may be inhibited or induced by a variety of
physiological, pathological conditions and by biological effectors such as
hormones, without being necessarily accompanied by an increase in
osteoclastogenesis (Tomkinson et al., 1997; Lee et al., 2004; Plotkin et al., 2005;
Hirose et al., 2007; Jika et al., 2013).
Osteocyte density is intimately related to bone architecture and thus to its
mechanical behaviour (Metz et al., 2003). Young osteocytes are polarized toward
the mineralization front, just like osteoblasts are, with the nucleus remaining in
close to vessels (Palumbo, 1986). As lamellar bone matures, the osteocytes tend to
spread their processes perpendicularly to the longitudinal axis of trabeculae and
long bones and appear as flattened cells. In immature bone, plump osteocytes with
randomly distributed processes predominate (Hirose et al., 2007).
2.5.3 Osteoclasts
Osteoclasts are multinucleated cells, of the same lineage as macrophages and
monocytes (Fig. 6).
Like macrophages, they have the ability to merge and form multinucleated cells,
and to phagocytise (Rubin & Greenfield, 2005). The cell precursor may differentiate
into either an osteoclast or a macrophage, and the differentiation path depends on
the precursor cell being exposed to a receptor activator of several ligands (Receptor
Activator of Nuclear factor κB Ligand - RANKL, osteoprotegerin (OPG) and
osteoclast differentiation factor - ODF) or to colony-stimulating factors related to
immune system (Nakagawa et al., 1998; Asagiri & Takayanagi, 2007; Takayanagi,
2008).
The osteoclast presents distinctive functional features:
• osteoclasts are able to attach firmly to the bone surface, isolating the area
under the cell membrane from its surroundings; the membrane domain
responsible for the isolation of the resorption site is called sealing zone
(Marchisio et al., 1984; Väänänen & Horton, 1995);
• osteoclasts acidify the mineral matrix by the action of protons pumps at
the ruffled border membrane, a resorbing organelle; the lowering of the pH
causes the dissolution of the hydroxyapatite crystals (Baron et al., 1985;
Blair et al., 1989; Rousselle & Heymann, 2002);
• osteoclasts are capable of synthetizing and secreting enzymes such as
tartrate-resistant acid phosphatase (TRAP) and cathepsins in a directional
manner; the proteases secreted by osteoclasts cleave the organic matrix;
Bone: functions, structure and physiology
29
through the combined action of lysosome enzymes, matrix
metalloproteinases and the pH reduction, bone is resorbed (Littlewood-
Evans et al., 1997; Vääräniemi et al., 2004);
• osteoclasts can phagocytise the resultant organic debris and minerals,
removing them from the resorption lacunae, through a transcytosis process
(Salo et al., 1997; Yamaki et al., 2005).
Fig. 6 On top, microphotograph of TRAP positive osteoclasts in cutting cone; on bottom, a schematic
detail of the ruffled border membrane in direct contact with bone. This is the resorbing organelle; along its enlarged ruffled contact surface, proton pumps lower the local pH, dissolving
hydroxyapatite.
The bone resorption process begins with differentiation and recruitment of
osteoclast precursors, which merge and originate matured multinucleated bone-
resorbing osteoclasts. To initiate resorption the osteoclast attaches to the bone
matrix via the interaction of integrins with matrix proteins, like osteopontin and
bone sialoprotein, previously laid down by osteoblasts (Väänänen & Horton, 1995).
However, bone resorption is only attainable if appropriate matrix mineralization
exists (Chambers & Fuller, 1985).
Bone: functions, structure and physiology
30
2.6 Bone remodelling and cell interplay
The dynamic process of bone resorption and formation occurs on both cortical and
trabecular bone, and arises in response to mechanical loading, calcium serum levels
and a wide array of paracrine and endocrine factors.
The bone remodelling process depends on the coordinate actions of osteoblasts,
osteoclasts, osteocytes and osteoblast-derived bone lining cells, along with other
cells, such as macrophages and immune cells, in what is known as the “Basic
Multicellular Unit” (BMU) or “Bone Remodelling Unit” (BRU). In the BMU, the
amount of bone destructed by osteoclasts is equal to the amount produced by
osteoblasts. The balance between osteoblastic and osteoclastic activity is known as
coupling. Osteoclasts can resorb bone in the absence of osteoblasts and bone is
formed in the absence of osteoclasts, signifying that osteoclasts and osteoblasts
within the BMU may function under the control of other cell types (Corral et al.,
1998; Kong et al., 1999). This scenario is reinforced by the fact that cells from the
osteoblast lineage express receptors for cytokines and other local secreted factors
that stimulate osteoclast formation (Suda et al., 1999). The BMU may be inhibited
by old age, drugs, endocrine, metabolic or inflammatory diseases.
Independently from the triggering stimulus, osteoclast formation depends on
RANKL. Osteoblasts express membrane-bond RANKL and this regulatory
molecule interacts with a receptor (receptor activator of nuclear factor-κB - RANK),
expressed on the surface of osteoclast precursors. The RANK activation by
RANKL is essential for fusion of the osteoclast precursor cells and osteoclast
formation (Miyamoto & Suda, 2003). Whilst some studies suggest down-regulation
of the RANKL expression by osteoblasts under mechanical stimulation, others
describe up-regulation of RANKL expression under similar mechanical conditions
(Fan et al., 2006; Kreja et al., 2008).
RANKL-bond (that is reported to increase) and soluble RANKL (reported to
decrease) are differentially secreted by osteoblasts in response to different
mechanical stimuli regimens (Kim & Lee, 2006). Human osteoblasts subjected to
strains varying from 0.8 to 3.2% respond to higher strain with increased expression
of osteocalcin, type I collagen and Cbfa1/Runx2, and to lower strain magnitudes
with an increase of alkaline phosphatase activity (Zhu et al., 2008).
Cells belonging to the osteoblast-cell lineage also produce OPG. OPG is soluble
and blocks the interaction between RANKL and RANK (it acts as a decoy receptor
for RANKL), thus inhibiting osteoclast formation. Osteoblasts, in addition, secrete
macrophage colony stimulating factor-1 (M-CSF-1); this factor promotes osteoclast
precursor proliferation and expression of RANK by these same precursor cells (Arai
et al., 1999; Romas et al., 2002), demonstrating how intimate is the interplay of
these different cell types.
Osteoblast-like cells cultures mechanically stimulated may respond by a decrease
in the production of OPG, without change in the RANKL production, with
consequent increase in the ratio of RANKL/OPG. In an in vivo scenario, this would
translate into increased bone remodelling. However, subjecting osteoclast-like cells
Bone: functions, structure and physiology
31
to the same mechanical stimuli regimen, decreased TRAP and with one-minute
stimulation at 0.3 Hz frequencies, a decrease in cell fusion and resorption activity
was observed (Kadow-Romacker et al., 2009).
RANKL expression by osteoblast-lineage cells is enhanced when microdamage
within the bone matrix occurs. Microdamage may occur in pathological conditions
or under physiological bone loading. The existence of microcracks is sensed by
osteocytes, and may induce osteocyte apoptosis, as suggested by several studies;
osteocyte apoptosis may also be induced by disuse and is closely correlated with
higher bone remodelling levels (Mori & Burr, 1993; Bentolila et al., 1998; Verborgt
et al., 2002; Noble et al., 2003; Mann et al., 2006; Martin, 2007, Jika et al., 2013).
Pulsating fluid flow (PFF)-treated osteocyte cultures condition the culture medium,
inhibiting osteoclast formation and decreasing in vitro bone resorption. These
effects have not been detected in the medium from PFF-treated fibroblast cultures
(Tan et al., 2007).
Consequently, osteocytes regulate osteoclastogenesis and osteoclast activity,
through soluble factors and messenger molecules. In osteocytes subjected to PFF,
nitric oxide is involved in the up and down regulation of at least two apoptosis-
related genes (Bcl-2 and caspase-3, with antiapoptotic protective and pro-apoptotic
functions, respectively) (Tan et al., 2008). Nitric oxide (NO) is a second messenger
molecule produced in response to mechanical stimulation of osteoblasts and
osteocytes, and other cell types such as endothelial cells, with a large variety of
biological functions (Smalt et al., 1997; Zaman et al., 1999; Rössig et al., 2000;
van’T Hof, 2001).
Other pathways are relevant for osteoblasts, osteocytes and osteoclasts interweaved
regulation, such as the Notch signalling pathway. In osteocytes, the Notch receptors
activation induces OPG and Wnt signalling, decreasing cancellous bone
remodelling and inducing cortical bone formation (Canalis et al., 2013).
2.7 Bone mechanotransduction
Bone mechanotransduction, essential in health and disease states, is not fully
understood, despite the many advances. The transduction elements include ECM,
cell-cell adhesions, cell-ECM adhesions, membrane components, specialized
surface processes, nuclear structures and cytoskeleton filaments.
2.7.1 The membrane elements, ECM-cell and cell-cell adhesions
Cell membrane-associated mechanotransduction mechanisms depend on the
integrity of the phospholipid bilayer. Mechanotransduction pathways are disrupted
if membrane cholesterol is depleted, inhibiting the response to hydrostatic and fluid
shear stress (Ferraro et al., 2004; Xing et al, 2011). Cytoskeleton actin
polymerization and assembly is influenced by membrane cholesterol levels
(Klausen et al., 2006; Qi et al., 2009). More recently, it has been proposed that actin
polymerization during synaptic vesicle recycling is influenced by vesicular
Bone: functions, structure and physiology
32
cholesterol, but not plasma membrane cholesterol, as shown by a study wherein the
inhibition of actin polymerization by the extraction of vesicular cholesterol resulted
in the dispersal of synaptic vesicle proteins (Dason et al., 2014). But even with an
intact membrane, if integrin binding is impaired, actin cytoskeleton will not
reorganize in response to shear stress (Radel & Rizzo, 2005).
The integrins are a superfamily of cell adhesion receptors that bind to ECM ligands,
cell-surface ligands, and soluble ligands. Integrins are heterodimers of non-
covalently associated 18α and 8β subunits, in mammals, that can combine to
generate 24 different receptors with different binding properties and different tissue
distribution (Hynes et al., 2002; Barczyk et al. 2010). These subunits possess an
extracellular portion with several domains, able to bind to large multi-adhesive
ECM molecules, which in turn bind to other ECM molecules, growth factors,
cytokines and matrix-degrading proteases (Barczyk et al., 2010). Integrins were first
acknowledged as bridging the ECM and the cell cytoskeleton, including the actin
cytoskeleton but also the intermediate filament network, essentially vimentin and
laminin (Nievers et al., 1999). Recruitment of vimentin has been shown to depend
on integrin β3 subunits, further pointing out the relationship between the various
cytoskeletal elements and integrins (Bhattacharya et al., 2009). The cytoplasmatic
portions of integrin β subunit are able to bind to talin, which can also directly bind
to vinculin and actin filaments (Cram & Schwarzbauer, 2004). On the other hand,
integrin α4 subunit binds to paxillin (Brown et al., 1996), a protein that integrates
focal adhesions.
Integrins allow communication between structures within and out of the cell, in a
bi-directional way. The inside-out signalling brings the integrin extracellular
domains into the active conformation. In the outside-in pathway, receptor clustering
and redistribution of cytoskeletal and signalling molecules occurs into focal
adhesions at the sites of cell-ECM contact (Cram & Schwarzbauer, 2004; Geiger et
al., 2009). Recently, it has been demonstrated that the connective tissue growth
factor (CTGF), which is a matrix protein, enhances osteoblast adhesion (via αvβ1
integrin) and cell proliferation, by inducing cytoskeletal reorganization and Rac1
activation (Hendesi et al., 2015). Another study suggested that another matrix
protein – osteoactivin – also plays a role in the regulation of osteoblast
differentiation and function, by stimulating alkaline phosphatase (ALP) activity,
osteocalcin production, nodule formation, and matrix mineralization (Moussa et al.,
2015). Finally, α5β1 integrin interacts with its high affinity ligand CRRETAWAC,
enhancing the Wnt/β-catenin signalling mechanism to promote osteoblast
differentiation independently of cell adhesion (Saidak et al., 2015).
Initial adhesions to substrates are characterized by small dot-like or punctuate areas
at the edges of lamellipodia, usually known as focal complexes. The mature
elongated form of cell-matrix adhesion, referred to as focal adhesions or focal
contacts, is associated with bundles of actin and myosin (stress fibres). There is a
specialized form of focal contact, in which integrin binds to fibronectin fibrils and
tensin but with low levels of tyrosine kinases (Katz et al., 2000; El-Hoss et al.,
2014). Most focal adhesions contain several types of signalling molecules like
Bone: functions, structure and physiology
33
tyrosine phosphatases and tyrosine kinases and adaptor proteins (Parsons, 1996;
Yamada & Geiger, 1997; Geiger et al., 2009; Teo et al., 2013).
Force application to bound integrins activates the GTPase Rho, causing myosin II
contraction, making the cell apply tension to the substrate; another one of the Rho
targets, when active, ensures by itself the development of focal contacts (Riveline
et al., 2001).
Cell adhesion and mechanical stimulation depend on integrin mediation (Carvalho
et al., 1998). Forces applied to integrin receptors cause local adhesion proteins to
be recruited and the cell adapts by making the integrin-cytoskeleton linkages more
rigid (Riveline et al., 2001). Different signalling pathways are triggered by sensed
stress through integrin receptors. Sequential expression of integrin ligands
(osteopontin, fibronectin and bone sialoprotein) in response to mechanical
stimulation of osteoblasts has been described (Carvalho et al., 2002). Bonds
between integrin and ligands becomes stronger in the presence of cell tension
(Friedland et al., 2009).
Osteocytes are highly specialized in their interaction with ECM; osteocyte cell
bodies express β1 integrins while cell processes express β3 integrins, the latter in a
punctuate distribution similar to matrix attachment sites but involving far fewer
integrins, being essential for mechanically induced bone formation (Phillips et al.,
2008; McNamara et al., 2009; Litzenberger et al., 2009 Litzenberger et al., 2010).
Thi et al. identified the cell processes as the mechanosensory organs in osteocytes
(Thi et al., 2013). Recently, it has been demonstrated that integrin αvβ3 is essential
for the maintenance of osteocyte cell processes and also for mechanosensation and
mechanotransduction by osteocytes (Haugh et al., 2015). These conclusions are
supported by another study, wherein cortical osteocytes from knockout mice were
depleted of β1 integrin, but the unloading of the hindlimb did not reduce cortical
bone size and strength, in contrast to wild type mice (Phillips et al., 2008). Another
study showed that ERK1/2 activation by strain prevented osteocyte apoptosis,
however it required the integrin/cytoskeleton/Src/ERK signalling pathway
activation (Plotkin et al., 2005).
Apart from integrin, other membrane proteins are responsible for conduction of
mechanical stimuli. Cadherins, which connect to the cytoskeleton, mediate force-
induced calcium influx (Gillespie & Walker, 2001; Kazmierczak et al., 2007), and
participate also in the Wnt/β-catenin pathway, potentially interfering in
osteoblastogenesis and bone formation (Marie et al., 2013). In osteoblasts,
mechanical load applied to β1-integrin subunit results in calcium influx
(Pommerenke et al., 2002), independently from gap junctions (Saunders et al.,
2001). Also in osteoblasts, it has been suggested that GPI-anchored proteins may
play an important role in osteoblastic mechanosensing, by demonstrating that the
overexpression of GPI-PLD, an enzyme that can specifically cleave GPI-anchored
proteins from cell membranes, inhibits flow-induced intracellular calcium
mobilization and ERK1/2 activation in MC3T3-E1cells (Xing et al., 2011). Ephrins
(ligands) and Ephs (receptors) contribute to cell-cell interactions between
osteoclasts and osteoblasts, helping to regulate bone resorption and formation, and
Bone: functions, structure and physiology
34
appear to be necessary for hMSC differentiation (Tamma & Zallone, 2012; Matsuo
& Otaki, 2012). Lastly, another family of proteins – galectins –, are also involved
in regulating osteogenesis; for example, Gal-3, which is expressed both by
osteocytes and osteoblasts, plays a significant role as a modulator of major
signalling pathways, such as Wnt signalling, MAPK pathway, and PI3K/AKT
pathway (Nakajima et al., 2016); Gal-8 induces RANKL expression by osteoblasts
and osteocytes, osteoclastogenesis and bone mass reduction in mice (Vinik et al.,
2015); and Gal-9 induces osteoblast differentiation through the CD44/Smad
signalling pathway in the absence of bone morphogenetic proteins (BMPs)
(Tanikawa et al., 2010).
Gap junctions are transmembrane channels that connect the cytoplasm of
neighbouring cells. Small metabolites, ions and signalling molecules like calcium
and cAMP pass through these channels, since molecular weight must be lower than
1 kDa (Flagg-Newton et al., 1979; Steinberg et al., 1994). Gap junctions are
essential for bone mechanosensation and thus for bone remodelling, since in
osteoblastic cells fluid flow induces PGE2 production, dependent on intact gap
junctions; if these are disturbed, PGE2 production does not occur (Saunders et al.,
2001; Saunders et al., 2003). Mice lacking Cx43 gap junctions in osteoblasts and/or
osteocytes exhibit increased osteocyte apoptosis, endocortical resorption, and
periosteal bone formation (Bivi et al., 2012).
2.7.2 Primary cilia
In different cell types, different structures ensure recognition of mechanical stimuli;
kidney epithelial cells possess a sole microvillar projection on their apical surface
(primary cilia). The same kind of structure was described in osteoblasts and
osteoblast-like cells (Myers et al., 2007; Delaine-Smith et al., 2014). Primary cilia
originate in the centrosome and project from the surface of bone cells; its deflection
during flow indicates that they have the potential to sense fluid flow. These cilia
deflect upon application of 0.03 Pa steady fluid flow and recoil after cessation of
flow (Xiao et al., 2006; Malone et al., 2007).
In bone, primary cilia translate fluid flow into cellular responses, independently of
Ca2+ flux and stretch-activated ion channels (Malone et al., 2007). Moreover,
recently it has been demonstrated in vitro that, apart from mediating the up-
regulation of specific osteogenic genes, primary cilia are also important mediators
of oscillatory fluid flow-induced extracellular calcium deposition, thereby playing
an essential role in load-induced mineral matrix deposition (Delaine-Smith et al.,
2014). Finally, two in vivo studies using knockout mice of Kif3a, which results in
defective primary cilia, showed that primary cilia are essential for the ability of pre-
osteoblasts to sense strain-related mechanical stimuli at a healing bone-implant
interface and induce differentiation into bone-forming osteoblasts (Leucht et al.,
2013) and MSCs to sense mechanical signals and enhance osteogenic lineage
commitment in vivo (Chen & Hoey et al., 2016).
Shear stresses resulting from fluid flow cause calcium influx through
mechanosensitive channels (Nauli et al., 2003; Praetorius et al., 2003). Calcium
Bone: functions, structure and physiology
35
influx occurs is osteoblasts in response to oscillatory fluid flow (Saunders et al.,
2001).
Finally, concerning osteocytes, there are still many conflicting information
regarding in vivo expression of cilia. Their role as mechanosensors depends on the
type and number of cells with cilia, and on the local mechanical environment. The
low incidence of primary cilia in osteocytes (about 4%) may indicate that cilia
function as mechanosensors on a selected number of cells or that cilia function in
concert with other mechanosensing mechanisms (Coughlin et al., 2015).
2.7.3 The cytoskeleton
Specific transmembrane receptors couple the cell cytoskeleton network to the ECM.
Integrins connect to the cytoskeleton through focal adhesions that contain actin-
associated proteins such as talin, vinculin, paxillin and zyxin. Both paxillin and
zyxin belong to a group of LIM domain proteins, which have been suggested as
mechanoresponders responsible for regulate stress fibres assembly, repair, and
remodelling in response to changing forces (Smith et al., 2014). The transfer of
forces across the network of microfilaments, microtubules and cell adhesions allows
that focused stresses applied to the surface membrane affect distant cellular sites
such as the mitochondria and nucleus, or the plasma membrane on the opposite side
of the cell. The transmission of strain towards the ECM stimulates structural
changes at a higher organization level, making it stronger (Wang et al., 1993; Wang
& Ingber, 1994).
The cell deformation in consequence of an applied stress does not correspond to the
predicted behaviour of an isotropic viscoelastic material; the interior of the cell, and
thus the cytoskeleton, is anisotropic. The complex network of microtubules and
microfilaments and the way this network spreads and is connected to the point of
applied force, may result in structures away from the load application point to be
further displaced than closer ones; displacements towards the origin of the
compressive stimulus are also possible. Behaving in an anisotropic way, cells are
able to respond to an external force according to its magnitude and direction (Hu et
al., 2003; del Álamo et al., 2008; Silberberg et al., 2008). An intact cytoskeleton is
necessary for the rendering of applied forces into mitochondria movements. Since
mitochondria are semi-autonomous organelles, highly dynamic, the distress caused
by mechanical stimulus exerts biological effects on their function (Silberberg et al.,
2008), both in health and disease (Koike et al., 2015).
Nonetheless, there is evidence that mechanical properties of the ECM affect the
behaviour of cells from osteoblastic lineage, with mature focal adhesions and a more
organized actin cytoskeleton associated with more rigid substrates, suggesting that
controlling substrate compliance enables control over differentiation (Khatiwala et
al., 2006) and that this influence on differentiation is independent from protein
tethering and substrate porosity (Wen et al., 2014).
Other factors are determinant for cell fate. A recent in vitro study showed similar
patterns in cell growth, differentiation, and gene expression in human osteoblasts
Bone: functions, structure and physiology
36
and endothelial cells, when implanted in two different ceramic scaffolds – beta
tricalciumphosphate and calcium-deficient hydroxyapatite –, with different
chemical and physical characteristics, which suggested that the interaction between
different cell types and scaffold materials is crucial for growth, differentiation, and
long-term outcomes of tissue-engineered constructs (Ritz et al., 2016). Moreover,
biomaterial surface modification with chitosan enhances osteoblast mechanical
response and induces favourable structural organization for the implant integration
(Moutzouri & Athanassiou, 2014). Lately, it has also been highlighted the
importance of surface roughness of the biomaterials in osteogenic differentiation,
and demonstrated the contribution of specific integrin subunits in mediating cell
response to different materials (Olivares-Navarrete et al., 2015); additionally, the
application of synthetic integrin-binding peptidomimetic ligands (αvβ3- or α5β1-
selective) to a titanium graft enhanced cell adhesion, proliferation, differentiation
and ALP expression in in vitro osteoblast-like cells, resulting in a higher
mineralization on the surfaces coated with the ligands (Fraioli et al., 2015).
The biochemical nature of the substrate, its rigidity and spatial organization are
recognized by cells through signalling from molecular complexes that are integrin-
based.
In most anchorage-dependent cells, cell spreading on ECM is required for cell
progression and growth; increasing cytoskeletal tension results in cell flattening, a
rise in actin bundling and bucking of microtubules. Spread cells are able to transfer
most of the load to the ECM.
The cell shape is influenced by how the cytoskeleton organizes its elements and it
is determinant for cell function. For example, osteocyte morphology and alignment
differ in two types of bone, fibula and calvaria, probably due to different mechanical
loading patterns, which influence cytoskeletal structure and thus cell shape (Vatsa
et al., 2008). Also, osteocyte and lacunae morphology may vary in pathological
bone conditions, and these morphological variations may be an adaptation to the
differences in matrix properties and thus, different bone strain levels under similar
stimulus (van Hove et al., 2009). Osteocyte morphology is characterized by long
dendritic-like processes, cell shape also assumed by osteoblast MC3T3 cells
cultured in 3D; however, differences in cytoskeleton elements in the processes of
these two cell types may indicate differences in function; microtubules are
predominant on osteoblasts’ processes while actin ensures integrity of osteocytes’
cytoplasmatic projections (Murshid et al., 2007). In agreement with section 2.7.1,
osteocyte sensitivity to mechanical load applied to the microparticles varies
between those attached to the cell bodies and those to the processes: a much smaller
displacement of the second ones is needed to cause an intracellular calcium influx
that rapidly propagates to the cell body; if local stimulus is applied to the cell body,
the reaction is slower and a higher displacement is needed to elicit the calcium
transient (Adachi et al., 2009).
Osteoblasts, osteoid-osteocytes and mature osteocytes have different mechanical
properties. The elastic modulus is higher on the cell peripheral area than in the
nuclear region; as bone cells mature, the elastic modulus decreases, both in the
Bone: functions, structure and physiology
37
peripheral and nuclear regions. These differences in elastic modulus probably
depend on the amount of actin filaments, as it has been shown in other cell types.
Furthermore, focal adhesion area is smaller in mature osteocytes, when comparing
to osteoblasts. If peptides containing RGD sequence are added to culture medium,
both the focal adhesion area and the elastic modulus of osteoblasts decreases whilst
osteocytes remain unaffected (Sugawara et al., 2008).
2.8 Mechanotransduction mechanisms
Although there is emergent gathered knowledge on mechanotransduction
mechanisms in distinct cells and tissues, the multitude of cellular structures,
messenger substances, environmental factors and organ levels of organization,
makes it extremely complex to understand how responses are composed at cellular,
organ and living organism levels.
2.8.1 Strain, frequency and loading duration
Strain magnitude, frequency and loading duration influence bone remodelling.
Wolff defined the mathematical equations that allowed prediction of trabeculae
orientation and thickness (Prendergast & Huiskes, 1995). Turner enunciated three
essential rules critical for bone remodelling:
1. Dynamic loading determines remodelling;
2. Short periods of loading quickly trigger a response; prolonging
loading times any further diminishes the magnitude of bone cell
response;
3. Bone cells have memory and accommodate to routine loading,
diminishing the amplitude of the answer triggered by a same repeated
stimulus.
In in vivo studies, increasing loading frequency decreased the threshold for
osteogenesis and increased strain-related bone deposition (Hsieh & Turner, 2001).
Cortical bone adaptation is nonlinear when it comes to frequency response; the
changes in geometry are more significant with increasing load frequency, with a
plateau for frequencies beyond 10 Hz (Warden & Turner, 2004). Bone formation
also depends on strain magnitude (Mosley et al., 1997), along with the number of
loading cycles at low frequencies (Cullen et al., 2001). The skeletal adaptation is
also conditioned by strain distribution. Unusual strain distribution will quickly
trigger an osteogenic response, as suggested by the extensive periosteal and
endosteal bone proliferation described by Rubin & Lanyon (1984) in a study
conducted in poultry. Rest periods between loading cycles also intensify osteogenic
response (Srinivasan et al., 2007) and maximize cell response (Pereira &
Shefelbine, 2014).
Other mechanisms apart from direct deformation of cells, are involved in bone cells
mechanical stimulation. Peak strains may be considerable high in long bones during
strenuous exercise, but strains as low as 0.15% are enough to ensure osteoblast
Bone: functions, structure and physiology
38
recruitment in vivo (Rubin & Lanyon, 1984). Due to bone’s architectural
complexity, it is impractical to measure with precision the separate actual
deformation of a cell.
Bone is a porous structure and the canalicular system within it is filled with fluid.
The fluid flows within the canalicular system wherein the osteocytes extend their
cell processes, and it is displaced by loading. Simulation of load levels as the ones
described as inducing significant osteogenesis, has produced higher shear stresses
due to fluid flow in the canaliculi, reinforcing osteocyte processes as the main
mechanosensing organ in mature bone cells (Verbruggen et al., 2014).
Fluid also carries electrically charged particles. When bone is deformed, a thin layer
of fluid with particles with opposite charge to that of the matrix and bone cells is
formed (Gross & Williams, 1982); when a non-uniform mechanical load is applied
to the bone structure, the freely moving ions in the fluid move away from the matrix.
The fluid flow phenomenon thus resulting is common to other biological tissues,
but not only. The fact that fluid flow changes interfacial chemistry has been
acknowledged; for example, the flow of fresh water along the surfaces disturbs the
equilibrium of dissolved ions, changing the surface charge and the molecular
orientation of the water at the interface (Waychunas, 2014). Likewise, in bone, the
displacement of the electrically charged fluid creates an electrical field aligned with
the fluid flow. This causes an electrical potential and the phenomenon is known as
strain generated bone streaming potential (Gross & Williams, 1982; Frijns et al.,
2005; Hong et al., 2008). The density of matrix fixed charges influences the
magnitude of the generated streaming potential (Iatridis et al., 2003), so the
mechanosensory ability along bone may vary and ultimately, influence dynamic
stiffness.
2.8.2 Bone piezoelectricity
Fukada and Yasuda first described bone piezoelectrical properties, in the 50’s. In
dry bone samples submitted to compressive load, an electrical potential was
generated, a phenomenon explicated by the direct piezoelectric effect (Fukada &
Yasuda, 1957). In connective tissues, such as bone, skin, tendon and dentine, the
dipole moments are probably related to the collagen fibres, composed by strongly
polar protein molecules aligned (Fukada & Yasuda, 1964; Elmessiery, 1981;
Halperin et al., 2004). The proper architecture of bone, with neatly aligned lamellae,
contributes for potentials’ generation along bone structure (Elmessiery, 1981).
The polarization generated per unit of mechanical stress, that is, the bone
piezoelectric constants, changes with moisture content, maturation state (immature
bone has lower piezoelectric constants than mature bone) and architectural
organization (altered areas, such as the ones with bone neoplasia osteosarcoma,
show lower values) (Marino & Becker, 1974). Piezoelectric constants are higher in
dentin when moisture contents increase and behave in an anisotropic fashion; tubule
orientation strongly effects piezoelectricity (Wang et al., 2007). Initially, it was also
argued whether or not wet bone behaved as a piezoelectric material; it is now
Bone: functions, structure and physiology
39
accepted that certainly it does (Fukada & Yasuda, 1957; Marino & Becker, 1974;
Reinish & Nowick, 1975).
Bone piezoelectrical properties have been related to bone remodelling processes,
and to streaming potential mechanisms (Ramtani, 2008; Ahn & Grodzinsky, 2009).
Due to its potential impact on therapeutic approaches to bone remodelling and
healing, more and more research is being conducted.
The use of a piezoelectric substrate and the piezoelectric converse effect were tested
in vitro and in vivo with promising results, mechanically stimulating osteoblastic
cells and bone, suggesting the potential for clinical application (Frias et al, 2010;
Reis et al, 2012). The development of new synthetic scaffolds, like for instance
hydroxyapatite/ barium titanate, with high piezoelectric coefficients that could
enhance bone remodelling, is a new emergent field for the bone tissue engineering
industry (Zhang et al., 2014).
Acknowledgements This work has been partially supported by the European Commission under the 7th Framework Programme through the project RESTORATION, grant agreement CP-TP 280575-2. The
support from Medtronic Spine LLC Company, Portugal in supplying surgical material is gratefully
acknowledged. The support from Hamamatsu Photonics in supplying the Nanozoomer SQ is also gratefully acknowledged. The authors would also like to thank Mr. Pedro Félix Pinto for the artwork
included in this chapter.
3. References 1. Abe E, Marians RC, Yu W et al (2003) TSH is a negative regulator of
skeletal remodelling. Cell 115:151–62.
2. Abu EO, Bord S, Horner A et al (1997) The expression of thyroid hormone
receptors in human bone. Bone 21:137-142.
3. Adachi T, Aonuma Y, Tanaka M et al (2009) Calcium response in single
osteocytes to locally applied mechanical stimulus: Differences in cell
process and cell body. J Biomech 42:1989-1995.
4. ADHR Consortium (2000) Autosomal dominant hypophosphataemic
rickets is associated with mutations in FGF23. Nat Genet 26: 345–348.
5. Ahn AC & Grodzinsky AJ (2009) Relevance of collagen piezoelectricity
to “Wolff’s Law”: A critical review. Med Eng Phys 31:733-741.
6. Anava S, Greenbaum A, Ben Jacob E et al (2009) The Regulative Role of
Neurite Mechanical Tension in Network Development. Biophys J
96:1661-1670.
7. Arai F, Miyamoto T, Ohneda O et al (1999) Commitment and
differentiation of osteoclast precursor cells by the sequential expression of
c-Fms and receptor activator of nuclear factor κb (RANK) receptors. J Exp
Med 190:1741-1754.
8. Arnett, T (2003) Regulation of bone cell function by acid–base balance
Proc Nutr Soc 62:511-520.
Bone: functions, structure and physiology
40
9. Asagiri M & Takayanagi H (2007) The molecular understanding of
osteoclast differentiation. Bone 40:251-264.
10. Ashizawa N, Graf K, Do YS et al (1996) Osteopontin is produced by rat
cardiac fibroblasts and mediates A (II)-induced DNA synthesis and
collagen gel contraction. J Clin Invest 98:2218-2227.
11. Barczyk M, Carracedo S & Gullberg D (2010) Integrins. Cell Tissue Res
339:269-80.
12. Baron R, Neff L, Louvard D & Courtoy PJ (1985) Cell-mediated
extracellular acidification and bone resorption: evidence for a low pH in
resorbing lacunae and localization of a 100-kD lysosomal membrane
protein at the osteoclast ruffled border. J Cell Biol 101:2210-2222.
13. Bassett JD & Williams GR (2016) Role of thyroid hormones in skeletal
development and bone maintenance. Endocr Rev, 37:135-187.
14. Baylink DJ, Finkelman RD & Mohan S (1993) Growth factors to stimulate
bone formation. J Bone Miner Res 8:S565-S572.
15. Beederman M, Lamplot JD, Nan G et al (2013) BMP signaling in
mesenchymal stem cell differentiation and bone formation. J Biomed Sci
Eng 6: 32–52.
16. Belanger LF (1969) Osteocytic osteolysis. Calcif Tissue Res 4:1–12.
17. Bellows CG & Heersche JNM (2001) The frequency of common
progenitors for adipocytes and osteoblasts and of committed and restricted
adipocyte and osteoblast progenitors in fetal rat calvaria cell populations.
J Bone Miner Res 16:1983-1993.
18. Bellows CG, Reimers SM & Heersche JNM (1999) Expression of mRNAs
for type-I collagen, bone sialoprotein, osteocalcin, and osteopontin at
different stages of osteoblastic differentiation and their regulation by 1,25
dihydroxyvitamin D3. Cell Tissue Res 297:249-259.
19. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V et al (2007) The parathyroid
is a target organ for FGF23 in rats. J Clin Invest 117:4003-4008.
20. Bentmann A, Kawelke N, Moss D et al (2010) Circulating fibronectin
affects bone matrix, whereas osteoblast fibronectin modulates osteoblast
function. J Bone Miner Res 25:706-715.
21. Bentolila V, Boyce TM, Fyhrie DP et al (1998) Intracortical remodelling
in adult rat long bones after fatigue loading. Bone 23:275-281.
22. Bhattacharya R, Gonzalez AM, DeBiase PJ et al (2009) Recruitment of
vimentin to the cell surface by β3 integrin and plectin mediates adhesion
strength. J Cell Sci 122:1390-1400.
23. Bivi N, Condon KW & Allen MR (2012) Cell autonomous requirement of
connexin 43 for osteocyte survival: consequences for endocortical
resorption and periosteal bone formation. J Bone Miner Res 27:374-389.
24. Blair HC, Teitelbaum SL, Ghiselli R & Gluck S (1989) Osteoclastic bone
resorption by a polarized vacuolar proton pump. Science 245:855-857.
25. Bodian DL, Chan T-F, Poon A et al (2009) Mutation and polymorphism
spectrum in osteogenesis imperfecta type II: implications for genotype-
phenotype relationships. Hum Mol Gen 18:463-471.
Bone: functions, structure and physiology
41
26. Boissy P, Saltel F, Bouniol C et al (2002) Transcriptional activity of nuclei
in multinucleated osteoclasts and its modulation by calcitonin.
Endocrinology 143:1913-1921.
27. Bonewald LF (2007) Osteocyte messages from a bony tomb. Cell Metab.
5:410–411.
28. Bray D (1979) Mechanical tension produced by nerve cells in tissue
culture. J Cell Sci 37: 391-410.
29. Brighton CT, Sennett BJ, Farmer JC et al (1992) The inositol phosphate
pathway as a mediator in the proliferative response of rat calvarial bone
cells to cyclical biaxial mechanical strain. J Orthop Res 10:385-393.
30. Britto JM, Fenton AJ, Holloway WR et al (1994) Osteoblasts mediate
thyroid hormone stimulation of osteoclastic bone resorption.
Endocrinology 134:169–176.
31. Brown MC, Perrotta JA & Turner CE (1996) Identification of LIM3 as the
principal determinant of paxillin focal adhesion localization and
characterization of a novel motif on paxillin directing vinculin and focal
adhesion kinase binding. J Cell Biol 135:1109-1123.
32. Burger EH & Klein-Nulend J (1999) Mechanotransduction in bone—role
of the lacuno-canalicular network. FASEB J 13:101-112.
33. Burr DB, Milgrom C, Fyhrie D et al (1996) In vivo measurement of human
tibial strains during vigorous activity. Bone 18:405-410.
34. Bushinsky DA & Krieger NS (2015) Acid–base balance and bone health.
In Nutrition and bone health (pp. 335-357). Springer New York.
35. Calvi LM, Adams GB, Weibrecht KW et al (2003) Osteoblastic cells
regulate the haematopoietic stem cell niche. Nature 425:841-846.
36. Canalis E, Adams DJ, Boskey A et al (2013) Notch signaling in osteocytes
differentially regulates cancellous and cortical bone remodelling. J Biol
Chem 288:25614-25625.
37. Carbonare LD, Valenti MT, Bertoldo F, et al (2005) Bone
microarchitecture evaluated by histomorphometry. Micron 36, 609-616.
38. Carreira AC, Lojudice FH, Halcsik E et al (2014) Bone morphogenetic
proteins facts, challenges, and future perspectives. J Dent Res 93:335-45.
39. Carter DR & Beaupré GS (2001) Skeletal tissue histomorphology and
mechanics. Skeletal function and form. Cambridge, United Kingdom.
40. Cartwright JHE, Piro O & Tuval I (2004) Fluid-dynamical basis of the
embryonic development of left-right asymmetry in vertebrates. Proc Natl
Acad Sci U S A 101:7234-7239.
41. Carvalho RS, Schaffer JL & Gerstenfeld LC (1998) Osteoblasts induce
osteopontin expression in response to attachment on fibronectin:
Demonstration of a common role for integrin receptors in the signal
transduction processes of cell attachment and mechanical stimulation. J
Cell Biochem 70:376-390.
42. Carvalho RS, Bumann A, Schaffer JL & Gerstenfeld LC (2002)
Predominant integrin ligands expressed by osteoblasts show preferential
regulation in response to both cell adhesion and mechanical perturbation.
J Cell Biochem 84:497-508.
Bone: functions, structure and physiology
42
43. Chambers TJ & Fuller K (1985) Bone cells predispose bone surfaces to
resorption by exposure of mineral to osteoclastic contact. J Cell Sci
76:155-165.
44. Chen JC, Hoey DA, Chua M et al (2016) Mechanical signals promote
osteogenic fate through a primary cilia-mediated mechanism. FASEB J
30:1504-1511.
45. Chen JH, Liu C, You L & Simmons CA (2010) Boning up on Wolff's Law:
mechanical regulation of the cells that make and maintain bone. J Biomech
43:108-118.
46. Cheng H, Jiang W, Phillips FM et al (2003) Osteogenic activity of the
fourteen types of human bone morphogenetic proteins (BMPs). J Bone
Joint Surg Am 85:1544-1552.
47. Cherian PP, Cheng B, Gu S et al (2003) Effects of mechanical strain on
the function of gap junctions in osteocytes are mediated through the
prostaglandin EP2 receptor. J Biol Chem 278:43146-43156.
48. Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc
Nephrol 3:S131-S139.
49. Collignon J, Varlet I & Robertson EJ (1996) Relationship between
asymmetric nodal expression and the direction of embryonic turning.
Nature 381:155-158.
50. Compston JE (2001) Sex steroids and bone. Physiol Rev 81:419-447.
51. Corral DA, Amling M, Priemel M et al (1998) Dissociation between bone
resorption and bone formation in osteopenic transgenic mice. Proc Natl
Acad Sci U S A 95:13835-13840.
52. Coughlin TR, Voisin M, Schaffler MB et al (2015) Primary cilia exist in a
small fraction of cells in trabecular bone and marrow. Calcif Tissue Int
96:65-72.
53. Cram EJ & Schwarzbauer JE (2004) The talin wags the dog: new insights
into integrin activation. Trends Cell Biol 14:55-57.
54. Cullen DM, Smith RT & Akhter MP (2001) Bone-loading response varies
with strain magnitude and cycle number. J Appl Physiol 91:1971-1976.
55. Currey JD (2003) The many adaptations of bone. J Biomech 36:1487-
1495.
56. Dason JS, Smith AJ, Marin L & Charlton MP (2014) Cholesterol and F‐actin are required for clustering of recycling synaptic vesicle proteins in
the presynaptic plasma membrane. J Physiol 592:621-633.
57. de Vries WN, Evsikov AV, Haak BE et al (2004) Maternal β-catenin and
E-cadherin in mouse development. Development 131:4435-4445.
58. del Álamo JC, Norwich GN, Y-shuan JL et al (2008) Anisotropic rheology
and directional mechanotransduction in vascular endothelial cells. Proc
Natl Acad Sci U S A 105:15411-15416.
59. Delaine-Smith RM, Sittichokechaiwut A & Reilly GC (2014) Primary cilia
respond to fluid shear stress and mediate flow-induced calcium deposition
in osteoblasts. FASEB J 28:430-439.
60. Delany AM, Amling M, Priemel M et al (2000) Osteopenia and decreased
bone formation in osteonectin-deficient mice. J Clin Invest 105:915-923.
Bone: functions, structure and physiology
43
61. Delany AM & Hankenson KD (2009) Thrombospondin-2 and
SPARC/osteonectin are critical regulators of bone remodelling. J Cell
Commun Signal, 3:227-238.
62. Dennerll TJ, Lamoureux P, Buxbaum RE & Heidemann SR (1989) The
cytomechanics of axonal elongation and retraction. J Cell Biol 109:3073-
3083.
63. Ding W, Li J, Singh J et al (2015) miR-30e targets IGF2-regulated
osteogenesis in bone marrow-derived mesenchymal stem cells, aortic
smooth muscle cells, and ApoE−/− mice. Cardiovasc Res, cvv030.
64. Doi S, Zou Y, Togao O et al (2011) Klotho inhibits transforming growth
factor-β1 (TGF-β1) signaling and suppresses renal fibrosis and cancer
metastasis in mice. J Biol Chem 286:8655-8665.
65. Draper CR, Edel MJ, Dick IM et al (1997) Phytoegens reduce bone loss
and bone resorption in oophorectomized rats. J Nut 127:1795-1799.
66. Ducy P, Amling M, Takeda S et al (2000). Leptin inhibits bone formation
through a hypothalamic relay: a central control of bone mass. Cell
100:197–207.
67. Duncan RL & Turner CH (1995) Mechanotransduction and the functional
response of bone to mechanical strain. Calcif Tissue Int 57:344-358.
68. El Hadidy M, Ghonaim M, El Gawad S & El Atta MA (2011) Impact of
severity, duration, and etiology of hyperthyroidism on bone turnover
markers and bone mineral density in men. BMC Endocr Disord 11.1:1.
69. El-Hoss J, Arabian A, Dedhar S & St-Arnaud R (2014) Inactivation of the
integrin-linked kinase (ILK) in osteoblasts increases mineralization. Gene,
533, 246-252.
70. Elefteriou F, Takeda S, Ebihara K et al (2004) Serum leptin level is a
regulator of bone mass. Proc Natl Acad Sci U S A 101:3258-3263.
71. Elmessiery MA (1981) Physical basis for piezoelectricity of bone matrix.
IEE Proc A 128:336-346.
72. Emerton KB, Hu B, Woo AA et al (2010) Osteocyte apoptosis and control
of bone resorption following ovariectomy in mice. Bone 46:577-583.
73. Faloni APS, Sasso-Cerri E, Katchburian E & Cerri PS (2007) Decrease in
the number and apoptosis of alveolar bone osteoclasts in estrogen-treated
rats. J Periodont Res 42:193–201.
74. Faloni APDS, Sasso‐Cerri E, Rocha FRG et al (2012) Structural and
functional changes in the alveolar bone osteoclasts of estrogen‐treated rats.
J Anat 220:77-85.
75. Fan X, Roy E, Zhu L et al (2004) Nitric oxide regulates receptor activator
of nuclear factor κB ligand and osteoprotegerin expression in bone marrow
stromal cells. Endocrinology 145:751-759.
76. Fan X, Rahnert JA, Murphy TC et al (2006) Response to mechanical strain
in an immortalized pre-osteoblast cell is dependent on ERK1/2. J Cell
Physiol 207:454-460.
77. Feng JQ, Ward LM, Liu S et al (2006) Loss of DMP1 causes rickets and
osteomalacia and identifies a role for osteocytes in mineral metabolism.
Nat Genet 38:1310-1315.
Bone: functions, structure and physiology
44
78. Ferraro JT, Daneshmand M, Bizios R & Rizzo V (2004) Depletion of
plasma membrane cholesterol dampens hydrostatic pressure and shear
stress-induced mechanotransduction pathways in osteoblast cultures. Am
J Physiol - Cell Physiol 286:831-839.
79. Ferreira AM, González G, González-Paz RJ et al (2009) Bone collagen
role in piezoelectric mediated remineralization. Acta Microsc 18:278-286.
80. Ferron M, Hinoi E, Karsenty G & Ducy P (2008) Osteocalcin differentially
regulates β cell and adipocyte gene expression and affects the development
of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A
105:5266-5270.
81. Ferron M, Wei J, Yoshizawa T et al (2010) Insulin signaling in osteoblasts
integrates bone remodelling and energy metabolism. Cell 142:296-308.
82. Fisher LW, Torchia DA, Fohr B et al (2001) Flexible structures of
SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys
Res Commun 280:460-465.
83. Flagg-Newton J, Simpson I & Loewenstein WR (1979) Permeability of the
cell-to-cell membrane channels in mammalian cell junctions. Science
205:404-407.
84. Fowlkes JL, Bunn RC, Liu L et al (2008) Runt-related transcription factor
2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated
throughout osteogenesis in type 1 diabetes mellitus. Endocrinology 149:
1697 –704.
85. Fraioli R, Rechenmacher F, Neubauer S et al (2015) Mimicking bone
extracellular matrix: Integrin-binding peptidomimetics enhance
osteoblast-like cells adhesion, proliferation, and differentiation on
titanium. Colloids Surfaces B 128:191-200.
86. Franceschi RT, Wang D, Krebsbach PH & Rutherford RB (2000) Gene
therapy for bone formation: in vitro and in vivo osteogenic activity of
adenovirus expressing BMP-7. Ann Arbor 1001:48109-1078.
87. Frias C, Reis J, e Silva FC, Potes J, Simões J & Marques AT (2010)
Polymeric piezoelectric actuator substrate for osteoblast mechanical
stimulation. J Biomech 43:1061-1066.
88. Frijns A, Huyghe J & Wijlaars M (2005) Measurements of deformations
and electrical potentials in a charged porous medium. In IUTAM
Symposium on Physicochemical and Electromechanical Interactions in
Porous Media, pp. 133-139.
89. Fukada E & Yasuda I (1957) On the piezoelectric effect of bone. J Phys
Soc Jpn 12:1158-1162.
90. Fukada E & Yasuda I (1964) Piezoelectric effects in collagen. Jpn. J. Appl.
Phys 3:117-121.
91. Fukumoto S & Martin TJ (2009) Bone as an endocrine organ. Trends
Endocrinol Metab 20:230-236.
92. Fukumoto S & Yamashita T (2007) FGF23 is a hormone-regulating
phosphate metabolism–unique biological characteristics of FGF23. Bone
40:1190–1195.
Bone: functions, structure and physiology
45
93. Fulzele K, Riddle RC, DiGirolamo DJ et al (2010) Insulin receptor
signaling in osteoblasts regulates postnatal bone acquisition and body
composition. Cell 142: 309 – 19.
94. Ganss B, Kim RH & Sodek J (1999) Bone sialoprotein. Crit Rev Oral Biol
Med 10:79-98.
95. Geiger B, Spatz JP & Bershadsky AD (2009) Environmental sensing
through focal adhesions. Nature Rev Mol Cell Biol 10:21-33.
96. Gillespie PG & Walker RG (2001) Molecular basis of mechanosensory
transduction. Nature 413:194-202.
97. Green J & Kleeman CR (1991) The role of bone in the regulation of
systemic acid-base balance. Kidney Int 39:9-26.
98. Gross D & Williams WS (1982) Streaming potential and the
electromechanical response of physiologically-moist bone. J Biomech
15:277-295.
99. Guevarra MS, Yeh JK, Castro Magana M & Aloia JF (2010) Synergistic
effect of parathyroid hormone and growth hormone on trabecular and
cortical bone formation in hypophysectomized rats. Hormone Res Paediatr
73: 248–257.
100. Hadjidakis DJ & Androulakis II (2006) Bone remodelling. Ann N Y Acad
Sci 1092:385-96.
101. Halperin C, Mutchnik S, Agronin A et al (2004). Piezoelectric effect in
human bones studied in nanometer scale. Nano Letters 4:1253-1256.
102. Hamrick MW, Ferrari SL (2008) Leptin and the sympathetic connection
of fat to bone. Osteoporos Int J Establ Result Coop Eur Found Osteoporos
Natl Osteoporos Found U S A 19:905–12.
103. Harada SI & Rodan GA (2003) Control of osteoblast function and
regulation of bone mass. Nature 423:349-355.
104. Harter LV, Hruska KA & Duncan RL (1995) Human osteoblast-like cells
respond to mechanical strain with increased bone matrix protein
production independent of hormonal regulation. Endocrinology 136:528-
535.
105. Harvey RD, McHardy KC, Reid IW et al (1991) Measurement of bone
collagen degradation in hyperthyroidism and during thyroxine
replacement therapy using pyridinium cross-links as specific urinary
markers. J Clin Endocrinol Metab 72:1189–94.
106. Haugh MG, Vaughan TJ & McNamara LM (2015) The role of integrin α
V β 3 in osteocyte mechanotransduction. J Mech Behav Biomed Mater
42:67-75.
107. Haussler MR, Whitfield GK, Haussler CA et al (1998) The nuclear vitamin
D receptor: biological and molecular regulatory properties revealed. J
Bone Miner Res 13:325-349.
108. Haussler MR, Whitfield GK, Kaneko I et al (2012). The role of vitamin D
in the FGF23, klotho, and phosphate bone-kidney endocrine axis. Rev
Endocr Metab Disord 13:57-69.
Bone: functions, structure and physiology
46
109. Heinonen A, Oja P, Kannus P et al (1995) Bone mineral density in female
athletes representing sports with different loading characteristics of the
skeleton. Bone 17:197-203.
110. Hendesi H, Barbe MF, Safadi FF et al (2015) Integrin mediated adhesion
of osteoblasts to connective tissue growth factor (CTGF/CCN2) induces
cytoskeleton reorganization and cell differentiation. PloS One 10.
111. Hirose S, Li M, Kojima T et al (2007) A histological assessment on the
distribution of the osteocytic lacunar canalicular system using silver
staining. J Bone Miner Metab 25:374-382.
112. Holloway WR, Collier FM, Aitken CJ et al (2002) Leptin inhibits
osteoclast generation. J Bone Miner Res 17:200-209.
113. Hong J, Ko S, Khang G & Mun M (2008) Intraosseous pressure and strain
generated potential of cylindrical bone samples in the drained uniaxial
condition for various loading rates. J Mater Sci Mater Med 19:2589-2594.
114. Hsieh Y-F & Turner CH (2001) Effects of loading frequency on
mechanically induced bone formation. J Bone Miner Res 16:918-924.
115. Hu S, Chen J, Fabry B et al (2003) Intracellular stress tomography reveals
stress focusing and structural anisotropy in cytoskeleton of living cells. Am
J Physiol 285:1082-1090.
116. Huang CP, Chen XM & Chen ZQ (2008) Osteocyte: The impresario in the
electrical stimulation for bone fracture healing. Med Hypotheses 70:287-
290.
117. Huang E, Zhu G, Jiang W et al (2012) Growth hormone synergizes with
BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1
pathway in murine multilineage cells. J Bone Miner Res 27:1566-1575.
118. Huang G, Zhang Y, Kim B et al (2009) Fibronectin binds and enhances the
activity of bone morphogenetic protein 1. J Biol Chem 284:25879-25888.
119. Hughes DE, Dai A, Tiffee JC et al (1996) Estrogen promotes apoptosis of
murine osteoclasts mediated by TGF-𝛽. Nature Med 2:1132–1136.
120. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines.
Cell 110:673-687.
121. Iatridis J, Laible J & Krag M (2003) Influence of fixed charge density
magnitude and distribution on the intervertebral disc: applications of a
poroelastic and chemical electric (PEACE) model. J Biomech Eng 125:12-
24.
122. Ingber DE (1997) Tensegrity: The Architectural Basis of Cellular
Mechanotransduction. Annu Rev Physiol 59:575-599.
123. Ingber DE (2006) Mechanical control of tissue morphogenesis during
embryological development. Dev Biol 50:255-266.
124. Isaksson OG, Jansson JO & Gause IA (1982) Growth hormone stimulates
longitudinal bone growth directly. Science 216:1237-1239.
125. Jee WSS, Mori S, Li XJ & Chan S (1990) Prostaglandin E2 enhances
cortical bone mass and activates intracortical bone remodelling in intact
and ovariectomized female rats. Bone 11, 253-266.
126. Jilka RL, Noble B & Weinstein RS (2013) Osteocyte apoptosis. Bone, 54:
264-271.
Bone: functions, structure and physiology
47
127. Kadow-Romacker A, Hoffmann JE, Duda G et al (2009) Effect of
mechanical stimulation on osteoblast- and osteoclast-like cells in vitro.
Cells Tissues Organs 190:61-68.
128. Kang, Q, Sun, MH, Cheng H et al (2004) Characterization of the distinct
orthotopic bone-forming activity of 14 BMPs using recombinant
adenovirus-mediated gene delivery. Gene Ther 11:1312-1320.
129. Kang Q, Song WX, Luo Q et al (2009) A comprehensive analysis of the
dual roles of BMPs in regulating adipogenic and osteogenic differentiation
of mesenchymal progenitor cells. Stem Cells Dev 18:545-559.
130. Karsenty G, Kronenberg HM & Settembre C (2009) Genetic control of
bone formation. Annu Rev Cell Dev Biol 25:629-648.
131. Kasten TP, Collin-Osdoby P, Patel N et al (1994) Potentiation of osteoclast
bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl
Acad Sci U S A 91:3569-3573.
132. Katz B-Z, Zamir E, Bershadsky A et al (2000) Physical state of the
extracellular matrix regulates the structure and molecular composition of
cell-matrix adhesions. Mol Biol Cell 11:1047-1060.
133. Kazmierczak P, Sakaguchi H, Tokita J et al (2007) Cadherin 23 and
protocadherin 15 interact to form tip-link filaments in sensory hair cells.
Nature 449:87-91.
134. Khatiwala CB, Peyton SR & Putnam AJ (2006) Intrinsic mechanical
properties of the extracellular matrix affect the behavior of pre-osteoblastic
MC3T3-E1 cells. Am J Physiol Cell Physiol 290:1640-1650.
135. Khosla S, Oursler MJ & Monroe DG (2012) Estrogen and the skeleton.
Trends Endocrinol Metab 23:576-581.
136. Kim DW, Lee HJ, Karmin JA et al (2006) Mechanical loading
differentially regulates membrane-bound and soluble RANKL availability
in MC3T3-E1 cells. Ann N Y Acad Sci 1068:568-572.
137. Kindblom JM, Ohlsson C, Ljunggren Ö et al (2009) Plasma osteocalcin is
inversely related to fat mass and plasma glucose in elderly Swedish men.
J Bone Miner Res 24:785–791.
138. Klausen TK, Hougaard C, Hoffmann EK & Pedersen SF (2006)
Cholesterol modulates the volume-regulated anion current in Ehrlich-
Lettre ascites cells via effects on Rho and F-actin. Am J Physiol Cell
Physiol 291:757-771.
139. Klein-Nulend J, Helfrich MH, Sterck JGH et al (1998) Nitric oxide
response to shear stress by human bone cell cultures is endothelial nitric
oxide synthase dependent. Biochem Biophys Res Commun 250:108-114.
140. Knothe Tate ML (2003) Whither flows the fluid in bone? An osteocyte’s
perspective. J Biomech 36:1409-1424.
141. Knothe Tate ML, Adamson JR, Tami AE & Bauer TW (2004) The
osteocyte. Int J Biochem Cell Biol 36:1-8.
142. Kong Y-Y, Feige U, Sarosi I et al (1999) Activated T cells regulate bone
loss and joint destruction in adjuvant arthritis through osteoprotegerin
ligand. Nature 402:304-309.
Bone: functions, structure and physiology
48
143. Kobayashi T, Lyons KM, McMahon AP & Kronenberg HM (2005) BMP
signaling stimulates cellular differentiation at multiple steps during
cartilage development. Proc Natl Acad Sci U S A 102:18023-18027.
144. Koike M, Nojiri H, OzawaY et al (2015) Mechanical overloading causes
mitochondrial superoxide and SOD2 imbalance in chondrocytes resulting
in cartilage degeneration. Sci Rep, 5. doi:10.1038/srep11722.
145. Kousteni S, Chen JR, Bellido T et al (2002) Reversal of bone loss in mice
by nongenotropic signaling of sex steroids. Science 298:843-846.
146. Krajisnik T, Bjorklund P, Marsell R et al (2007) Fibroblast growth factor-
23 regulates parathyroid hormone and 1alpha-hydroxylase expression in
cultured bovine parathyroid cells. J Endocrinol 195:125–131.
147. Kreja L, Liedert A, Hasni S, Claes L & Ignatius A (2008) Intermittent
mechanical strain increases RANKL expression in human osteoblasts. J
Biomech 41:S462-S462.
148. Kringelbach TM, Aslan D, Novak I et al (2015) Fine-tuned ATP signals
are acute mediators in osteocyte mechanotransduction. Cell Signal
27:2401-2409.
149. Krings A, Rahman S, Huang S et al (2012) Bone marrow fat has brown
adipose tissue characteristics, which are attenuated with aging and
diabetes. Bone 50:546-552.
150. Kurosu H, Ogawa Y, Miyoshi M et al. (2006) Regulation of fibroblast
growth factor-23 signaling by klotho. J Biol Chem 281:6120–6123.
151. Kuzma M, Kuzmova Z, Zelinkova Z et al (2014) Impact of the growth
hormone replacement on bone status in growth hormone deficient adults.
Growth Horm IGF Res 24:22–28.
152. Lamoureux F, Baud’huin M, Duplomb L et al (2007) Proteoglycans: key
partners in bone cell biology. BioEssays 29: 758-771.
153. le Noble F, Klein C, Tintu A et al (2008) Neural guidance molecules, tip
cells, and mechanical factors in vascular development. Cardiovasc Res
78:232-241.
154. Lee KC, Jessop H, Suswillo R et al (2004) The adaptive response of bone
to mechanical loading in female transgenic mice is deficient in the absence
of oestrogen receptor-alpha and -beta. J Endocrinol 182:193-201.
155. Lee NK & Karsenty G (2008) Reciprocal regulation of bone and energy
metabolism. Trends Endocrinol Metab 19:161-166.
156. Leucht P, Monica SD, Temiyasathit S et al (2013) Primary cilia act as
mechanosensors during bone healing around an implant. Med Eng Phys
35:392-402.
157. Li RD, Deng ZL, Hu N et al (2012) Biphasic effects of TGFβ1 on BMP9-
induced osteogenic differentiation of mesenchymal stem cells. BMB Rep
45:509-514.
158. Liel Y, Shany S, Smirnoff P & Schwartz B (1999) Estrogen increases 1,
25-dihydroxyvitamin D receptors expression and bioresponse in the rat
duodenal mucosa 1. Endocrinology 140:280-285.
Bone: functions, structure and physiology
49
159. Lin GL & Hankenson KD (2011) Integration of BMP, Wnt, and notch
signaling pathways in osteoblast differentiation. J Cell Biochem
112:3491–3501.
160. Littlewood-Evans A, Kokubo T, Ishibashi O et al (1997) Localization of
cathepsin K in human osteoclasts by in situ hybridization and
immunohistochemistry. Bone 20:81-86.
161. Litzenberger JB, Tang WJ, Castillo AB & Jacobs CR (2009) Deletion of
β1 integrins from cortical osteocytes reduces load-induced bone formation.
Cell Mol Bioeng 2:416-424.
162. Litzenberger JB, Kim JB, Tummala P & Jacobs CR (2010) β1 integrins
mediate mechanosensitive signaling pathways in osteocytes. Calcif Tissue
Int 86:325-332.
163. Liu H, Fergusson MM, Castilho RM et al (2007) Augmented Wnt
signaling in a mammalian model of accelerated aging. Science 317:803-
806.
164. López I, Rodríguez-Ortiz ME, Almadén Y et al (2011). Direct and indirect
effects of parathyroid hormone on circulating levels of fibroblast growth
factor 23 in vivo. Kidney Int 80:475-482.
165. López I, Pineda C, Raya AI et al (2016) Leptin directly stimulates
parathyroid hormone secretion. Endocrine Abstracts 41:GP144.
166. Lupu F, Terwilliger JD, Lee K et al (2001) Dev. Biol. 229:141–162.
167. Lyles KW, Halsey DL, Friedman NE & Lobaugh B (1988) Correlations of
serum concentrations of 1,25-dihydroxyvitamin D, phosphorus, and
parathyroid hormone in tumoral calcinosis. J Clin Endocrinol Metab
67:88–92.
168. Malaval L, Wade-Guéye NM, Boudiffa M et al (2008) Bone sialoprotein
plays a functional role in bone formation and osteoclastogenesis. J Exp
Med 205:1145-1153.
169. Malone AMD, Anderson CT, Tummala P et al (2007) Primary cilia
mediate mechanosensing in bone cells by a calcium-independent
mechanism. Proc Natl Acad Sci U S A. 104:13325-13330.
170. Mann V, Huber C, Kogianni G et al (2006) The influence of mechanical
stimulation on osteocyte apoptosis and bone viability in human trabecular
bone. J Musculoskelet Neuronal Interact 6, 408-417.
171. Mantzoros CS, Magkos F, Brinkoetter M et al (2011). Leptin in human
physiology and pathophysiology. Am J Physiol Endocrinol Metab
301:E567-E584.
172. Maor G, Rochwerger M, Segev Y & Phillip M (2002) Leptin acts as a
growth factor on the chondrocytes of skeletal growth centres. J Bone Miner
Res 17:1034-1043.
173. Marchisio PC, Cirillo D, Naldini L et al (1984) Cell-substratum interaction
of cultured avian osteoclasts is mediated by specific adhesion structures. J
Cell Biol 99:1696-1705.
174. Marino AA & Becker RO (1974) Piezoelectricity in bone as a function of
age. Calcif Tissue Int 14:327-331.
Bone: functions, structure and physiology
50
175. Martin RB (2007) Targeted bone remodelling involves BMU steering as
well as activation. Bone 40:1574-1580.
176. Masuyama R, Stockmans I, Torrekens S et al (2006). Vitamin D receptor
in chondrocytes promotes osteoclastogenesis and regulates FGF23
production in osteoblasts. J Clin Invest 116:3150-3159.
177. Matsuo K & Otaki N (2012) Bone cell interactions through Eph/ephrin:
bone modeling, remodelling and associated diseases. Cell Adh Migr
6:148-156.
178. Matthews BD, Overby DR, Mannix R & Ingber DE (2006) Cellular
adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension
and mechanosensitive ion channels. Journal Cell Sci 119:508-518.
179. McGrath J, Somlo S, Makova S et al (2003) Two Populations of Node
Monocilia Initiate Left-Right Asymmetry in the Mouse. Cell 114:61-73.
180. McNamara LM, Majeska RJ, Weinbaum S et al (2009) Attachment of
osteocyte cell processes to the bone matrix. Anat Rec 292:355-363.
181. Metz LN, Martin RB & Turner AS (2003) Histomorphometric analysis of
the effects of osteocyte density on osteonal morphology and remodelling.
Bone 33:753-759.
182. Meyer U & Wiesmann HP (2006) Bone and cartilage. In Bone and
Cartilage Engineering, 1st edn, ed. Schröder G, pp. 7-46 Springer-Verlag,
Berlin.
183. Mitchison TJ & Cramer LP (1996) Actin-based cell motility and cell
locomotion. Cell 84:371-379.
184. Miyamoto T & Suda T (2003) Differentiation and function of osteoclasts.
Keio J Med 52:1-7.
185. Mohan S & Baylink DJ (1991) Bone growth factors. Clin Orthop Relat
Res 263:30-48.
186. Mori S & Burr DB (1993) Increased intracortical remodelling following
fatigue damage. Bone 14:103-109.
187. Mosley JR, March BM, Lynch J & Lanyon LE (1997) Strain magnitude
related changes in whole bone architecture in growing rats. Bone 20:191-
198.
188. Moussa FM, Hisijara IA, Sondag GR et al (2014) Osteoactivin promotes
osteoblast adhesion through HSPG and αvβ1 integrin. J Cell biochem
115:1243-1253.
189. Moutzouri AG & Athanassiou GM (2014) Insights into the alteration of
osteoblast mechanical properties upon adhesion on chitosan. BioMed Res
Int 2014.
190. Mullender M, El Haj AJ, Yang Y et al (2004) Mechanotransduction of
bone cells in vitro: mechanobiology of bone tissue. Med Biol Eng Comput
42:14-21.
191. Murayama A, Takeyama K, Kitanaka S et al (1998) The promoter of the
human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive
and negative responsiveness to PTH, calcitonin, and 1α,25(OH)2D3.
Biochem Biophys Res Commun 249:11–16.
Bone: functions, structure and physiology
51
192. Murshid SA, Kamioka H, Ishihara Y et al (2007) Actin and microtubule
cytoskeletons of the processes of 3D-cultured MC3T3-E1 cells and
osteocytes. J Bone Miner Metab 25:259-259.
193. Myers KA, Rattner JB, Shrive NG & Hart DA (2007) Osteoblast-like cells
and fluid flow: Cytoskeleton-dependent shear sensitivity. Biochem
Biophys Res Commun 364:214-219.
194. Nakagawa N, Kinosaki M, Yamaguchi K et al (1998). RANK is the
essential signaling receptor for osteoclast differentiation factor in
osteoclastogenesis. Biochem Biophys Res Commun 253:395-400.
195. Nakajima K, Kho DH, Yanagawa T et al (2016) Galectin-3 in bone tumor
microenvironment: a beacon for individual skeletal metastasis
management. Cancer Metastasis Rev 1-14.
196. Nakamura H (2007) Morphology, function, and differentiation of bone
cells. Journal of Hard Tissue Biology 16:15-22.
197. Nakamura T, Mine N, Nakaguchi E et al (2006) Generation of Robust Left-
Right Asymmetry in the Mouse Embryo Requires a Self-Enhancement and
Lateral-Inhibition System. Dev Cell 11:495-504.
198. Nauli SM, Alenghat FJ, Luo Y et al (2003). Polycystins 1 and 2 mediate
mechanosensation in the primary cilium of kidney cells. Nature Genet
33:129-137.
199. Nievers MG, Schaapveld RQJ & Sonnenberg A (1999) Biology and
function of hemidesmosomes. Matrix Biol 18:5-17.
200. Noble BS, Peet N, Stevens HY et al (2003) Mechanical loading: biphasic
osteocyte survival and targeting of osteoclasts for bone destruction in rat
cortical bone. Am J Physiol 284:934-943.
201. Noris-Suárez K, Lira-Olivares J, Ferreira AM et al (2007) In vitro
deposition of hydroxyapatite on cortical bone collagen stimulated by
deformation-induced piezoelectricity. Biomacromolecules 8:941-948.
202. Novince CM, Michalski MN, Koh AJ, Sinder BP, Entezami P, Eber MR,
Pettway GJ, Rosol TJ, Wronski TJ, Kozloff KM & McCauley LK (2012).
Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid
hormone skeletal anabolism. J Bone Miner Res 27: 11-25.
203. Ohlsson C, Bengtsson BA, Isaksson OG et al (1998) Growth Hormone and
Bone. Endocrine Rev 19:55-79.
204. Okada Y, Nonaka S, Tanaka Y et al (1999) Abnormal Nodal Flow
Precedes Situs Inversus in iv and inv mice. Mol Cell 4:459-468.
205. Olivares-Navarrete R, Rodil SE, Hyzy SL et al (2015) Role of integrin
subunits in mesenchymal stem cell differentiation and osteoblast
maturation on graphitic carbon-coated microstructured surfaces.
Biomaterials 51:69-79.
206. Oster GF, Murray JD & Harris AK (1983) Mechanical aspects of
mesenchymal morphogenesis. J Embryol Exp Morphol 78:83-125.
207. Oury F, Sumara G, Sumara O et al (2011) Endocrine regulation of male
fertility by the skeleton. Cell 144:796-809.
208. Palumbo C (1986) A three-dimensional ultrastructural study of osteoid-
osteocytes in the tibia of chick embryos. Cell Tissue Res 246: 125-131.
Bone: functions, structure and physiology
52
209. Parsons JT (1996) Integrin-mediated signalling: regulation by protein
tyrosine kinases and small GTP-binding proteins. Curr Opin Cell Biol
8:146-152.
210. Patwari P & Lee RT (2008) Mechanical Control of Tissue Morphogenesis.
Circ Res 103:234-243.
211. Pereira AF & Shefelbine SJ (2014) The influence of load repetition in bone
mechanotransduction using poroelastic finite-element models: the impact
of permeability. Biomechan model mechanobiol 13:215-225.
212. Perrien DS, Brown EC, Aronson J et al (2002) Immunohistochemical
study of osteopontin expression during distraction osteogenesis in the rat.
J Histochem Cytochem 50:567-574.
213. Phillips JA, Almeida EA, Hill EL et al (2008) Role for β1 integrins in
cortical osteocytes during acute musculoskeletal disuse. Matrix Biol,
27:609-618.
214. Pienkowski D & Pollack SR (1983) The origin of stress-generated
potentials in fluid-saturated bone. J Orthop Res 1:30-41.
215. Pittas AG, Harris SS, Eliades M et al (2009) Association between serum
osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab
94:827–832.
216. Plotkin LI, Mathov I, Aguirre JI et al (2005) Mechanical stimulation
prevents osteocyte apoptosis: requirement of integrins, Src kinases, and
ERKs. Am J Physiol 289:633-643.
217. Pommerenke H, Schmidt C, Durr F et al (2002) The mode of mechanical
integrin stressing controls intracellular signaling in osteoblasts. J Bone
Miner Res 17:603-611.
218. Praetorius HA, Frokiaer J, Nielsen S & Spring KR (2003) Bending the
primary cilium opens Ca2+-sensitive intermediate-conductance K+
channels in MDCK Cells. J Membr Biol 191:193-200.
219. Prendergast PJ & Huiskes R (1995) The biomechanics of Wolff’s law:
recent advances. Ir J Med Sci 164:152-154.
220. Prince RL (1994) Counterpoint: estrogen effects on calcitropic hormones
and calcium homeostasis. Endocr rev 15:301-309.
221. Qi M, Liu Y, Freeman MR & Solomon KR (2009) Cholesterol-regulated
stress fibre formation. J Cell Biochem 106:1031-1040.
222. Quarles LD (2012) Role of FGF23 in vitamin D and phosphate
metabolism: implications in chronic kidney disease. Exp Cell Res
318:1040-1048.
223. Radel C & Rizzo V (2005) Integrin mechanotransduction stimulates
caveolin-1 phosphorylation and recruitment of Csk to mediate actin
reorganization. Am J Physiol 288:936-945.
224. Rahman MS, Akhtar N, Jamil HM et al (2015) TGF-/BMP signaling and
other molecular events: regulation of osteoblastogenesis and bone
formation. Bone Res 3.
225. Ramtani S (2008) Electro-mechanics of bone remodelling. Int J Eng Sci
46:1173-1182.
Bone: functions, structure and physiology
53
226. Rawlinson SCF, Pitsillides AA & Lanyon LE (1996) Involvement of
different ion channels in osteoblasts’ and osteocytes’ early responses to
mechanical strain. Bone 19:609-614.
227. Reid IR, Ames R, Evans MC et al (1992) Determinants of total body and
regional bone mineral density in normal postmenopausal women--a key
role for fat mass. J Clin Endocrinol Metab 75:45-51.
228. Reinish GB & Nowick AS (1975) Piezoelectric properties of bone as
functions of moisture content. Nature 253:626-627.
229. Reis J, Frias C, Canto e Castro C, Botelho ML, Marques AT, Simões JA,
Capela e Silva F & Potes J (2012) A new piezoelectric actuator induces
bone formation in vivo: a preliminary study. BioMed Res Int.
230. Rho J-Y, Kuhn-Spearing L & Zioupos P (1998) Mechanical properties and
the hierarchical structure of bone. Med Eng Phys 20:92-102.
231. Rhee Y, Bivi N, Farrow E et al (2011) Parathyroid hormone receptor
signaling in osteocytes increases the expression of fibroblast growth
factor-23 in vitro and in vivo. Bone, 49:636-643.
232. Ribot C, Tremollieres F, Pouilles JM et al (1987) Obesity and
postmenopausal bone loss: the influence of obesity on vertebral density
and bone turnover in postmenopausal women. Bone 8:327-331.
233. Riggs BL, Khosla S & Melton LJ (1998) A unitary model for involutional
osteoporosis: estrogen deficiency causes both type I and type II
osteoporosis in postmenopausal women and contributes to bone loss in
aging men. J Bone Miner Res 13:763-773.
234. Ritz U, Götz H, Baranowski A et al (2016) Influence of different calcium
phosphate ceramics on growth and differentiation of cells in osteoblast–
endothelial co‐cultures. J Biomed Mater Res B: Appl Biomater doi:
10.1002/jbm.b.33728.
235. Riveline D, Zamir E, Balaban NQ et al (2001) Focal contacts as
mechanosensors: externally applied local mechanical force induces growth
of focal contacts by an mDia1-dependent and ROCK-independent
mechanism. J Cell Biol 153:1175-1185.
236. Robinson LJ, Yaroslavskiy BB, Griswold RD et al (2009) Estrogen
inhibits RANKL-stimulated osteoclastic differentiation of human
monocytes through estrogen and RANKL-regulated interaction of
estrogen receptor-α with BCAR1 and Traf6. Exp Cell Res 315: 1287-1301.
237. Rodan GA & Martin TJ (2000) Therapeutic approaches to bone diseases.
Science 289:1508-1514.
238. Rodriguez-Ortiz ME, Lopez I, Muñoz-Castañeda JR et al (2012) Calcium
deficiency reduces circulating levels of FGF23. J Am Soc Nephrol
23:1190-1197.
239. Roelofs-Iverson RA, Mulder DW, Elveback LR et al (1984) ALS and
heavy metals: a pilot case‐control study. Neurology 34:393-393.
240. Romas E, Sims NA, Hards DK et al (2002) Osteoprotegerin reduces
osteoclast numbers and prevents bone erosion in collagen-induced
arthritis. Am J Pathol 161:1419-1427.
Bone: functions, structure and physiology
54
241. Rosen CJ, Ackert-Bicknell C, Rodriguez JP & Pino AM (2009) Marrow
fat and the bone microenvironment: developmental, functional, and
pathological implications. Crit Rev Eukaryot Gene Expr 19(2).
242. Rössig L, Haendeler J, Hermann C et al (2000) Nitric oxide down-
regulates MKP-3 mRNA levels. J Biol Chem 275:25502-25507.
243. Rousselle AV & Heymann D (2002) Osteoclastic acidification pathways
during bone resorption. Bone 30:533-540.
244. Rosset EM & Bradshaw AD (2016) SPARC/osteonectin in mineralized
tissue. Matrix Biol 52:78-87.
245. Rubin CT & Lanyon LE (1984) Regulation of bone formation by applied
dynamic loads. J Bone Joint Surg 66:397-402.
246. Rubin J & Greenfield EM (2005) Osteoclast: origin and differentiation. In
Bone Resorption ed. Farach-Carson MC, Bronner F & Rubin J, pp. 1-23.
Springer-Verlag, London.
247. Saidak Z, Le Henaff C, Azzi S et al (2015) Wnt/β-catenin signaling
mediates osteoblast differentiation triggered by peptide-induced α5β1
integrin priming in mesenchymal skeletal cells. J Biol Chem 290:6903-
6912.
248. Saini RK, Kaneko I, Jurutka PW et al (2013) 1, 25-dihydroxyvitamin d3
regulation of fibroblast growth factor-23 expression in bone cells:
Evidence for primary and secondary mechanisms modulated by leptin and
interleukin-6. Calcif Tissue Int 92:339-353.
249. Salo J, Lehenkari P, Mulari M et al (1997) Removal of osteoclast bone
resorption products by transcytosis. Science 276:270-273.
250. Saunders MM, You J, Trosko JE et al (2001) Gap junctions and fluid flow
response in MC3T3-E1 cells. Am J Physiol - Cell Physiol 281:1917-1925.
251. Saunders MM, You J, Zhou Z et al (2003) Fluid flow-induced
prostaglandin E2 response of osteoblastic ROS 17/2.8 cells is gap junction-
mediated and independent of cytosolic calcium. Bone 32:350-356.
252. Schiller PC, D’Ippolito G, Balkan W et al (2001) Gap-junctional
communication is required for the maturation process of osteoblastic cells
in culture. Bone 28:362-369.
253. Schmidt A, Brixius K & Bloch W (2007) Endothelial precursor cell
migration during vasculogenesis. Circ Res 101:125-136.
254. Sharma B, Singh S & Siddiqi NJ (2014) Biomedical implications of heavy
metals induced imbalances in redox systems. BioMed Research Int, 2014.
255. Shi Y, Yadav VK, Suda N et al (2008) Dissociation of the neuronal
regulation of bone mass and energy metabolism by leptin in vivo. Proc Natl
Acad Sci U S A 105:20529–20533.
256. Shimada T, Mizutani S, Muto T et al (2001) Cloning and characterization
of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl
Acad Sci U S A 98:6500–6505.
257. Shimada T, Hasegawa H, Yamazaki Y et al (2004) FGF-23 is a potent
regulator of vitamin D metabolism and phosphate homeostasis. J Bone
Miner Res 19:429–435.
Bone: functions, structure and physiology
55
258. Silberberg YR, Pelling AE, Yakubov GE et al (2008) Mitochondrial
displacements in response to nanomechanical forces. J Mol Recognit
21:30-36.
259. Small J, Anderson K & Rottner K (1996) Actin and the coordination of
protrusion, attachment and retraction in cell crawling. Biosci Rep 16:351-
368.
260. Smalt R, Mitchell FT, Howard RL & Chambers TJ (1997) Induction of NO
and prostaglandin E2 in osteoblasts by wall-shear stress but not mechanical
strain. Am J Physiol273:751-758.
261. Smith MA, Hoffman LM & Beckerle MC (2014) LIM proteins in actin
cytoskeleton mechanoresponse. Trends Cell Biol 24:575-583.
262. Sommerfeldt D & Rubin C (2001) Biology of bone and how it orchestrates
the form and function of the skeleton. Eur Spine J 10:S86-S95.
263. Souza Faloni AP, Sasso-Cerri E, Rocha FRG et al (2012) Structural and
functional changes in the alveolar bone osteoclasts of estrogen-treated rats.
J Anat 220:77–85.
264. Srinivasan S, Ausk BJ, Poliachik SL et al (2007) Rest-inserted loading
rapidly amplifies the response of bone to small increases in strain and load
cycles. J Appl Physiol 102:1945-1952.
265. Steinberg TH, Civitelli R, Geist ST et al (1994) Connexin43 and
connexin45 form gap junctions with different molecular permeabilities in
osteoblastic cells. EMBO J 13:744-750.
266. Suda T, Takahashi N, Udagawa N et al (1999) Modulation of osteoclast
differentiation and function by the new members of the tumor necrosis
factor receptor and ligand families. Endocr Rev 20:345-357.
267. Suchacki KJ, Cawthorn WP & Rosen CJ (2016) Bone marrow adipose
tissue: formation, function and regulation. Curr Opin Pharmacol 28:50-56.
268. Sugawara Y, Ando R, Kamioka H et al (2008) The alteration of a
mechanical property of bone cells during the process of changing from
osteoblasts to osteocytes. Bone 43:19-24.
269. Sun L, Vukicevic S, Baliram R et al (2008) Intermittent recombinant TSH
injections prevent ovariectomy-induced bone loss. Proc Natl Acad Sci U
S A 105:4289–4294.
270. Takayanagi H (2008) Regulation of osteoclastogenesis and
osteoimmunology. Bone 42:S40-S40.
271. Takeichi M (1988). The cadherins: cell-cell adhesion molecules
controlling animal morphogenesis. Development 102:639-655.
272. Tamma R & Zallone A (2012) Osteoblast and osteoclast crosstalks: from
OAF to Ephrin. Inflamm Allergy-Drug Targets 11:196-200.
273. Tan SD, de Vries TJ, Kuijpers-Jagtman AM et al (2007) Osteocytes
subjected to fluid flow inhibit osteoclast formation and bone resorption.
Bone 41:745-751.
274. Tan SD, Bakker AD, Semeins CM et al (2008) Inhibition of osteocyte
apoptosis by fluid flow is mediated by nitric oxide. Biochem Biophys Res
Commun 369:1150-1154.
Bone: functions, structure and physiology
56
275. Tanikawa R, Tanikawa T, Hirashima M et al (2010) Galectin-9 induces
osteoblast differentiation through the CD44/Smad signaling pathway.
Biochem Biophys Res Commun 394:317-322.
276. ten Bolscher M, Netelenbos JC, Barto R & van Buuren LM (1999)
Estrogen regulation of intestinal calcium absorption in the intact and
ovariectomized adult rat. J Bone Miner Res, 14:1197-1202.
277. Teo BKK, Wong ST, Lim CK et al (2013) Nanotopography modulates
mechanotransduction of stem cells and induces differentiation through
focal adhesion kinase. ACS Nano 7:4785-4798.
278. Teti A & Zallone A (2009) Do osteocytes contribute to bone mineral
homeostasis? Osteocytic osteolysis revisited. Bone 44:11-16.
279. Thi MM, Suadicani SO, Schaffler MB, Weinbaum S & Spray DC (2013)
Mechanosensory responses of osteocytes to physiological forces occur
along processes and not cell body and require αVβ3 integrin. Proc Natl
Acad Sci U S A 110: 21012-21017.
280. Thurner PJ, Chen CG, Ionova-Martin S et al (2010) Osteopontin
deficiency increases bone fragility but preserves bone mass. Bone
46:1564-1573.
281. Tomkinson A, Reeve J, Shaw RW & Noble BS (1997) The death of
osteocytes via apoptosis accompanies estrogen withdrawal in human bone.
J Clin Endocrinol Metab 82:3128-3135.
282. Tsuji K, Maeda T, Kawane T et al (2010) Leptin stimulates fibroblast
growth factor 23 expression in bone and suppresses renal 1α25-
dihydroxyvitamin D3 synthesis in leptin-deficient ob/ob mice. J Bone
Miner Res 25:1711-1723.
283. Turner CH (1998) Three rules for bone adaptation to mechanical stimuli.
Bone 23:399-407.
284. Turner CH (2006) Bone strength: current concepts. Ann N Y Acad Sci
1068:429-446.
285. Turner RT, Riggs BL & Spelsberg TC (1994) Skeletal Effects of
Estrogen*. Endocr Rev 15:275-300.
286. Urakawa I, Yamazaki Y, Shimada T et al (2006) Klotho converts canonical
FGF receptor into a specific receptor for FGF23. Nature 444:770–774.
287. Urist MR (1965) Bone: formation by autoinduction. Science 150:893–899.
288. Väänänen HK & Horton M (1995) The osteoclast clear zone is a
specialized cell-extracellular matrix adhesion structure. J Cell Sci
108:2729-2732.
289. Väänänen HK (2005) Mechanism of osteoclast mediated bone resorption-
rationale for the design of new therapeutics. Adv Drug Deliv Rev 57:959–
971.
290. Vääräniemi J, Halleen JM, Kaarlonen K et al (2004) Intracellular
machinery for matrix degradation in bone-resorbing osteoclasts. J Bone
Miner Res 19:1432-1440.
291. Van Bezooijen RL, Roelen BA, Visser A et al (2004) Sclerostin is an
osteocyte-expressed negative regulator of bone formation, but not a
classical BMP antagonist. J Exp Med 199:805–814.
Bone: functions, structure and physiology
57
292. Van De Graaff K (2001) Skeletal system: introduction and the axial
skeleton. In Human Anatomy, 6th edn, ed. Lange M, Tibbetts K & Queck
K, pp. 131-171. McGraw-Hill College, Boston.
293. van der Meijden K, Bakker AD, van Essen HW et al (2016) Mechanical
loading and the synthesis of 1, 25 (OH) 2 D in primary human osteoblasts.
J Steroid Biochem Mol Biol 156:32-39.
294. Van Hove RP, Nolte PA, Vatsa A et al (2009) Osteocyte morphology in
human tibiae of different bone pathologies with different bone mineral
density—Is there a role for mechanosensing? Bone 45:321-329.
295. Vanderschueren D, Vandenput L, Boonen S et al (2004) Androgens and
bone. Endocr Rev 25:389-425.
296. van’T Hof RJ & Ralston SH (2001) Nitric oxide and bone. Immunology
103:255-261.
297. Vatsa A, Breuls RG, Semeins CM et al (2008) Osteocyte morphology in
fibula and calvaria—is there a role for mechanosensing? Bone 43:452-458.
298. Verborgt O, Tatton NA, Majeska RJ & Schaffler MB (2002) Spatial
distribution of Bax and Bcl-2 in osteocytes after bone fatigue:
complementary roles in bone remodelling regulation? J Bone Miner Res
17:907-914.
299. Verbruggen SW, Vaughan TJ & McNamara LM (2014) Fluid flow in the
osteocyte mechanical environment: a fluid–structure interaction approach.
Biomechan model mechanobiol 13: 85-97.
300. Vinik Y, Shatz-Azoulay H, Vivanti A et al (2015) The mammalian lectin
galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass
reduction in mice. Elife 4:e05914.
301. Waychunas GA (2014) Disrupting dissolving ions at surfaces with fluid
flow. Science 344:1094-1095.
302. Wang N, Butler JP & Ingber DE (1993) Mechanotransduction across the
cell surface and through the cytoskeleton. Science 260:1124-1127.
303. Wang N & Ingber DE (1994) Control of cytoskeletal mechanics by
extracellular matrix, cell shape, and mechanical tension. Biophys J
66:2181-2189.
304. Wang T, Feng Z, Song Y & Chen X (2007) Piezoelectric properties of
human dentin and some influencing factors. Dent Mater 23:450-453.
305. Warden SJ & Turner CH (2004) Mechanotransduction in the cortical bone
is most efficient at loading frequencies of 5-10 Hz. Bone 34:261-270.
306. Waring AC, Harrison S, Fink HA et al (2013) A prospective study of
thyroid function, bone loss, and fractures in older men: The MrOS study.
J Bone Miner Res 28:472-479.
307. Weiner S, Traub W & Wagner HD (1999) Lamellar bone: structure-
function relations. J Struct Biol 126:241-255.
308. Wen JH, Vincent LG, Fuhrmann A et al (2014) Interplay of matrix
stiffness and protein tethering in stem cell differentiation. Nat Mater
13:979-987.
309. Wiren KM & Marcus R (2010) Fundamentals of Osteoporosis.
Bone: functions, structure and physiology
58
310. Xiao Z, Zhang S, Mahlios J et al (2006) Cilia-like structures and
polycystin-1 in osteoblasts/osteocytes and associated abnormalities in
skeletogenesis and Runx2 expression. J Biol Chem 281:30884-30895.
311. Xing Y, Gu Y, Xu LC et al (2011) Effects of membrane cholesterol
depletion and GPI‐anchored protein reduction on osteoblastic
mechanotransduction. J Cell Physiol 226:2350-2359.
312. Yamada KM & Geiger B (1997) Molecular interactions in cell adhesion
complexes. Curr Opin Cell Biol 9:76-85.
313. Yamaki M, Nakamura H, Takahashi N et al (2005). Transcytosis of
calcium from bone by osteoclast-like cells evidenced by direct
visualization of calcium in cells. Arch Biochem Biophys 440:10-17.
314. Yamashita T, Yoshioka M & Itoh N (2000) Identification of a novel
fibroblast growth factor, FGF-23, preferentially expressed in the
ventrolateral thalamic nucleus of the brain. Biochem Biophys Res
Commun 277:494–498.
315. Young MF (2003) Bone matrix proteins: their function, regulation, and
relationship to osteoporosis. Osteoporos Int 14:35-42.
316. Zallone A, Teti A, Primavera MV & Pace G (1983) Mature osteocytes
behaviour in a repletion period: the occurrence of osteoplastic activity.
Basic Appl Histochem 27:191-204.
317. Zaman G, Pitsillides AA, Rawlinson SCF et al (1999) Mechanical strain
stimulates nitric oxide production by rapid activation of endothelial nitric
oxide synthase in osteocytes. J Bone Miner Res 14:1123-1131.
318. Zhang M, Xuan S, Bouxsein ML et al (2002) Osteoblast-specific knockout
of the insulin-like growth factor (IGF) receptor gene reveals an essential
role of IGF signaling in bone matrix mineralization. J Biol Chem
277:44005-44012.
319. Zhang W, Shen X, Wan C et al (2012) Effects of insulin and insulin‐like
growth factor 1 on osteoblast proliferation and differentiation: differential
signalling via Akt and ERK. Cell Biochem Funct 30:297-302.
320. Zhang Y, Chen L, Zeng J et al (2014) Aligned porous barium
titanate/hydroxyapatite composites with high piezoelectric coefficients for
bone tissue engineering. Mater Sci Eng: C 39:143-149.
321. Zhu J, Zhang X, Wang C et al (2008) Different magnitudes of tensile strain
induce human osteoblasts differentiation associated with the activation of
ERK1/2 phosphorylation. Int J Mol Sci 9:2322-2332.
Chapter 3
Analgesia em Modelo Animal Superior
para Ortopedia Abstract published in the Proceedings Book of the 6th Portuguese Congress on Biomechanics,
February 2015, ISSN: 2333-4959.
61
62
63
64
65
66
Chapter 4
Ex vivo Model for Percutaneous
Vertebroplasty Published in Key Engineering Materials,
2015, Volume 631: 408-413
Chapter 5
Percutaneous vertebroplasty: a
new animal model Published in The Spine Journal,
October 2016, Volume 16(10): 1253-1262.
Chapter 6
Novel mesoporous bioactive
glass/calcium sulphate cement for
percutaneous vertebroplasty and
kyphoplasty: in vivo study
Submitted in December 2016
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
91
Novel mesoporous bioactive glass/calcium sulphate cement for
percutaneous vertebroplasty and kyphoplasty: in vivo study
M.T. Oliveira1,*, J. Potes1, M.C. Queiroga1, J.L. Castro2, A.F. Pereira2, J.C. Fragoso3, A. Manca4, C. Vitale-
Brovarone5, J.C. Reis6.
1DMV, ECT, ICAAM, Universidade de Évora, Apartado 94, 7002-554, Évora, Portugal.
2DZ, ECT, ICAAM, Universidade de Évora, Portugal.
3ZEA – Sociedade Agrícola, Lda., Évora, Portugal.
4Interventional Radiology Team, Radiology Unit, Candiolo Cancer Institute– FPO, IRCCS
Candiolo, Torino, Italy.
5Politecnico di Torino, Torino, Italy; COREP, Torino, Italy.
6DMV, ECT, Universidade de Évora, Portugal; CICECO, Universidade de Aveiro, Portugal.
*corresponding author: [email protected], tel: +351266760859, fax: +351266760944
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
92
Abstract
In the field of tissue engineering, synthetic cements are in expansion as valid alternatives
to existing therapeutic options. To develop an innovative, resorbable and injectable composite
cement – Spine-Ghost –, type III α-calcium sulphate hemihydrate was used as the bioresorbable
matrix, while spray-dried mesoporous bioactive particles were added for high bioactivity, and
a zirconia containing glass-ceramic was added to increase radiopacity. An injectable paste was
obtained by adding water. To test the suitability of the injectable cement for percutaneous
vertebroplasty, a sheep study was conducted, following a previously developed animal model.
Two groups of mature Merino sheep were defined (n=8): A) the control group injected with a
known commercial calcium sulphate-based biphasic cement; B) the experimental group
injected with the novel cement. Bone defects were manually drilled percutaneously in the L4
vertebral bodies. Micro-CT overall mean tissue volume, an indicator of the injected defect
volume, was 1.217±0.235 mL. All sheep survived and completed the 6-month implantation
period. After sacrifice, the samples were assessed by micro-CT and by histological,
histomorphometric, and immunohistological studies. There were no signs of infection or
inflammation. Importantly, there was cement resorption and new bone formation. Spine-Ghost
proved to be an adequate material for percutaneous vertebroplasty.
Keywords: Spine-Ghost; resorbable cement; percutaneous vertebroplasty; kyphoplasty; in vivo
study; ovine.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
93
1. Introduction
Vertebral compression fractures (VCFs) are the most frequent osteoporosis-related event
in the elderly, especially in post-menopausal women [1-3]. Other causes, particularly in
younger patients, include trauma [4] and cancer [5]. With the existing tendency of population
ageing, the prevalence of VCFs will continue increasing [6]. VCFs not healing with
conservative management and not demanding open surgery for spine instability, are currently
treated through minimally invasive surgical techniques performed with radiological guidance:
percutaneous vertebroplasty (PVP) and percutaneous kyphoplasty (PKP). Both techniques aim
to augment and/or stabilize the defective vertebral body by percutaneously injecting a material
that will interdigitate with the cancellous bone or fill the bone defect thus achieving immediate
and lasting pain relief with functional recovery [7-9].
In the field of tissue engineering, synthetic materials composites are in expansion as valid
bone graft alternatives. Optimal bone cement for vertebroplasty would show a reduced Young’s
modulus - around 120 MPa [10] –, comparable to that of the cancellous bone; a reduced
polymerization temperature – approximately 40 ºC at most [10]; and an increased bioactivity
and resorbability. Additionally, it should be injectable to enable percutaneous vertebral
augmentation procedures; easy to handle and sterilize; and present high radiopacity to allow
fluoroscopic guidance [11].
Presently, most of the cements used in percutaneous bone interventions are based on a
polymeric matrix – polymethylmethacrylate (PMMA) –, provide immediate effect and safety
and have been thoroughly used and investigated over the years. However, they can present some
complications: 1) secondary fractures of the contiguous vertebral bodies due to the cement high
elastic modulus [12]; 2) high polymerization temperatures: around 70 ºC [13], but can rise over
90 °C, as assessed by in vivo measurements [14], which can cause inflammation/ necrosis of
the neighboring tissues; 3) excessive setting times; 4) low bioactivity and bioinertia [7]; 5)
absence of resorbability, inhibiting the formation of new healthy tissue [15]; 6) pulmonary
embolism and cardiorespiratory arrest due to PMMA leakage [16,17].
Calcium sulphate-based injectable ceramic cements, like Cerament™ (Bone Support,
Lund, Sweden) are effective, well documented bone substitutes [18-20] since they are
biocompatible, resorbable, and osteoconductive, displaying mechanical properties similar to
those of cancellous bone, with reduced Young’s Modulus [18], and a low risk of infection or
donor site morbidity. Some disadvantages include their limited shear and compressive strength.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
94
In order to overcome these limitations, ceramic biomaterials are most of the times combined
with other composites [21].
To go beyond the state of art, a new bioactive injectable cement for percutaneous
vertebroplasty was developed – Spine-Ghost – based on Vitale-Brovarone’s patent
(EP2569025), as described elsewhere [22]. It is composed of type III α-calcium sulphate
hemihydrate combined with mesoporous particles of a bioactive glass (MBG), and a radiopaque
glass-ceramic phase. MBG was used for its high bioactivity and ability to release silicon and
calcium ions, which had been proven to be osteoinductive [23]. Arcos et al. reported the
production of spherical mesoporous particles of bioactive glass by spray-drying [24] – to
overcome the time-consuming sol-gel synthesis combined with an evaporation-induced self-
assembly (EISA) process [25] –, and they were used as the dispersed phase in the calcium
sulphate matrix to impart high bioactivity to the material. This allows a faster and more
repeatable process [26]. An additional dispersed phase was added, consisting of a glass-ceramic
bioactive phase containing zirconia (ZrO2) to enhance the injectable cement’s radiopacity.
Sheep are considered an appropriate large animal model for biomedical research,
including orthopedic research [27], because of their anatomical similarities to human bones
[28]. To date, most studies wherein a vertebral bone defect model was presented were executed
using “open surgery” techniques [29,30]. Also, only a small number of percutaneous
vertebroplasty preclinical studies have been performed in large animals, and those have faced
several drawbacks, including cement leakage into the vertebral foramen [31], incomplete defect
filling and lack of information on postoperative evolution [32,33]. To overcome these
difficulties, we’ve previously developed a modified parapedicular approach model, wherein the
overall mean tissue volume, an indicator of the injected defect volume, was 1.217±0.235 mL,
maintaining a 100% survival rate [34].
In the present work, we report the in vivo results of Spine-Ghost implantation in a sheep
vertebral defect model. The performance was compared to a commercial biphasic cement –
Cerament™|Spine Support. Cerament™’s application for VCFs has been well documented [18-
20]. After the 6 month-experimental period sheep were euthanized and the vertebrae (L4) were
collected. Samples were assessed by micro-CT, histological, histomorphometric, and
immunohistological methods, for osteointegration and cement resorbability evaluation
purposes. After the implantation period, cement resorption with concomitant integration into
the newly formed bone was observed, both in control and experimental groups.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
95
Spine-Ghost seems a very promising material for vertebroplasty applications, showing an
identical – if not superior – biological response to the one elicited by the commercial available
control Cerament™.
2. Material and methods
2.1 Cement development and characterization
Spine-Ghost is a new bioactive injectable cement for percutaneous vertebroplasty that
was developed based on Vitale-Brovarone’s patent (EP2569025). As described elsewhere [22],
a composite cement was obtained mixing four different phases. In particular, commercial type
III dental α-calcium sulphate hemihydrate (CSH) was used as matrix that was enriched by
spray-dried mesoporous bioactive particles (W-SC). CSH was used due to its well-known
biocompatibility and ability to set upon mixing with water.
W-SC were produced through the water-based synthesis described in a previously
submitted paper [35] and were used for their known high bioactivity and ability to release
silicon and calcium ions, which have been proven to be osteoinductive [23]. A glass-ceramic
radiopaque phase containing ZrO2 (SiO2/CaO/Na2O/ZrO2, 57/30/6/7 %mol) coded as SCNZgc
was dispersed as a third phase to increase the mechanical properties of the cement and to impart
a satisfactory radiopacity, in order to allow the radiological control of the cement injection. The
different powders were mixed in the following proportion α-CSH/SCNZgc/W-SC: 70/20/10
%wt. and were then combined with water inside a syringe using an optimized liquid to powder
ratio (L/P=0.4 ml/g), in order to obtain an injectable paste [22].
Prior to the in vivo study, the cement went through bioactivity and resorbability, ex vivo
injection, mechanical and in vitro testing [22,36]. All the tests were carried out using a
commercial reference as control prepared according to the manufacturer’s instructions
(Cerament™).
2.2 In vivo large animal model
Animal handling and surgical procedures were implemented following the European
Community guidelines for the care and use of laboratory animals (Directive 2010/63/UE) and
with the required legal consent from the national competent authorities [37,38]. Cerament™
and Spine-Ghost were implanted in a vertebral body defect (L4), according to the developed
model [34]. 16 skeletally mature sheep, with an average body weight of 56.8±5.3 kg, were
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
96
randomly allocated into two groups: control group A, injected with Cerament™; and
experimental group B, injected with Spine-Ghost. All underwent PVP. Prior to surgery the
animals fasted for 24 hours. Following anesthesia pre-medication with atropine (0.05 mg/kg
subcutaneous), xylazine (0.1 mg/kg intramuscular), butorphanol (0.01 mg/kg intravenous) and
carprofen (2 mg/kg subcutaneous); induction was achieved with thiopental sodium 5% (5-10
mg/kg intravenous). After induction, the sheep were positioned and fixed on a radiolucent table
in ventral decubitus with the hind limbs retracted caudally. Anesthesia maintenance was assured
with isoflurane 1-2% under spontaneous ventilation. The surgical field was clipped and
aseptically prepared. L4 was identified under tactile and fluoroscopic guidance (Digital C-Arm
ZEN 2090 Pro, Genoray, Co., Ltd., Korea). A V-shaped defect was bilaterally manually drilled
in the cranial hemivertebrae, in a modified parapedicular approach, as advocated in the formerly
developed model [34]. Cerament™ and Spine-Ghost were prepared at room temperature,
according to the manufacturers’ instructions and were injected under fluoroscopic guidance into
the defect, using a bone-filler system device (Medtronic Spine LLC, Portugal). The mean time
of injection was one minute and the injected volume was approximately 1.2 mL. Both injected
materials were allowed to set in the anaesthetized sheep for 2 hours. Amoxicillin and
clavulanate acid (15 mg/kg, once a day, subcutaneous), carprofen (2 mg/kg, once a day,
subcutaneous) and butorphanol (0.15 mg/kg, twice a day, intramuscular), were administered for
7 days after surgery. A fluorochrome (calcein green, 15 mg/kg) was also subcutaneously
injected fifteen days after surgery. Sheep were released into the pasture the whole 6-month
implantation period. Another fluorochrome (alizarin complexone 25 mg/kg) was
subcutaneously injected two weeks before sacrifice. After the 6-months implantation period,
the animals were sedated with xylazine and sacrificed by pentobarbiturate intravenous injection
and the vertebrae explanted. Biological response and material integration were assessed firstly
by micro-CT, and then by histological studies, as described below.
2.3. Assessment of tissue regeneration
a. Macroscopic inspection
All vertebrae were identified under tactile and fluoroscopic guidance. Vertebrae were
assessed in situ for signs of soft tissue inflammation, of new bone formation and cement
presence. Then the 16 vertebral segments (L4) were collected from the cadavers of the two
groups. Soft tissue was extracted, and using a bone saw, the spinous and transverse processes
were removed to fit the vertebrae into the micro-computed tomography (micro-CT) chamber
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
97
while preserving the vertebral arch. Vertebrae were stored immersed in 4% formaldehyde in
phosphate buffered saline for two weeks, for fixation. After micro-CT scanning, vertebrae were
divided in two parts, following their sagittal plane. Each sample was trimmed in order to
exclude the vertebral canal and arch. Vertebral bodies’ defects were evaluated macroscopically
regarding cement integration/resorption, new bone formation and cortical disruptions.
b. Micro-CT assessment
All vertebrae underwent micro-CT scanning (Skyscan 1174, Kontich, Belgium) while
still intact. The vertebrae were removed from 4% formaldehyde, rinsed with distilled water and
coated with Parafilm M® (Sigma Aldrich, Missouri, USA), to avoid sample dehydration.
Subsequently, vertebrae were posed in a rotation stage fixed by commercial play-dough, with
their longitudinal axis matching the system’s rotational axis. Scans were performed with 50-
kVp, 800-µA, and a 1-mm aluminum filter. The pixel size was 62.08, exposure time 2,200 ms,
rotation step 0.8°, full rotation over 360°, with 2 average frames per image. Each vertebra went
through one scan, over approximately 59 minutes, assuring the imaging of the cranial
hemivertebrae containing the bone defects, comprising 450 cross-sections. The cross-section
images were reconstructed using N-Recon software (Skyscan, Kontich, Belgium). In the
analyzer software (CTAn, Skyscan, Kontich, Belgium) two volumes of interest (VOIs) were
defined for each vertebra: 1) VOI Defect, constituted by a set of regions of interest (ROIs),
which outlined the defect (and residual cement), every other ten sections along the totality of
the defect, and 2) VOI CHv, an elliptical VOI containing only intact trabecular bone, identical
for all vertebrae, with 15 mm of length and 7 mm of height (100 cross-sections), defined within
the caudal hemivertebrae. Next, the following 3D structural parameters were evaluated: relative
bone volume (BV/TV), specific surface (BS/BV), trabecular thickness (Tb.Th), trabecular
separation (Tb.Sp), trabecular number (Tb.N), and tissue volume (TV); this last one in an
attempt to consistently characterize the volume of the injected defect. A uniform threshold
method was applied.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
98
c. Histology
i. Undecalcified histology
For qualitative evaluation of the slides and posterior histomorphometry, sections were
included in resin. Initially the samples were fixed in 70% alcohol, followed by gradual
dehydration with alcohol in increasing concentrations and defatting with xylol. Subsequently
they were embedded in Technovit 9100 New® (Heraeus-Kulzer, Wehrheim, Germany),
according to the manufacturer’s instructions. From each resulting block, a minimum of three
70-80 µm slices was attained by the means of a Leica SP1600 Saw Microtome (Germany), at
very low speeds. Sections were cut in such a way that the defective vertebral body with cement
and adjoining bone were included. Samples were then processed for routine staining with
Giemsa-Eosin and mounted for fluorescence microscopy.
For the slides observation and imaging, slides were digitized by means of the
Nanozoomer SQ (Hamamatsu Photonics, Kyoto, Japan). For fluorescence microscopy,
unstained resin sections of each sample were mounted in aqueous mounting medium;
observation and pictures were done using an optic fluorescence microscope (Olympus BX41)
equipped with a WB Fluorescence cube (Olympus U-LH100HG).
For histomorphometric studies, measurements were made with resource to Giemsa Eosin
staining and fluorochromes labelling. NDP.2 View software (Nanozoomer Digital Pathology,
Hamamatsu Photonics, Japan) was used. Two circular areas of interest (AOI), with the same
diameter – 20 mm2 –, were defined to evaluate the bone-cement interface: A) within the defect
to evaluate new bone formation; and B) outside the bone defect to evaluate mature trabecular
bone (Figure 1).
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
99
Figure 1. Histomorphometric study. Giemsa staining, 0.55x magnification; the circles are limiting the two areas
of interest: A) newly formed trabecular bone within the defect; B) mature trabecular bone outside the defect.
Scale bar on image.
The following bone parameters were assessed for each region of interest, following the
guidelines of the American Society for Bone and Mineral Research (ASBMR): bone area (B.Ar,
mm2), relative bone volume (BV/TV, %) and trabecular thickness (Tb.Th, µm); mineral
apposition rate (MAR) was also calculated for both groups through the fluorochromes labelling.
ii. Decalcified histology
For demineralization, samples were immersed in a formic acid 5% solution and
subsequently followed routine processing and paraffin inclusion. Each paraffin block was cut
into 4-5 µm slices for posterior histochemistry and immunohistochemistry processing.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
100
For histochemistry sections were stained with Masson and Mallory Trichrome using Bio-
Optica kits (Bio-Optica Milano, Milan, Italy), followed by dehydration and mounting, for better
imaging of connective tissue. Again, slides were digitized using Nanozoomer SQ for ulterior
observation and imaging.
For immunohistochemistry, the samples were checked for the expression of osteogenic
differentiation markers (osteopontin, osteocalcin) and osteoclast differentiation markers
(TRAP). An enzymatic antigen retrieval protocol was developed and applied. Incubation with
a Trypsin-EDTA 0.5% solution at 37 ºC, followed by RT cooling of sections was performed.
The positive controls consisted in slides containing bone, known to show positive reaction with
osteocalcin and osteopontin, and lung, known to show positive reaction with TRAP. The
negative control was prepared using thymus, lymph node and cerebellum. Additional controls
were prepared with sample bone sections and the primary antibody omitted.
2.4 Statistical Analysis
Results from the micro-CT analysis and histomorphometry were analyzed using SPSS 22
for Windows (SPSS Inc., Chicago, IL). One way ANOVA analysis was performed, with means
compared by the Tukey test (0.05 level), whenever assumptions were respected. Normality was
verified using the Shapiro-Wilk test (p < 0.05), and homogeneity of variance was verified with
resource to Levene’s test for equality of variances. For variables that did not have a normal
distribution, Kruskal-Wallis ANOVA was applied.
3. Results
3.1 Cement development and characterization
Prior to the in vivo study, the cement went through bioactivity, resorbability, ex vivo
injection, mechanical, and in vitro testing, all of which with favorable results [22,36], qualifying
it for further in vivo studies.
Injectability and radiopacity have been positively demonstrated in explanted vertebrae,
using a 13-gauge vertebroplasty needle for injection. As can be seen in Figure 2A the cement
could be easily injected without interruption and it showed a satisfactory radiopacity, assessed
inside the interventional radiology operating room of the Candiolo Cancer Institute (Figure 2B).
In comparison to the commercial reference, Spine-Ghost cement showed a high bioactivity
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
101
already after 8 hours of soaking in simulated body fluid (SBF), with the appearance of
diffraction peaks identified with hydroxyapatite. In Figure 2C many cauliflower
hydroxyapatite crystals can be observed after 7 days of soaking in SBF. Spine-Ghost showed
mechanical properties comparable to the one of the healthy vertebral cancellous bone [22] and
significantly higher (14 MPa-18MPa in wet and dry conditions respectively) than the
commercial reference Cerament™. Spine-Ghost was able to harden completely in less than 1
hour in good agreement with the clinically used commercial reference and thus suitable for the
vertebroplasty procedure.
Figure 2. Cement characterization. A) Syringe after the injection of Spine-Ghost, coupled with a 13-gauge
vertebroplasty needle and Spine-Ghost cement extruded on a paper sheet to prove its injectability; B) Spine-
Ghost radiopacity assessment C) FE-SEM micrograph of precipitated HAp on Spine-Ghost after 7 days of
immersion in SBF and relative EDS spectrum.
3.2 In vivo findings
All sheep remained anesthetized for 2 hours after injection and recovered well from
surgery. Two sheep from group A experienced an abrupt drop in the arterial blood pressure
during cement injections. No cardiovascular changes were observed in the other animals. In the
second sheep intervened, from group A, rupture of the ventral cortical bone of the vertebral
body was observed under the fluoroscope, with a minor leakage of cement to the ventral surface
of the vertebral body. One sheep from group A developed proprioceptive deficits of the hind
limbs, possibly due to cement leakage around the defect entry point, which affected the spinal
nerve roots; nevertheless, this sheep remained ambulatory and had fully recovered after
approximately 2 months. In two sheep from group A, the connection between the two bilateral
defects was not wide enough so the cement was injected bilaterally to avoid leakage. In vivo
procedures were successful with a survival rate of 100%, and all animals completed the 6-month
implantation period. At the time of sacrifice all the animals presented a body condition score of
4/5, were alert and active and presented normal species behavior. All animals gained weight
during the implantation period (an average increment of 6.4 kg with an initial body weight of
56.84±5.28 kg).
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
102
3.3 Assessment of tissue regeneration
a. Macroscopic
No sheep showed obvious signs of inflammation of the surrounding soft tissues and,
under fluoroscopic guidance, radiopacity differences between the intervened vertebra and the
adjoining vertebrae were not noteworthy (minimal to null). Explanted vertebrae from both
groups had minimal to null signs of the PVP, with no signs of the cements or of the surgical
instrumentation entry points, which were in all cases covered by newly formed cortical bone,
showing in just a few cases a minor pale to rose discoloration (Figure 3A).
Figure 3. Macroscopic assessment. A) Instrumentation entry point with a pink discoloration pointed by the
cannula; B) hemivertebra, after sagittal cut, with cement still evident (large white arrow) and adjoining newly
formed bone (small white arrow); C) macroscopic evidence of cortical disruption of the vertebral canal.
After micro-CT scanning, vertebrae were cut along their sagittal plane and again
macroscopically inspected. At this point, one vertebra from group A, belonging to the first
sheep intervened, had to be discarded due to technical issues. Consequently, the rest of the study
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
103
and corresponding results are for n=7, when it comes to group A. All vertebrae, from groups A
(n=7) and B (n=8), showed evident signs of cement resorption and new bone formation (Figure
3B), with no gaps between the cement and the bone. One vertebra from group A, belonging to
the fifth sheep intervened, showed macroscopic signs of cortical disruption (Figure 3C). There
was also evident in all samples an orange coloration over the newly formed bone, due to alizarin
orange administration.
b. Micro-CT assessment
After the first macroscopic evaluation, micro-CT scanning of the intact vertebrae was
performed. It presents the major advantage of enabling the sample evaluation without
destroying it; however, in this study, it must be taken into consideration that the residual
presence of the cements could not be separated from the new trabecular bone, due to the similar
radiopacities in between them. Therefore, all further measurements and rendered models were
attained and analyzed taking this fact into consideration.
The qualitative analysis of the reconstructed cross-section images, using CTAn (Skyscan,
Kontich, Belgium), allowed the in situ comparison between the two injected cements resorption
and new bone formation. In three of the samples (two controls and one Spine-Ghost augmented)
the defect was hard to visualize clearly. Moreover, the evaluation of cases of disruption of the
vertebral canal, the vertebral cortex, the nutritional foramina, and the interconnection of the
defects was also enabled, as presented in the following graphic (Figure 4).
Figure 4. Clustered stacked chart presenting micro-CT qualitative evaluation. Data obtained from the
injected vertebrae: group A (n=7) – Cerament™ –, and group B (n=8) – Spine-Ghost. Legend: ND – not
disrupted; D – disrupted.
25
8
2
1
5
7
1 1
6
7
2 2
5
6
Num
ber
of
Cas
es (
n)
Cerament
Micro-CT Qualitative Evaluation
Defects not Interconnected
Defects Interconnected
D Nutritional Foramen
ND Nutritional Foramen
D Vertebral Cortex
ND Vertebral Cortex
D Vertebral Canal
ND Vertebral Canal
Spine-Ghost
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
104
Still in CTAn (Skyscan, Kontich, Belgium) 3D structural parameters were calculated for
the defect and the caudal hemivertebrae (CHv) areas, as shown in Table 1. Data are presented
as mean ± standard deviation.
Table 1. Descriptive analysis of the 3D structural parameters
Biomaterial Defect CHv
[Mean±Std. Deviation] [Mean±Std. Deviation]
BV/TV % Cerament 68.43±5.80 42.49±6.69
Spine Ghost 79.00±10.24 40.20±9.97
BS/BVmm2/mm3 Cerament 9.54±2.03 14.36±2.20
Spine Ghost 6.58±2.90 13.87±3.00
Tb.Th mm Cerament 0.41±0.11 0.25±0.03
Spine Ghost 0.58±0.21 0.25±0.04
Tb.Sp mm Cerament 0.21±0.02 0.33±0.05
Spine Ghost 0.24±0.17 0.39±0.04
Tb.N 1/mm Cerament 1.77±0.35 1.72±0.15
Spine Ghost 1.48±0,39 1.59±0.16
TV mm3 Cerament 1299.51±291.21 510.72±0.00
Spine Ghost 1146.36±158.92 510.72±0.00
Table 1. Descriptive analysis of the 3D structural parameters. Data acquihired from the
injected vertebrae from group A (n=7) – Cerament™ –, and group B (n=8) – Spine-Ghost. Legend:
BV/TV - relative bone volume; BS/BV – specific surface; Tb.Th - trabecular thickness; Tb.Sp -
trabecular separation; Tb.N - trabecular number; and TV – tissue volume.
Mean trabecular thickness (Tb.ThDefect) and mean trabecular separation (Tb.SpDefect) of
the two groups, regarding the defect area, present no statistically significant differences; Spine-
Ghost values are slightly superior.
Likewise, there is no statistically significant difference in the trabecular number
(Tb.NDefect) of the two cements, though Cerament™’s mean value is superior. On the contrary,
the mean relative bone volume (BV/TVDefect) was significantly higher in Spine-Ghost
augmented vertebrae, when compared to Cerament™, and no significant differences were
found in the caudal hemivertebra intact bone that could justify the higher bone volume ration
found in the Spine-Ghost group. BS/BV or specific surface was significantly lower in Spine-
Ghost samples when comparing to control. This suggests a thicker structure and might be
related to a lower bone turn-over rate because bone resorption and formation occurs on bone
surfaces. Moreover, when comparing the mean values of all structural parameters between the
Defect and the CHv areas, mean trabecular number (Tb. N) is the only one that does not present
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
105
a statistically significant difference, indicating a normal tissue evolution, with an emergent open
tissue structure.
3D models were also assembled in the rendering software (CTVol, Skyscan, Kontich,
Belgium), enabling the visualization of the injected defects and the comparison between the
two cements. Cement resorption was observed in both groups, with subsequent new bone
formation filling the defects, which presents a porosity slightly closer than that of the normal
trabecular bone observed in the caudal hemivertebrae (Figure 5). These images are in
accordance to the abovementioned assumptions made based on the 3D structural parameters.
Figure 5. Micro-CT post-mortem assessment. Here it can be seen the reconstructed cross-section images and the
3D rendered models of 2 injected vertebrae – one from each group –, explanted from the sheep closest to the
mean, when it comes to the trabecular bone mineral densities of the intact caudal hemivertebrae (BMDCHv): 1)
vertebra injected with Spine-Ghost, with a BMDCHv of 0.45 gcm-3; 2) vertebra injected with Cerament™, with a
BMDCHv of 0.50 gcm-3; a) cross-section image of CHv; b) 3D rendered image of 30 cross-sections of VOICHv; c)
cross-section image of the defect; d) 3D rendered image of 30 cross-sections of VOIDefect.
c. Histology
i. Undecalcified histology
As described in the methods section, undecalcified sections were stained with Giemsa
Eosin. Mature bone is stained in a darker shade of red/pink, whilst younger bone takes a lighter
shade. Soft tissue and nuclei are stained in different shades of blue.
Qualitative evaluation of the slides showed new bone formation within the area of the
defect for both groups in most of the vertebrae (13 out of 15); the pattern of long trabeculae,
mostly parallel to the long axis of the vertebrae, was interrupted by a denser net of highly
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
106
interconnected trabeculae, in both groups (Figure 6A and B). In all sections bone was directly
in contact with residual cements and no fibrous tissue or inflammatory reactions were observed.
Also, the newly formed bone in the defect areas was mostly mature bone, with some areas of
lighter pink stain where bone was more recently mineralized (Figure 6A). In the Spine-Ghost
sections an affinity of Giemsa to the biomaterial was observed (Figure 6B).
In two samples from Cerament™ group and one from Spine-Ghost there were relatively
large areas of defect yet to be occupied by bone (Figure 6C and 6D). The unoccupied area was
larger in the Spine-Ghost single sample where this occurred (Figure 6D), whilst empty space
areas were observed in three out of seven samples of the Cerament™ group (Figure 6C). In
none of these sections a fibrous capsule was observed neither was inflammatory reaction.
Figure 6. Undecalcified Technovitt 9100 sections of two vertebrae. A) Cerament™ augmented vertebra section
(magnification 0.55x) with areas of lighter pink stain where bone was more recently mineralized (black arrows);
B) Spine-Ghost augmented vertebra section (magnification 0.54x) showing the affinity of Giemsa to the
biomaterial, which stains in shades of blue (white arrowheads). Both defect areas are fulfilled with an intricate
network of trabeculae, with multiple directions, surrounding and penetrating the remains of the cements. In
contrast, is evidenced the trabecular structure of intact tissue, mostly parallel to the long axis of the vertebrae. C)
Cerament™ augmented vertebrae section (magnification 0.55x) where empty areas with some cement present
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
107
may be seen; it’s also visible the disruption of the cortex of the vertebral canal (black arrow). This section
belongs to same vertebra shown above in Figure 3. D) Spine-Ghost augmented vertebra section (magnification
0.55x) where an empty area with some cement present may be seen. This was the only section from this group
where the defect cavity wasn’t filled with trabeculae. Scale bar on images.
Histomorphometric results showed no statistically significant differences between the
two groups regarding trabecular thickness within the defect and in the intact tissue. No
statistically significant differences were found in the area occupied by bone and the relative
bone volume, although they were higher in the defect Spine-Ghost sections (yet lower in the
intact tissue). Results are summarized in Table 2.
Table 2. Descriptive analysis of the Histomorphometric Parameters
Biomaterial Defect CHv
[Mean±Std. Deviation] [Mean±Std. Deviation]
B.Ar mm2 Cerament 13.51±3.78 8.51±0.87
Spine Ghost 14.33±2.01 8.01±1.56
BV/TV % Cerament 67.5 42.5
Spine Ghost 71.65 40.1
Tb.Th mm Cerament 0.21±0.09 0.20±0.09
Spine Ghost 0.20±0.10 0.21±0.10
Table 2. Descriptive analysis of the histomorphometric parameters. Legend: B.Ar – trabecular
bone area; BV/TV - relative bone volume; Tb.Th - trabecular thickness.
Since there was no fibrous capsule observed in any of the sections, the affinity index can
be considered of 100%.
The data suggest that after 6-month implantation time, Spine-Ghost has a similar behavior
when compared to control.
Unstained resin sections of each sample were mounted in aqueous mounting medium and
observed using an optic fluorescence microscope. Observation of some of the sections suggests
that new bone formation started closer to cement, since the red line – correspondent to the
second fluorochrome injected (alizarin complexone) – is located further away from cement
remains (Figure 7A), and also calcein green was the first label injected. However, this was not
the only pattern of bone deposition observed, since there are areas in which the alizarin
complexone appears limiting the trabeculae, and areas of bone remodeling within the trabecular
structure are also apparent (Figure 7B). The mineral apposition rate (MAR) was calculated as
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
108
being of 1.60±0.27 µm/day in the control group and 1.39±0.54 µm/day in the experimental
group.
Figure 7. Spine-Ghost augmented vertebra section. A) double fluorochrome labelling obvious, with the calcein
green line placed closer to material (large arrow) than alizarin complexone (small arrow); B) double
fluorochrome marking showing different patterns of bone apposition and bone remodeling, with alizarin
complexone (small arrow) encircling a trabecula. Scale bar on images.
ii. Decalcified histology
Histological observations were made on decalcified samples that followed routine
processing and paraffin inclusion, and subsequently were cut into 4-5 µm slices (Figure 8).
Mallory and Masson trichromes staining (Bio-Optica, Milan, Italy) allowed a more detailed
observation.
In both groups, the vertebral body defects were being filled by an intricate network of
trabeculae with neatly organized collagen fibres, as evidenced by Masson’s trichrome (Figure
8A and 8C). It was also evident the presence of bone marrow within the trabeculae, and cement
residues, which were integrated in the trabeculae themselves (Figure 8B and 8D). In
Cerament™ group sections, larger quantities of cement are apparent within the trabeculae when
compared to Spine-Ghost sections. Again, no inflammatory reaction, signs of increased bone
resorption or fibrous encapsulation of both biomaterials were seen. Most of the sections (4 out
of the 7 control samples and 7 out of 8 Spine-Ghost samples) showed complete filling of the
defect area with new trabecular bone.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
109
Figure 8. Sections of decalcified histology with Mallory and Masson trichromes staining. A) Spine-Ghost
augmented vertebra demineralized section (Masson Trichrome with aniline blue), 0.5x magnification, showing
the intricated net of trabecular bone within the defect area; B ) and D) Spine-Ghost and Cerament™ augmented
vertebrae demineralized sections, respectively (Mallory’s trichrome), 10x magnification, showing biomaterial
integration into the trabecular bone structure (arrowheads), blue staining of collagen fibres (small arrows); C)
Cerament™ augmented vertebra demineralized section (Masson Trichrome with aniline blue), 0.58x
magnification. Scale bar on images.
For immunohistochemistry, the samples were checked for the expression of osteogenic
differentiation markers (osteopontin, osteocalcin) and osteoclast differentiation markers
(TRAP). Antibodies were strongly adsorbed by cement particles, leading to ulterior staining by
DAB chromogen (Figure 9A).
Apart from the TRAP adsorbed to the cement, no relevant TRAP detection was detected
in Spine-Ghost sections. The same applies to Cerament™ sections. No osteoclasts were
observed at the bone/cement interface (Figure 9B).
No relevant differences were found between the two groups.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
110
Figure 9. Sections of immunohistochemistry of Spine-Ghost augmented vertebra demineralized sections. A)
100x magnification, anti-osteopontin antibody, showing DAB stained biomaterial (large arrow); osteocytes, bone
lining cells and cells within bone marrow are also positive (arrowheads). B) 1000x magnification, anti-TRAP
antibody. The image shows an area of cement/bone interface. Scale bar on images.
4. Discussion
In vivo model was considered appropriate for preclinical studies, although requiring
surgical expertise. No cement leakage was observed into the vertebral foramina, which is in
accordance with the low number of animals presenting post-surgical neurologic deficits, even
if mild (1 out of 16), and with the high survival rate (100%) obtained.
There were some limitations in the micro-CT quantitative analysis of new bone
formation, namely the presence of residual cements within the defects. Cerament™’s
radiopacity is conferred by the presence of iohexol in its constitution. Contrariwise, Spine-
Ghost radiopacity is granted by the presence of zirconia oxide in the glass-ceramic phase
(SCNZgc). At previous ex vivo studies, Cerament™ presented more image artefacts than Spine-
Ghost, due to its greater initial radiopacity [36]. However, we have observed that at the end of
the implantation this artefact was considerably reduced, not interfering significantly with the
sample’s image acquisition. On the contrary, due the radiodensity similarities between both of
the residual cements and trabecular bone, as a result of the presence of calcium sulphate in their
constitutions, we were not able to isolate the trabecular bone from the residual cements, at
binary selection. To overcome this technical problem, we chose to use a global threshold
method, to ensure that the differences between study groups were due to experimental effects
rather than image processing effects, and we also analyzed an equal volume of interest
(510.72053 mm3) of normal trabecular bone for every caudal hemivertebrae (VOICHv).
Regardless, this may be one of the reasons that explain the statistically significant differences
in most of the 3D structural parameters when comparing between the defect area and the CHv
area. The degree of this influence could not be determined.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
111
Another concern is related to the nominal isotropic resolution of the equipment. The
smallest feasible voxel size (i.e., highest scan resolution) was used. However, while it is
generally considered that the highest ratio of voxels to object size is 2, this is associated with
substantial local errors (fairly small when averaged over an entire structure) [39]. Ideally, the
ratio should be higher for accurate morphologic measurements. When considering relatively
large structures such as trabeculae in human and ovine bone (100 to 200 μm thick), small
differences in voxel size (e.g., 10 to 20 μm) have little effect [39]. 3D micro-CT analysis data
are known to be highly correlated with 2D histomorphometric data [40,41] and results from
both methods should be interpreted in complement and bearing in mind advantages and
limitations of both methods.
Finally, when intending to compare micro-CT 3D structural parameters with 2D
histomorphometric measurements, it is recommended that the sample is scanned and posteriorly
cut following the same plane. This was not possible in this study because of the vertebrae’s
geometry, which made them impossible to fix over the micro-CT rotation stage in any other
way; on the other hand, two symmetric samples from every vertebrae were compulsory to
histology. Therefore, in this particular study we chose to scan the vertebrae in a different plane
from the histology cuts, in detriment to the comparison of the attained values in micro-CT vs.
histomorphometry.
Histomorphometry is less sensitive in detecting global bone mass changes when
compared to micro-CT. The limited number of sections observed in manual histomorphometric
cannot illustrate as accurately as 3D micro-CT analysis volumetric changes. However, the
overall results show a trend in BV/TV and bone occupied area that micro-CT data analysis
reveal as significant. Differences in mean trabecular thickness values are harder to explain, but
again, we believe there is an overestimation of the micro-CT mean trabecular thickness values
in Defect areas due the presence of the residual cements. This also can be confirmed by looking
at the 3D rendered models where we can see a more open trabecular net in the normal bone
sites (CHv) rather than in the defect areas. Contrariwise, in histomorphometry, though a total
of 525 trabeculae were hand measured, this was done in a limited number of sections.
Nonetheless, though the mean trabecular thickness values are different, no statistically
significant differences were found between the two groups with either of the methods.
At optic fluorescence microscopy, some degree of label escape was observed, probably
due to the length of the interval between both labels, particularly regarding calcein green, and
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
112
a clear labelling line was not always seen. Another difficulty whilst analyzing the samples was
the strong bone marrow auto fluorescence. Nevertheless, it allowed to observe not only new
bone formation but also bone remodeling within the trabecular structure. Also, mineral
apposition rate was calculated and presented no statistically significant differences between the
two groups though Spine-Ghost presented a lower value, suggesting a slower resorption rate.
In a future study of the same model it would be worthwhile to consider another fluorochrome
labelling protocol or other data labelling method to overcome these difficulties.
Histological observations allowed a more detailed observation. Mallory and Masson
trichromes staining (Bio-Optica, Milan, Italy) evidenced the neatly organized collagen fibres
present in the newly formed bone, as well as the biomaterial integration into the trabecular bone
structure. Nevertheless, no inflammatory reaction, signs of increased bone resorption or fibrous
encapsulation of both biomaterials were seen in none of the groups and most of the sections (4
out of the 7 control samples and 7 out of 8 Spine-Ghost samples) showed complete filling of
the defect area with new trabecular bone.
For immunohistochemistry, an enzymatic antigen retrieval protocol was applied. The size
and nature of the samples posed technical difficulties for the completion of the standard thermal
antigen retrieval step. Therefore, for the present samples an alternative method through
incubation with a Trypsin-EDTA 0,5% solution at 37 ºC, followed by RT cooling of sections
was applied. This allowed good epitope labelling, with no background and excellent tissue
morphology preservation. Immunohistochemistry sections showed no relevant differences
between the two groups and the relatively low levels of detected antigens were what would be
expected to occur in mature, stable bone. No osteoclasts were observed at the bone/cement
interface, though in a small part of the sections, a small number of osteoclasts-like cells, TRAP
positive, were detected within the new trabeculae, suggesting that bone remodeling processes
were in course, as it is to be expected.
To finish, it would be interesting to further investigate the potential of the test material in
promoting new bone formation at different implantation times and different bone defect models,
and to assess the in vivo mechanical strength of the filled vertebral body defect.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
113
5. Conclusions
Spine-Ghost was successfully created as an injectable composite cement, presenting high
bioresorbability and high bioactivity. It is particularly suited for vertebroplasty, since it proved
to be radiopaque enough for fluoroscopy guided vertebral augmentation, and, once set, showed
a mechanical strength comparable to the compressive strength of healthy vertebral trabecular
bone and higher than the commercial reference. Moreover, it is easily injected into bone defects
and presents an ex vivo reduced setting time, when compared to control cement. The new ovine
model used, though requiring surgical expertise, is considered adequate for preclinical in vivo
studies, simultaneously efficient and safe, with a survival rate of 100 percent in the present
study.
Spine-Ghost demonstrated to be a very promising bone substitute biomaterial for
vertebroplasty applications, with a biological response identical, if not superior – as suggested
by the higher mean BV/TV measured – to the one elicited by the available commercial control.
New bone formation was observed in every sheep, with concurrent cement resorption and
integration into the new trabecular bone.
Acknowledgements: This work has been supported by the European Commission under the
7th Framework Programme through the project RESTORATION, grant agreement CP-TP
280575-2. The support from Medtronic Spine LLC Company, Portugal in supplying surgical
material is gratefully acknowledged. The support from Hamamatsu, Portugal in supplying
Nanozoomer is also gratefully acknowledged. Dr. Francesca Tallia, Dr. Lucia Pontiroli and
Mehran Dadkah are kindly acknowledged for their support in developing the Spine-Ghost
cement. To finish, we would like to thank Dr. José Abranches, for his selfless help and extensive
knowledge, vital for our model development.
Conflicts of interest: The authors have no potential conflict of interest.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
114
References
[1] D. Alexandru, & W. So, Evaluation and management of vertebral compression fractures,
Perm. J. 16 (2012) 46-51. Doi: 10.7812/TPP/12-037.
[2] T. P. van Staa, E. M. Dennison, H. G. Leufkens, & C. Cooper, Epidemiology of fractures
in England and Wales, Bone 29 (2001) 517–522. Doi:10.1016/S8756-3282(01)00614-7.
[3] The European Prospective Osteoporosis Study (EPOS) Group, Incidence of vertebral
fracture in Europe: Results from the European Prospective Osteoporosis Study (EPOS). J Bone
Miner Res 17 (2002) 716–724. Doi: 10.1359/jbmr.2002.17.4.716.
[4] Y. Katsuura, J. M. Osborn, & G. W. Cason, The epidemiology of thoracolumbar trauma: a
meta-analysis, J. Orthopaed. 13 (2016) 383-388. Doi: 10.1016/j.jor.2016.06.019.
[5] Y.F. Gu, Y.D. Li, C.G. Wu, Z.K. Sun, & C.J. He, Safety and efficacy of percutaneous
vertebroplasty and interventional tumor removal for metastatic spinal tumors and malignant
vertebral compression fractures, Am. J. Roentgenol. 202 (2014) 298-305. Doi:
10.2214/AJR.12.10497.
[6] H.J. Jiang, J. Xu, Z.Y. Qiu, X.L. Ma, et al., Mechanical properties and cytocompatibility
improvement of vertebroplasty pmma bone cements by incorporating mineralized collagen,
Materials 8 (2015) 2616-2634. Doi: 10.3390/ma8052616.
[7] P.F. Heini, U. Berlemann, M. Kaufmann, K. Lippuner, et al., Augmentation of mechanical
properties in osteoporotic vertebral bones–a biomechanical investigation of vertebroplasty
efficacy with different bone cements, Eur. Spine J. 10 (2001) 164-171. Doi:
10.1007/s005860000204.
[8] W. Clark, P. Bird, P. Gonski, et al., Safety and efficacy of vertebroplasty for acute painful
osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-
controlled trial, Lancet. 388 (2016):1408-1416. Doi: 10.1016/S0140-6736(16)31341-1.
[9] D. Wardlaw, S. R. Cummings, J. Van Meirhaeghe, et al., Efficacy and safety of balloon
kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a
randomised controlled trial, Lancet. 373(2009) 1016-1024. Doi: 10.1016/S0140-
6736(09)60010-6.
[10] A. Boger, A. Bisig, M. Bohner, P. Heini, & E. Schneider, Variation of the mechanical
properties of PMMA to suit osteoporotic cancellous bone, J. Biomat. Sci. Polym. E. 19 (2008)
1125-1142. Doi: 10.1163/156856208785540154.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
115
[11] D. Arens, S. Rothstock, M. Windolf, & A. Boger, Bone marrow modified acrylic bone
cement for augmentation of osteoporotic cancellous bone, J. Mech. Behav. Biomed. Mater. 4
(2011) 2081-2089. Doi: 10.1016/j.jmbbm.2011.07.007.
[12] B.M. Frankel, T. Monroe, & C. Wang, Percutaneous vertebral augmentation: an elevation
in adjacent-level fracture risk in kyphoplasty as compared with vertebroplasty, Spine J. 7 (2007)
575-582. Doi: 10.1016/j.spinee.2006.10.020.
[13] G. Lewis, Properties of acrylic bone cement: state of the art, J. Biomed. Mater. Res. 38
(1997) 155-182. Doi:10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C.
[14] G. C. Anselmetti, A. Manca, K. Kanika, et al., Temperature Measurement During
Polymerization of Bone Cement in Percutaneous Vertebroplasty: An In vivo Study in Humans,
Cardiovasc Intervent Radiol 32 (2009) 491-498. Doi: 10.1007/s00270-009-9509-7.
[15] J. Lieberman, & G. Friedlaender, Bone Regeneration and Repair: Biology and Clinical
Applications, first ed., Humana Press, Totowa, New Jersey, 2005. Doi: 10.1385/1592598633.
[16] N. Aebli, D. Schwenke, G. Davis, T. Hii, et al., Polymethylmethacrylate causes prolonged
pulmonary hypertension during fat embolism: A study in sheep, Acta orthopaed. 76 (2005) 904-
911. Doi: 10.1080/17453670510045570
[17] L.M. Benneker, J. Krebs, V. Boner, A. Boger, et al., Cardiovascular changes after PMMA
vertebroplasty in sheep: the effect of bone marrow removal using pulsed jet-lavage, Eur. Spine
J. 19 (2010) 1913-1920. Doi: 10.1007/s00586-010-1555-y.
[18] S. Marcia, C. Boi, M. Dragani, S. Marini, et al., Effectiveness of a bone substitute
(CERAMENTTM) as an alternative to PMMA in percutaneous vertebroplasty: 1-year follow-up
on clinical outcome, Eur. Spine J. 21 (2012) 112–118. Doi: 10.1007/s00586-012-2228-9.
[19] M. Rauschmann, T. Vogl, A. Verheyden, R. Pflugmacher, et al., Bioceramic vertebral
augmentation with a calcium sulphate/hydroxyapatite composite (Cerament™ SpineSupport)
in vertebral compression fractures due to osteoporosis, Eur. Spine J. 19 (2010) 887-892. Doi:
10.1007/s00586-010-1279-z.
[20] S. Masala, G. Nano, S. Marcia, M. Muto, et al., Osteoporotic vertebral compression
fractures augmentation by injectable partly resorbable ceramic bone substitute (Cerament™|
SPINE SUPPORT): a prospective nonrandomized study, Neuroradiology 54 (2012) 589-596.
Doi: 10.1007/s00234-011-0940-5.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
116
[21] A. Gupta, N. Kukkar, K. Sharif, B.J. Main, et al., Bone graft substitutes for spine fusion:
A brief review, World J. Orthop., 6 (2015), 449-456. Doi: 10.5312/wjo.v6.i6.449.
[22] M. Dadkhah, L. Pontiroli, S. Fiorilli, A. Manca, F. Tallia, I. Tcacencu, C. Vitale-
Brovarone, Preparation and characterisation of an innovative injectable calcium sulphate based
bone cement for vertebroplasty application, J. Mater. Chem. B. 5 (2017) 102-115.
[23] L.L. Hench, Genetic design of bioactive glass, J. Eur. Ceram. Soc. 29 (2009) 1257-1265.
Doi: 10.1016/j.jeurceramsoc.2008.08.002
[24] D. Arcos, A. López-Noriega, E. Ruiz-Hernández, O. Terasaki, M. Vallet-Regí, Ordered
mesoporous microspheres for bone grafting and drug delivery, Chem. Mater. 21 (2009) 1000-
1009. Doi: 10.1021/cm801649z
[25] X. Yan, C. Yu, X. Zhou, J. Tang, & D. Zhao, Highly Ordered Mesoporous Bioactive
Glasses with Superior In Vitro Bone-Forming Bioactivities, Angew. Chem. Int. Ed. 43 (2004)
5980-5984. Doi: 10.1002/anie.200460598
[26] A.B.D. Nandiyanto, & K. Okuyama, Progress in developing spray-drying methods for the
production of controlled morphology particles: From the nanometer to submicrometer size
ranges, Adv. Powder Tech. 22 (2011) 1-19. Doi: 10.1016/j.apt.2010.09.011.
[27] M. Alini, S.M. Eisenstein, K. Ito, C. Little, et al., Are animal models useful for studying
human disc disorders/degeneration? Eur. Spine J. 17 (2008) 2-19. Doi: 10.1007/s00586-007-
0414-y.
[28] H.-J. Wilke, A. Kettler, K.H. Wenger, & L.E. Claes, Anatomy of the sheep spine and its
comparison to the human spine, Anat. Rec. 247 (1997) 542-555. Doi: 10.1002/(SICI)1097-
0185(199704)247:4<542::AID-AR13>3.0.CO;2-P.
[29] E. Verron, M.L. Pissonnier, J. Lesoeur, V. Schnitzler, et al., Vertebroplasty using
bisphosphonate-loaded calcium phosphate cement in a standardized vertebral body bone defect
in an osteoporotic sheep model, Acta biomater. 10 (2014) 4887-4895. Doi:
10.1016/j.actbio.2014.07.012.
[30] H.L. Yang, X.S. Zhu, L. Chen, C.M. Chen, et al., Bone healing response to a synthetic
calcium sulphate/β‐tricalcium phosphate graft material in a sheep vertebral body defect model,
J. Biomed. Mater. Res. B Appl. Biomater. 100 (2012) 1911-1921. Doi: 10.1002/jbm.b.32758.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
117
[31] L.M. Benneker, A. Gisep, J. Krebs, A. Boger, et al., Development of an in vivo
experimental model for percutaneous vertebroplasty in sheep, Vet. Comp. Orthop. Traumatol.
V.C.O.T. 25 (2012) 173-177. Doi: 10.3415/VCOT-11-02-0026.
[32] L.A. Galovich, A. Perez-Higueras, J.R. Altonaga, J.M. Gonzalo Orden, et al.,
Biomechanical, histological and histomorphometric analyses of calcium phosphate cement
compared to PMMA for vertebral augmentation in a validated animal model, Eur. Spine J. 20
(2011) 376-382. Doi: 10.1007/s00586-011-1905-4.
[33] A. Boger, L.M. Benneker, J. Krebs, V. Boner, et al., The effect of pulsed jet lavage in
vertebroplasty on injection forces of PMMA bone cement: an animal study, Eur. Spine J. 18
(2009) 1957-1962. Doi: 10.1007/s00586-009-1079-5.
[34] M.T. Oliveira, J. Potes, M.C. Queiroga, J.L. Castro, et al., Percutaneous vertebroplasty: a
new animal model, Spine J. 16 (2016) 1253–1262, Doi: 10.1016/j.spinee.2016.06.011.
[35] L. Pontiroli, M. Dadkhah, G. Novajra, I. Tcacencu, S. Fiorilli, C. Vitale-Brovarone, An
aerosol-spray-assisted approach to produce mesoporous bioactive glass microspheres under
mild acidic aqueous conditions, Matter. Lett. (unpublished results).
[36] M.T. Oliveira, S. Lucena, J. Potes, M.C. Queiroga, et al., Ex vivo model for percutaneous
vertebroplasty, Key Eng. Mater. 631 (2015) 408–413. Doi:
10.4028/www.scientific.net/KEM.631.408.
[37] Directive 2010/63/EU, Official Journal of the European Union, L276/33-79, 2010, ISSN
1725-2601.
[38] Decreto-Lei nº 113/2013, de 7 de Agosto. Diário da República, 1.ª série — N.º 151.
Ministério da Agricultura, do mar, do ambiente e do ordenamento do território, Lisboa.
[39] M.L. Bouxsein, S.K. Boyd, B.A. Christiansen, R.E. Guldberg, et al., Guidelines for
assessment of bone microstructure in rodents using micro–computed tomography, J. Bone
Miner. Res. 25 (2010), 1468-1486. Doi: 10.1002/jbmr.141.
[40] R. Müller, H. Van Campenhout, B. Van Damme, G. Van der Perre, et al., Morphometric
analysis of human bone biopsies: a quantitative structural comparison of histological sections
and micro-computed tomography, Bone 23 (1998) 59-66. Doi: 10.1016/S8756-3282(98)00068-
4.
Novel mesoporous bioactive glass/calcium sulphate cement for percutaneous vertebroplasty and kyphoplasty: in vivo study
118
[41] T. Uchiyama, T. Tanizawa, H. Muramatsu, N. Endo, et al., A morphometric comparison
of trabecular structure of human ilium between microcomputed tomography and conventional
histomorphometry, Calcif. Tissue. Int. 61 (1997) 493-498. Doi: 10.1007/s002239900373.
Chapter 7
Discussion
Discussion
121
7. Discussion
7.1. Welfare and analgesia in animal models
When assembling a team, one must be conscious of the responsibility of each researcher
for reinforcing the 3R’s concept. From the breeding farms’ conditions, to transportation,
accommodation, and the experiment itself, it is the responsibility of all the research members
in the team to minimize each animal’s pain, suffering and distress (Decreto-Lei no. 113/2013;
European Directive 2010/63). The multidisciplinarity of the research team was considered of
extreme importance, creating the specific knowledge confluence needed for the developed
project. The actions pertaining animal welfare include those of a) choice of the flock and latency
period; b) providing husbandry conditions – adequate accommodation and food supply,
according to the local climate –; c) developing an optimized experimental design –
conscientious number of cases, ex vivo training, suitable radiologic ancillary means and
fluorochromes, minimally invasive procedures, adjusted anaesthetic protocols and
postoperative care –; and d) establishing clear “humane endpoints”, from which the experiment
would be terminated, ending the animal’s suffering and/ or distress.
One of the main difficulties when working with sheep is the recognition of pain and/or
distress signs. Sheep are very stoic animals, which will uneasily show evident signs of pain. It
is of utmost importance for the researcher to know the normal individual and herd behaviour,
thus being able to analyse subtle deviations of posture, appetite, urination, or defecation from
normal, which can be caused by pain (Plummer et al., 2008; Lizarraga & Chambers, 2013).
In this field veterinarians have an added responsibility towards animal physical integrity,
welfare, and – particularly – health, as they are supposedly the most apt team members to
correct pain and/ or illness, as well as to ensure good pre-emptive analgesia and anaesthesia
protocols – with minimal side effects –, and to develop refinement techniques – such as better
surgical models –, when required.
For the present study, the anaesthetic protocol included, as pre-medication, drugs to
provide pre-emptive analgesia and sedation: 1) an α2-agonist – xylazine – for its well-
recognized sedation, analgesia and muscle relaxant effects (Kästner, 2006; Moolchand et al.,
2014); 2) an opioid – butorphanol – to control postoperative acute pain; and 3) a
cyclooxygenase-2 (COX-2)-specific NSAID – carprofen – for postoperative pain, due to its
long-acting analgesic properties with minimal adverse effects (DiVincenti et al., 2014).
Atropine was administered as needed for its anticholinergic action, to decrease saliva secretion;
Discussion
122
although several authors have reported its limited use (Galatos, 2011; Flecknell, 2015; Seddighi
& Doherty, 2016), as large and repeated doses are often needed (0.5 mg/kg intramuscular) to
achieve and maintain the desired effects, and also because of the secondary increase of saliva’s
viscosity, impairing the cleansing of the pharyngeal area (Flecknell, 2015; Seddighi & Doherty,
2016). Induction was achieved with intravenous thiopental sodium, and anaesthesia
maintenance was ensured by the volatile anaesthetic agent – isoflurane 1-2.5% – in oxygen
under spontaneous ventilation.
Several other drugs could have been used. For instance, to replace xylazine, other α2-
agonists – medetomidine, dexmedetomidine or detomidine – are available; yet, xylazine is
known to provide better sedative and analgesic effects than the other drugs in sheep (Kästner,
2006; Moolchand et al., 2014). Attention must be taken when using α2-agonists, because of the
risk of hypoxemia – secondary to alveolar edema and pulmonary congestion –, hypotension and
decrease in gastrointestinal motility. Nevertheless, α2-agonists actions can be reversed by their
antagonists, such as atipamezole, yohimbine and tolazoline. Benzodiazepines, like diazepam
and midazolam, are good alternatives as tranquilizers, also leading to muscle relaxation;
however, they have no analgesic effect and should be used in combination with other agents,
because they can cause transient excitation when administered alone (Seddighi & Doherty,
2016). Likewise, phenothiazines – e.g. acepromazine – can be used as sedatives, but have no
analgesic effect.
Opioids are effective analgesics, but analgesia has a short duration in sheep. The
combination of some opioids – such as tramadol, methadone and morphine – with the α2-
agonist xylazine is known to improve sedation when compared with administration of the α2-
agonist alone, allowing to reduce the α2-agonist’s dose and, subsequently, the incidence and
severity of side effects (de Carvalho et al., 2016). For the present study, an opioid with agonist-
antagonist activity – butorphanol – was the chosen opioid, for its efficacy in sheep (Waterman
et al., 1991), availability and cost-effectiveness. Other possible agents would have been
morphine, pethidine, buprenorphine, fentanyl, hydromorphone, and oxymorphone (Galatos,
2011; Lizarraga et al., 2012). Some authors support the use of fentanyl patches for pain
management, in sheep used for orthopaedic studies (Ahern et al., 2009; Christou et al., 2014).
Moreover, a comparison between transdermally administered fentanyl and intramuscular
administered buprenorphine showed that the first one was superior for alleviation of
postoperative orthopedic pain in sheep (Ahern et al., 2009). Nevertheless, recent studies support
the use of sustained-release buprenorphine as a mean of providing effective, long-acting
analgesia in sheep (Walkowiak & Graham, 2015; Zullian et al., 2016).
Discussion
123
Also for analgesia, NSAIDs are used to induce long-acting analgesia. Combined with
other analgesics, they are effective in providing pre-emptive and long-lasting postoperative
analgesia in small ruminants (Galatos, 2011). NSAIDs are known to reduce inflammation
through inhibition of COX enzymes and prostanoid production in the periphery, thus preventing
peripheral sensitisation (Welsh & Nolan, 1995; Colditz et al., 2011); moreover, it is also
acknowledged NSAIDs’ efficacy in reducing central sensitisation (Lizarraga & Chambers,
2006). The main side effect of NSAIDs is the abomasal ulceration (Lizarraga & Chambers,
2006), thus, their use should be cautious. For this study, the drug of choice was carprofen, for
its long-acting analgesic properties in sheep, with a plasma half-life of 48-72 hours, and its
lower ulcerogenic effect, when compared to most other NSAIDs (Welsh et al., 1992). Flunixin
would also have been a good alternative, as it has already been recognized its efficacy at
increasing the thresholds to noxious mechanical stimulation after just one day of treatment in
sheep suffering from footrot (Welsh & Nolan, 1995). However, it can cause myonecrosis and
injection site inflammation, so it should be administered intravenously (Pyörälä et al., 1999).
As injectable anaesthetics, ketamine or propofol would have been valid alternatives to
thiopental (Gatson et al., 2015). Ketamine has the advantage of compensating the negative
cardiorespiratory effects of both α2-agonists and benzodiazepines, as it possesses incremental
effects on the heart rate, blood pressure and respiratory rate. A recent study by Özkan et al.
(2010), showed that the combinations xylazine-ketamine and diazepam provide sufficient
anaesthesia for minor procedures. The same study concluded that for major surgeries, e.g.
maxillofacial surgery, the combination xylazine-ketamine would present better results, with
faster inductions, better pain control, stable depth of anaesthesia and faster recoveries.
Likewise, propofol is characterized by smooth inductions, effective surgical anaesthesia and
rapid recoveries (Correia et al., 1996), presenting better results, when administered through a
constant rate infusion, than a multimodal protocol using xylazine, thiopental and halothane (Lin
et al., 1997). More recently a synthetic neuroactive steroid – alfaxalone – has also been studied
as an injectable agent for the induction and/ or maintenance of anaesthesia, in total intravenous
anaesthesia (TIVA) protocols; by interacting with the gamma-aminobutyric acid (GABA)
receptor, this hypnotic agent induces mild to moderate anaesthesia and muscle relaxation, with
no clinically significant alterations in cardiovascular function and mild respiratory depression
(Moll et al., 2013). The use of a constant rate infusion of alfaxalone is known to decrease the
needed dose of the volatile anaesthetic agent, desflurane (Granados et al., 2012). Another recent
study in goats supports the combined use of alfaxalone and fentanyl, to reduce alfaxalone’s
dose and minimize adverse cardiopulmonary effects during anaesthesia. (Dzikiti et al., 2016).
Discussion
124
Isoflurane was the volatile agent used for convenience. Other agents, such as sevoflurane
and desflurane would have been effective alternatives, presenting cardiopulmonary effects
similar to those elicited by isoflurane, and allowing faster recoveries (Mohamadnia et al., 2008;
Okutomi et al., 2009). However, sevoflurane is known to induce higher cerebral cortical spike
activity in sheep (Voss et al., 2006), consistent with the poor recoveries – with excitation and
restlessness – obtained by the aforesaid authors (Mohamadnia et al., 2008). Halothane has
fallen in disuse, for its more patent cardiopulmonary effects and slower recoveries (Gençcelep
et al., 2004).
7.2. Ex vivo model development
To reliably test the new cement for VCFs and reproduce the procedure in humans while
reducing the discomfort and pain caused in the experimental animals, the chosen technique was
the minimally invasive PVP. At the time the project started, few techniques had been described
in sheep. Several studies were found with reproducible vertebral bone defect models in sheep;
yet, the authors used “open” lateral approaches to the vertebral bodies (Kobayashi et al., 2007;
Zhu et al., 2011; Verron et al., 2014).
At that time, only two percutaneous vertebroplasty models in sheep were found in the
scientific literature. Galovich et al. (2011) developed a sheep PVP model for biocements
testing, in which a lateral approach to the vertebral body was performed; still, the created bone
defects were small, making the model not suitable for biomechanical analysis of biocements.
Likewise, Benneker et al. (2012) developed a model with a para- to transpedicular approach,
aiming towards the cranial- and caudal hemivertebra; however, cement leakage into the
vertebral foramen was observed in 19 of the 33 vertebrae studied. Moreover, as this was a
terminal study, the authors weren’t able to present any information regarding the clinical
condition of the animals in the postsurgical period. Consequently, for the present project, the
development of a new animal model was mandatory.
The developed new model is innovative in the sense that two interconnected bone defects
in the cranial hemivertebrae – with a mean volume of 1.234±0.240 mL (n=12) – were created,
through a bilateral modified parapedicular approach, therefore avoiding the wide lumbar
nutritional foramen, which is a potential point of cement leakage into the circulation. This
approach also reduces the risks of pedicle’s fracture and vertebral foramina’s disruption verified
in the transpedicular approach (Benneker et al., 2012), enabling the creation of larger defects.
Discussion
125
More recently, another model has been developed and described by Bungartz et al.
(2016), who also referred several setbacks, including the sacrifice of two animals after surgery,
secondary to cement leakage into the vertebral foramina.
Like the aforementioned authors (Galovich et al., 2011; Benneker et al., 2012; Bungartz
et al., 2016) some difficulties were felt in avoiding the disruption of either the vertebral
foramina or the ventral cortex of the vertebral bodies, while trying to create a wide enough
vertebral body bone defect. This was mostly because of some of the anatomical peculiarities of
ovine vertebrae – e.g. the orientation angle of the lumbar facet joints and pedicles (less than 30°
to the frontal plane, compared to over 60° in humans) and the relative short and sagitally
oriented pedicles (Wilke et al., 1997; Mageed et al., 2013). The right orientation angle of the
surgical instrumentation at the entry point proved fundamental. Consequentially, the extreme
value of fluoroscopy for this procedure should be acknowledge.
Another difficulty was to breach the hard cortical bone of the ovine lumbar vertebrae to
create the trabecular defect. As advocated by Benneker et al. (2012), the use of the surgical
high speed drill – instead of the manual drill – would have been an alternative; however, to
reproduce more consistently the surgical technique used in humans (Mathis & Wong, 2003) the
manual drill was used.
At the time, the new model was developed, L4, L5 and L6 were the chosen vertebrae for
manipulation. At the end of the experiment, the hypothesis of using L6 was discarded, due to
its short vertebral body, which led to smaller defects than the defects created in the other
vertebrae. In a future study, L1-L3 vertebrae should also be considered, due to their similarities
to L4-L5, as observed in studies by Mageed et al. (2013) and Wilke et al. (1997).
One limitation of this study was regarding the mechanical tests. The intact thawed
vertebrae were mounted in parallel flat PMMA (Vertex, Cure) plates, adapting some previously
published protocols (Buckley et al., 2009; Tarsuslugil et al., 2013; Fang et al., 2014). Still,
when the axial compression load was applied, the plates fractured and failed before the
vertebrae, which prevented the calculation of the compressive strength of vertebrae.
Nonetheless, vertebrae stiffness and corrected vertebrae stiffness values were obtained.
This limitation was caused by the great trabecular bone density of sheep vertebrae, and
consequently the high mechanical stiffness and strength of vertebral bodies (Keller, 1994;
Mitton et al., 1997; Liebschner, 2004). In comparison, several large animal species, like the
Discussion
126
dog, the pig, the sheep, the goat, and the calf present higher BMDs than humans – with the
sheep having the highest one and the pig the lowest one (closer to human’s BMD). This occurs
because of the constant forces generated by the support of the large muscle bulk along the
quadruped animals’ backs, which expose them to higher axial compression stresses (Aerssens
et al., 1998; Reinwald & Burr, 2008). Moreover, Aerssens et al. (1998), showed that the fracture
stress was lowest in the samples from human and pig, intermediate in dog and cow samples,
and highest in sheep samples.
Another important remark regarding the mechanical testing is that all vertebrae were
conserved by freezing at -18 ºC and went through the same number of freezing/ thawing cycles,
during the experimental period. Panjabi et al. (1985) made a long-term study on vertebrae
frozen at -18 °C, where they found no significant differences in the mechanical properties of
vertebrae tested on the first day and vertebrae tested after long-term freezing. Another study by
Borchers et al. (1995) showed that repeated freezing-thawing cycles at -20 ºC did not
compromise the structural integrity and compressive mechanical properties of trabecular bone.
Other possibilities for conservation of the vertebrae would be ethanol or buffered formalin.
However, a recent study by Stefan et al. (2010) showed that these two conservation methods
alter significantly the plastic mechanical properties of cortical bovine bone and therefore should
not be used when biomechanical testing to evaluate the failure load of a new orthopaedic
implant is in view. Another study by Wieding et al. (2015) yielded the same conclusions
regarding ovine cortical bone; moreover, in this study, freezing had no influence on the
mechanical properties of the ovine cortical bone. Finally, a study by Nazarian et al. (2009),
conducted in murine femurs and vertebral bodies, showed that bone preservation by freezing
and formalin fixation over a 2-week period did not alter the elastic mechanical properties;
however, formalin fixation weakened the viscoelastic properties of murine bone.
All vertebrae were tested under the same conditions – at room temperature, in air –, as it
has already been proven that different test conditions could lead to different results: for instance,
a study from Mitton et al. (1997) showed that the shear strength of a sample of cancellous bone
from the lumbar vertebrae of ewes was higher when the tests were conducted at room
temperature in air than when they were conducted with a sample in physiological saline bath
regulated at 37 °C.
Finally, considering the bone anatomy, structure, modelling and remodelling processes,
close to human’s, the pig would have been an alternative – as a large animal model for testing
Discussion
127
new composites – to sheep (Mosekilde et al., 1993; Turner, 2002; Thorwarth et al., 2005;
Schlegel et al., 2006). Nevertheless, commercial pigs are rarely chosen as models for implant
biomaterial research because of their large growth rates and very high body weight (Li et al.,
2015); moreover, they are considered difficult to handle, noisy, aggressive, and expensive, and
are often disregarded in favour of sheep and goat (Turner, 2007). Also the dog, due to its
similarities regarding the bone composition (ash weight, hydroxyproline, extractable proteins
and IGF-1 content) and easy handling, has been commonly acknowledged as a large animal
model for orthopaedic research (Aerssens et al., 1998; Pearce et al., 2007); however, its use is
in decline because of the higher cost, the interspecies difference in the rate of bone remodelling,
and the existent social concerns, since it is seen as a companion animal.
7.3. In vivo study
Regarding the in vivo procedures, there were some issues – cardiovascular changes and/
or arrest – during the cement injection, which were overcome simply by increasing the time of
injection. These changes are most likely due to fat pulmonary embolism, as previously
described by Aebli et al. (2002) and Benneker et al. (2010), being a potential life-threatening
complication of the procedure. The same complication is frequently observed in humans
(Saracen & Kotwica, 2016) and a recent study has shown that it can be prevented by performing
vertebral body lavage prior to cement augmentation (Hoppe et al., 2016).
In accordance with what was observed in the ex vivo study, another surgical difficulty
was the orientation angle of the surgical instrumentation, which if it was not correct it would
have hindered the defect creation, and eventually it would have led to cortical disruption.
During the present study, ventral cortical disruption occurred in one sheep and cortical
disruption of the vertebral foramen occurred in two sheep. Just one of those animals developed
neurological signs – moderate proprioceptive deficits of the hind limbs –, probably due to the
cement leakage around the defect entry point affecting the spinal nerve roots; nonetheless, the
sheep remained ambulatory and after approximately two months with conservative therapy for
an initial period the animal had fully recovered.
Also noteworthy is the two sheep in which the cement couldn’t be injected only from one
side. At the time of the surgery, the defects appeared interconnected, due to the data obtained
from fluoroscopy and also from the instrumentation manipulation; however, as the cement was
injected, only one half of the defect was being filled and resistance was felt upon injection,
which compelled the surgeon to fill the contralateral defect.
Discussion
128
It’s important to note that all these setbacks occurred during the first group of four
surgeries performed. Thereafter, with the natural progression of the surgeon’s learning curve,
the procedure become safer and no more problems were observed in later surgeries.
Concerning the biomaterials, they are of utmost importance for this kind of surgeries. As
referred before, beside the osteoconductive/ osteoinductive and bioactivity features, they should
assemble several physical characteristics that enable their usage during surgery. According to
Lewis (2006), the key properties for injectable bone cements are: 1) easy injectability (with
adequate viscosity), 2) high radiopacity, which allow their visualization during injection, and
3) a resorption rate that is neither too high nor too low. The cements should present high
porosities – microporosity with mean pore diameter <10 µm, to allow circulation of body fluid
and macroporosity with mean pore diameter >100 µm, to provide a scaffold for blood–cell
colonization –, rapid setting times, easy preparation and handleability, appropriate adhesiveness
and viscosity (initially relatively low, to allow injection without extravasation, and constant
after the setting time). Finally, the biomaterials should have the requisite mechanical properties
– e.g. values of modulus of elasticity and mechanical strength similar to those of the healthy
cancellous bone, which is in the range of 2-12 MPa – that would allow for immediate
reinforcement of the vertebral body with ensuing normal function and pain relief (Lewis, 2006;
Campana et al., 2014).
Relatively to the used biomaterials, a few remarks should be made. Both Cerament™
(control group) and Spine-Ghost (experimental group) are calcium sulphate (CaS)-based
injectable cements (Rauschmann et al., 2010; Dadkhah et al., 2017). However, while
Cerament™ is a biphasic cement consisting of 60% α-CaS hemihydrates – known for its
biocompability – and 40 % hydroxyapatite (HA) – to provide long-term support, with its
radiopacity conferred by the presence of the non-ionic contrast agent iohexol (Rauschmann et
al., 2010), Spine-Ghost is a biphasic cement consisting of 70% α-CaS hemihydrate, 20% glass-
ceramic radiopaque phase and 10% mesoporous particles of a bioactive glass (MBG) – used for
its high bioactivity and osteoinductive properties (Hench et al., 2009), which combined with
water results in an injectable paste (Dadkhah et al., 2017). Spine-Ghost’s radiopacity was
similar to that of the soft tissues, which made it difficult to visualize the cement during injection;
nevertheless, Spine-Ghost’s radiopacity is long-lasting and will keep the bone cement visible
until its complete resorption, as it is conferred by its glass-ceramic phase, while Cerament™’s
radiopacity fade away over time, hindering the visualization of the bone cement at follow-ups
(Dadkhah et al., 2017). Both the materials have proved to be bioactive and resorbable (Marcia
Discussion
129
et al., 2012; Dadkhah et al., 2017). Both cements were easy to handle and have adequate
injectabilities; regardless, Spine-Ghost was less viscous than Cerament, so easier to be injected
(Dadkhah et al., 2017). Cerament’s working/ hardening time is 7 minutes (Abramo et al., 2010),
while Spine-Ghost’s is 8-20 minutes (Dadkhah et al., 2017), both being sufficient for the
procedure. Both cements present final setting times within 1 hour (Rauschmann et al., 2010;
Dadkhah et al., 2017); however, for reasons of safety, Cerament™’s manufacturers instruct the
surgeons to maintain the patients at rest for two hours (Rauschmann et al., 2010), which obliged
the surgical team to keep all sheep anaesthetized for that long after the procedure was
concluded. The same anaesthetic times were observed for Spine-Ghost. Finally, both cements
showed adequate properties in terms of stiffness and strength, with Spine-Ghost presenting a
higher compressive strength in both wet and dry conditions compared to Cerament™, ensuring
an enhanced mechanical support when compared to control (Rauschmann et al., 2010; Dadkhah
et al., 2017).
Micro-CT assessment was considered essential for the ex vivo and in vivo studies. In the
ex vivo study, micro-CT allowed, among other things, to visualize in 3D rendered models the
specificities of the sheep vertebrae. Moreover, during the in vivo study, it enabled qualitative
evaluation of the vertebrae, like the visualization of cortical disruptions – confirming our
suspicions at surgery – and the calculation of 3D structural parameters, without destroying the
samples (Guldberg et al., 2008; Peyrin, 2011; Apple et al., 2013). This non-destructive
visualization and quantification of the 3D structure of trabecular bone is perhaps one of micro-
CT’s greater advantage, when compared to the more conventional histology, since the 3D
structural parameters – e.g. bone mineral density, relative bone volume, structural model index
– obtained are correlated with the trabecular bone mechanical properties (Mittra et al., 2005;
Teo et al., 2007).
Even so, there are some limitations in the micro-CT quantitative analysis of new bone
formation. In the present study, the main difficulty was the accurate segmentation of
mineralized tissue from the biomaterials within the cross-section images. This is particularly
relevant when using bioceramics, due to the radiodensities’ similarities between the bone and
the materials (Guldberg et al., 2008; Apple et al., 2013), rather than, for instance, with metallic
implants. Thus, the contact surface and integration of bone around the scaffold can not be
accurately calculated. As recommended by several authors, we chose to use the global threshold
method (Rajagopalan et al., 2005; Brun et al., 2011). Nonetheless, other authors recommend
more sophisticated segmentation algorithms to separate materials with overlapping density
Discussion
130
distributions (Hilldore et al., 2007; Guldberg et al., 2008). Another major limitation was related
to the equipment itself. When intending to calculate the structural parameters, high resolutions
(small voxel sizes) should be attempted. Large structures such as trabeculae in human and ovine
bone (100 to 200 μm thick) should be scanned with voxel sizes never more than 60 μm
(Thomsen et al., 2005), as it is generally considered that the ratio of voxels to object size should
be 2 (Bouxsein et al., 2010). The voxel size used was borderline with this limit – 62 μm –;
however, if considering the 100 μm-thick trabeculae, these resolution values become low, as
the maximum voxel size used should be 50 μm. Despite this fact, the 3D structural parameters
were calculated so that the results could be compared with the 2D morphologic measurements
obtained in histomorphometry, as it is acknowledged that these data are highly correlated
(Müller et al., 1998; Chappard et al., 2005; Park et al., 2011). Nevertheless, these methods are
known to be complementary and the results should be interpreted bearing in mind the
advantages and limitations of both methods. To try to minimize the equipment’s limitations
internal controls were used – the caudal hemivertebrae with intact trabecular bone – to be able
to appreciate the significant differences within groups. The planes used for the sample’s
scanning and cutting were different, due to the vertebrae geometry – which hinders the
vertebrae’s positioning at the micro-CT rotation stage – and the requirement of having two
symmetric hemi-samples for histology (undecalcified and decalcified bone samples).
Concerning the micro-CT analysis of the in vivo study presented in this project, the
following results were observed: regarding the defect augmented area, the mean relative bone
volume (BV/TV) was significantly higher in Spine-Ghost augmented vertebrae, when
compared to Cerament™, and no significant differences were found in the caudal
hemivertebrae area – which contains only intact trabecular bone – that could justify the higher
bone volume ration found in the Spine-Ghost group. Contrariwise, the specific surface (BS/BV)
was significantly lower in Spine-Ghost samples when compared to Cerament™. A lower
BS/BV may suggest a thicker structure of the Spine-Ghost augmented vertebrae and might be
related to a lower bone turn-over rate, because bone resorption and formation occurs on bone
surfaces. The remaining parameters – mean trabecular thickness (Tb.Th), mean trabecular
separation (Tb.Sp) and trabecular number (Tb.N) – presented no statistically significant
differences between the two groups – Spine-Ghost and Cerament™ –, though the first two
parameters presented slightly superior values in the Spine-Ghost group. To finalize, when
comparing the mean values of all the structural parameters between the defect augmented area
and the caudal hemivertebrae area, the only value that presented no statistically significant
difference was the mean trabecular number (Tb.N), indicating a normal tissue evolution, with
Discussion
131
an emergent open tissue structure, for both cements. Micro-CT assessment also enabled the
reconstruction and visualization of the injected vertebrae, through the rendering software. This
option enabled the visual comparison between the two cements and the confirmation of the data
obtained through the analysis software. Thus, cement resorption was observed in both groups
followed by new bone formation, which presented a slightly closer porosity than the intact
trabecular bone from the caudal hemivertebrae.
Histomorphometry or quantitative histology is a time-consuming, laborious and
destructive method. Histomorphometry is also less sensitive in detecting global bone mass
changes when compared to micro-CT, because of the limited number of sections observed in
manual histomorphometric. Nonetheless, histology is still the gold standard for bone
remodelling processes evaluation, as it is the only method that enables the visualization of bone
microstructure – bone cells and their activities (Iwaniec et al., 2008; Brandi et al., 2009).
Several authors refer to the imperative use of the conventional method to overcome micro-CT’s
technical difficulties, like for example the impossibility of distinguish between woven from
lamellar bone (Rühli et al., 2007; Tamminen et al., 2011). In the in vivo study, the obtained
histomorphometric results showed no statistically significant differences between the two
groups – Spine-Ghost and Cerament™ – regarding trabecular thickness, relative bone volume
and bone area within the defect and in the intact tissue. Since there was no fibrous capsule
observed in any of the sections, the affinity index can be considered of 100%. In accordance to
the abovementioned, these results were compared with the results obtained through micro-CT
analysis, and though there were differences, they were not statistically significant and the same
trend was shown. The main difference was in the mean Tb.Th, which was overestimated by
micro-CT. This is a recognized feature of the micro-CT analysis (Chappard et al., 2005);
additionally, there is possibly a potential overestimation of the micro-CT values in the defect
augmented areas due the presence of the residual cements, as confirmed by looking at the 3D
rendered models.
The optic fluorescence microscopy is considered an indispensable tool for bone tissue
engineering studies, as it enables the determination of the onset time and location of
osteogenesis (van Gaalen et al., 2010), without sacrificing the animal, thus serving the ideal of
the 3R’s concept. However, protocols’ standardization is not a current reality (van Gaalen et
al., 2010). The protocol used for this project – adapted from the protocols advocated by other
authors (Lee et al., 2003; Pautke et al., 2005; van Gaalen et al., 2010) – presented some flaws,
for instance, some degree of label escape, probably due to the length of the interval between
Discussion
132
the labels, and also the strong bone marrow auto fluorescence. Still, the labelling was sufficient
to enable MAR calculation (1.60±0.27 µm/day in the control group and 1.39±0.54 µm/day in
the experimental group). The strong bone marrow fluorescence is common in fluorochrome
labelling and it’s hardly a problem as it is distributed throughout all the bone regions and can
then easily be distinguished from the fluorochrome labelling (van Gaalen et al., 2010).
Nevertheless, in a future study it should be considered the use of another fluorochrome labelling
protocol or other data labelling method to overcome these difficulties.
The qualitative observation of the slides was performed for both undecalcified and
decalcified samples. The evaluation of the undecalcified samples showed new bone formation
within the area of the defect for both groups in most of the vertebrae, with the pattern of long
trabeculae, mostly parallel to the long axis of the vertebrae interrupted by a denser net of highly
interconnected trabeculae. Also, in both groups the bone was in direct contact with residual
cements and no fibrous tissue or inflammatory reactions were observed. Most of the newly
formed bone was mature. Three vertebrae – two from Cerament™ group and one from Spine-
Ghost – showed relatively large areas of defect yet to be occupied by bone. Moreover, empty
space areas were observed in three out of seven samples of the Cerament™ group. Histological
observations on decalcified samples allowed a more detailed observation. Thus, Masson’s
trichrome evidenced the precisely organized collagen fibres in the newly formed trabecular
network in the defect area. And both trichromes confirmed the presence of bone marrow within
the trabeculae, and cement residues, which were integrated in the trabeculae themselves. In
Cerament™ group sections, larger quantities of cement are apparent within the trabeculae when
compared to Spine-Ghost sections. Again, no inflammatory reaction, signs of increased bone
resorption or fibrous encapsulation of both biomaterials were seen.
Immunohistochemistry is considered an essential technique when testing new
biomaterials, as it allows to evaluate the cell activity at the bone-biomaterial interface, thus
providing information about the osteogenic potential of the biomaterial and its effect on
osteoblastic differentiation. Most of the available information on immunohistochemical
detection of osteogenic markers in decalcified bone sections in sheep is scarce and vague
(Haque et al., 2006; Adeyemo et al., 2008). The main limitations are technical, as the size and
nature of the samples posed difficulties associated with the sectioning of calcified tissue,
preservation of tissue morphology and remaining antigen integrity (Klein & Memoli, 2011). A
recent study by Katoh et al. (2016) advocate the use of microwave to assist tissue fixation and
staining and presents several protocols using microwave irradiation found in literature. Another
Discussion
133
study recommended the use of hyaluronidase and pepsin for predigestion of the bone sample
combined with alkaline phosphatase-mediated chromogenic detection (Li et al., 2015). To
overcome these difficulties an enzymatic antigen retrieval protocol was developed and applied,
which allowed good epitope labelling, with no background and excellent tissue morphology
preservation. Immunohistochemistry sections showed no relevant differences between the two
groups – Cerament™ and Spine-Ghost – and the relatively low levels of detected antigens were
what would be expected to occur in mature, stable bone. No osteoclasts were observed at the
bone/cement interface, though in a small part of the sections, a small number of osteoclasts-like
cells, TRAP positive, were detected within the new trabeculae, suggesting that bone remodeling
processes were in course, as it was expected.
Discussion
134
7.4. References
Abramo, A., Geijer, M., Kopylov, P., & Tägil, M. (2010). Osteotomy of distal radius fracture
malunion using a fast remodeling bone substitute consisting of calcium sulphate and
calcium phosphate. Journal of Biomedical Materials Research Part B: Applied
Biomaterials, 92(1), 281-286.
Adeyemo, W. L., Reuther, T., Bloch, W., Korkmaz, Y., Fischer, J. H., Zöller, J. E., & Kuebler,
A. C. (2008). Healing of onlay mandibular bone grafts covered with collagen membrane
or bovine bone substitutes: a microscopical and immunohistochemical study in the sheep.
International journal of oral and maxillofacial surgery, 37(7), 651-659.
Ahern, B. J., Soma, L. R., Boston, R. C., & Schaer, T. P. (2009). Comparison of the analgesic
properties of transdermally administered fentanyl and intramuscularly administered
buprenorphine during and following experimental orthopedic surgery in sheep. American
journal of veterinary research, 70(3), 418-422.
Appel, A. A., Anastasio, M. A., Larson, J. C., & Brey, E. M. (2013). Imaging challenges in
biomaterials and tissue engineering. Biomaterials, 34(28), 6615-6630.
Baroud, G., Bohner, M., Heini, P., & Steffen, T. (2004). Injection biomechanics of bone
cements used in vertebroplasty. Biomedical materials and engineering, 14(4), 487-504.
Borchers, R. E., Gibson, L. J., Burchardt, H., & Hayes, W. C. (1995). Effects of selected thermal
variables on the mechanical properties of trabecular bone. Biomaterials, 16(7), 545-551.
Bouxsein, M. L., Boyd, S. K., Christiansen, B. A., Guldberg, R. E., Jepsen, K. J., & Müller, R.
(2010). Guidelines for assessment of bone microstructure in rodents using micro–
computed tomography. Journal of bone and mineral research, 25(7), 1468-1486.
Brun, F., Turco, G., Accardo, A., & Paoletti, S. (2011). Automated quantitative characterization
of alginate/hydroxyapatite bone tissue engineering scaffolds by means of micro-CT
image analysis. Journal of Materials Science: Materials in Medicine, 22(12), 2617-2629.
Buckley, J. M., Parmeshwar, R., Deviren, V., & Ames, C. P. (2009). An improved metric for
quantifying the stiffnesses of intact human vertebrae. Proceedings of the Institution of
Mechanical Engineers, Part H: Journal of Engineering in Medicine, 223(5), 537-543.
Discussion
135
Bungartz, M., Maenz, S., Kunisch, E., Horbert, V., Xin, L., Gunnella, F., & Sachse, A. (2016).
First-time systematic postoperative clinical assessment of a minimally invasive approach
for lumbar ventrolateral vertebroplasty in the large animal model sheep. The Spine
Journal, 16(10), 1263-1275.
Campana, V., Milano, G. I. U. S. E. P. P. E., Pagano, E., Barba, M., Cicione, C., Salonna, G. &
Logroscino, G. (2014). Bone substitutes in orthopaedic surgery: from basic science to
clinical practice. Journal of Materials Science: Materials in Medicine, 25(10), 2445-
2461.
de Carvalho, L. L., Nishimura, L. T., Borges, L. P., Cerejo, S. A., Villela, I. O., Auckburally,
A., & de Mattos-Junior, E. (2016). Sedative and cardiopulmonary effects of xylazine
alone or in combination with methadone, morphine or tramadol in sheep. Veterinary
anaesthesia and analgesia, 43(2), 179-188.
Chappard, D., Retailleau‐Gaborit, N., Legrand, E., Baslé, M. F., & Audran, M. (2005).
Comparison insight bone measurements by histomorphometry and μCT. Journal of Bone
and Mineral Research, 20(7), 1177-1184.
Christou, C., Rawlinson, J., Mitchell, G., Oliver, R., & Walsh, W. (2014). The use of fentanyl
patches for sheep in orthopaedic research. Bone Joint Journal, 96(Supp 11), 215-215.
Correia, D., Nolan, A. M., & Reid, J. (1996). Pharmacokinetics of propofol infusions, either
alone or with ketamine, in sheep premedicated with acepromazine and papaveretum.
Research in veterinary science, 60(3), 213-217.
Cremers, S., Garnero, P., & Seibel, M. J. (2008). Biochemical markers of bone metabolism. In:
Bilezikian, J. P., Raisz, L. G., & Martin, T.J. (Eds), Principles of Bone Biology, 3rd
Ediction, San Diego: Academic Press, p.1857-1881.
Dadkhah, M., Pontiroli, L., Fiorilli, S., Manca, A., Tallia, F., Tcacencu, I., & Vitale-Brovarone,
C. (2017). Preparation and characterisation of an innovative injectable calcium sulphate
based bone cement for vertebroplasty application, J. Mater. Chem. B. 5(1) 102-115.
Decreto-Lei nº 113/2013, de 7 de Agosto. Diário da República, 1.ª série — N.º 151. Ministério
da Agricultura, do mar, do ambiente e do ordenamento do território, Lisboa.
Discussion
136
Directive 2010/63/EU, Official Journal of the European Union, L276/33-79, 2010, ISSN 1725-
2601.
DiVincenti, J., Westcott, R., & Lee, C. (2014). Sheep (Ovis aries) as a model for cardiovascular
surgery and management before, during, and after cardiopulmonary bypass. Journal of
the American Association for Laboratory Animal Science, 53(5), 439-448.
Dzikiti, B. T. (2013). Intravenous anaesthesia in goats: A review. Journal of the South African
Veterinary Association, 84(1), 1-8.
Dzikiti, B. T., Ndawana, P. S., Zeiler, G., Ferreira, J. P., & Dzikiti, L. N. (2016). Determination
of the minimum infusion rate of alfaxalone during its co-administration with fentanyl at
three different doses by constant rate infusion intravenously in goats. Veterinary
anaesthesia and analgesia, 43(3), 316-325.
Fang, Z., Giambini, H., Zeng, H., Camp, J. J., Dadsetan, M., Robb, R. A., An, K. N., Yaszemski,
M. J., & Lu, L. (2014). Biomechanical evaluation of an injectable and biodegradable
copolymer P (PF-co-CL) in a cadaveric vertebral body defect model. Tissue Engineering
Part A, 20(5-6), 1096-1102.
Flecknell, P. (2015). Laboratory animal anaesthesia. Academic Press.
Gatson, B. J., Pablo, L., Plummer, C. E., & Granone, T. D. (2015). Effects of premedication
with sustained-release buprenorphine hydrochloride and anesthetic induction with
ketamine hydrochloride or propofol in combination with diazepam on intraocular
pressure in healthy sheep. American journal of veterinary research, 76(9), 771-779.
Gençcelep, M., Atasoy, N., & Tas, A. (2004). The effects of inhalation anaesthetics (halothane
and isoflurane) on certain clinical and haematological parameters of sheep. Small
Ruminant Research, 53(1), 157-160.
Granados, M. M., Domínguez, J. M., Fernández-Sarmiento, A., Funes, F. J., Morgaz, J.,
Navarrete, R., Carrillo, J. M., Rubio, M., Muñoz-Rascón, P., Gómez de Segura, I. A., &
Gómez-Villamandos, R. (2012). Anaesthetic and cardiorespiratory effects of a constant-
rate infusion of alfaxalone in desflurane-anaesthetised sheep. Veterinary Record, 171(5),
125.
Discussion
137
Guldberg, R. E., Duvall, C. L., Peister, A., Oest, M. E., Lin, A. S., Palmer, A. W., & Levenston,
M. E. (2008). 3D imaging of tissue integration with porous biomaterials. Biomaterials,
29(28), 3757-3761.
Heini, P., & Berlemann, U. (2001). Bone substitutes in vertebroplasty. European Spine Journal,
10(2), S205-S213.
Hench, L. L. (2009). Genetic design of bioactive glass. Journal of the European Ceramic
Society, 29(7), 1257-1265.
Hilldore, A., Wojtowicz, A., & Johnson, A. W. (2007). Micro‐CT based quantification of non‐
mineralized tissue on cultured hydroxyapatite scaffolds. Journal of Biomedical Materials
Research Part A, 82(4), 1012-1021.
Hoppe, S., Elfiky, T., Keel, M. J. B., Aghayev, E., Ecker, T. M., & Benneker, L. M. (2016).
Lavage prior to vertebral augmentation reduces the risk for cement leakage. European
spine journal, 25(11), 3463-3469.
Iwaniec, U. T., Wronski, T. J., & Turner, R. T. Histological analysis of bone. Methods Mol
Biol 2008; 447:325-41.Brandi, M. L. (2009). Microarchitecture, the key to bone quality.
Rheumatology, 48(suppl 4), iv3-iv8.
Katoh, K. (2016). Microwave-Assisted Tissue Preparation for Rapid Fixation, Decalcification,
Antigen Retrieval, Cryosectioning, and Immunostaining. International Journal of Cell
Biology, 2016 (9), 1-9.
Kästner, S. B. (2006). A2‐agonists in sheep: a review. Veterinary anaesthesia and analgesia,
33(2), 79-96.
Keller, T. S. (1994). Predicting the compressive mechanical behavior of bone. Journal of
biomechanics, 27(9), 1159-1168.
Klein, M. J., & Memoli, V. A. (2011, February). Orthopaedic specimen preparation: what
pathologists should know and do. In Seminars in diagnostic pathology (Vol. 28, No. 1,
pp. 4-12). WB Saunders.
Kobayashi, N., Ong, K., Villarraga, M., Schwardt, J., Wenz, R., Togawa, D., Fujishiro, T.,
Turner, A. S., Seim, H. B. 3rd, & Bauer, T. W. (2007). Histological and mechanical
Discussion
138
evaluation of self‐setting calcium phosphate cements in a sheep vertebral bone void
model. Journal of Biomedical Materials Research Part A, 81(4), 838-846.
Lee, T. C., Mohsin, S., Taylor, D., Parkesh, R., Gunnlaugsson, T., O'Brien, F. J., Giehl, M., &
Gowin, W. (2003). Detecting microdamage in bone. Journal of Anatomy, 203(2), 161-
172.
Li, S., Liu, B., Tian, M., Zhang, L., Tickner, J., Xu, J., & Rong, L. (2015). An effective and
practical immunohistochemical protocol for bone specimens characterized by
hyaluronidase and pepsin predigestion combined with alkaline phosphatase-mediated
chromogenic detection. Histology and histopathology, 30(3), 331-343.
Li, Y., Chen, S. K., Li, L., Qin, L., Wang, X. L., & Lai, Y. X. (2015). Bone defect animal
models for testing efficacy of bone substitute biomaterials. Journal of Orthopaedic
Translation, 3(3), 95-104.
Liebschner, M. A. (2004). Biomechanical considerations of animal models used in tissue
engineering of bone. Biomaterials, 25(9), 1697-1714.
Lin, H. C., Purohit, R. C., & Powe, T. A. (1997). Anesthesia in sheep with propofol or with
xylazine‐ketamine followed by halothane. Veterinary Surgery, 26(3), 247-252.
Lizarraga, I., & Chambers, J. P. (2012). Use of analgesic drugs for pain management in sheep.
New Zealand veterinary journal, 60(2), 87-94.
Mageed, M., Berner, D., Jülke, H., Hohaus, C., Brehm, W., & Gerlach, K. (2013).
Morphometrical dimensions of the sheep thoracolumbar vertebrae as seen on digitised
CT images. Laboratory animal research, 29(3), 138-147.
Marcia, S., Boi, C., Dragani, M., Marini, S., Marras, A., Piras, E., Anselmetti, G., & Masala, S.
(2012). Effectiveness of a bone substitute (CERAMENTTM) as an alternative to PMMA
in percutaneous vertebroplasty: 1-year follow-up on clinical outcome, Eur. Spine J. 21
112–118.
Mathis, J. M., & Wong, W. (2003). Percutaneous vertebroplasty: technical considerations.
Journal of vascular and interventional radiology, 14(8), 953-960.
Mitton, D., Rumelhart, C., Hans, D., & Meunier, P. J. (1997). The effects of density and test
Discussion
139
conditions on measured compression and shear strength of cancellous bone from the
lumbar vertebrae of ewes. Medical engineering & physics, 19(5), 464-474.
Mittra, E., Clinton, R., & Qin, Y. X. (2005). Interrelationship of trabecular mechanical and
microstructural properties in sheep trabecular bone. Journal of biomechanics, 38(6),
1229-1237.
Mohamadnia, A. R., Hughes, G., & Clarke, K. W. (2008). Maintenance of anaesthesia in sheep
with isoflurane, desflurane or sevoflurane. The Veterinary Record, 163(7), 210-215.
Moll, X., Santos, L., García, F., & Andaluz, A. (2013). The effects on cardio-respiratory and
acid–base variables of a constant rate infusion of alfaxalone–HPCD in sheep. The
Veterinary Journal, 196(2), 209-212.
Moolchand, M., Kachiwal, A. B., Soomro, S. A., & Bhutto, Z. A. (2014). Comparison of
sedative and analgesic effects of xylazine, detomidine, and medetomidine in sheep.
Egyptian Journal of Sheep & Goat Sciences, 9(2), 43-48.
Mosekilde, L., Weisbrode, S. E., Safron, J. A., Stills, H. F., Jankowsky, M. L., Ebert, D. C.,
Danielsen, C. C., Sogaard, C. H., Franks, A. F., Stevens, M. L., Paddock, C. L., & Boyce,
R. W. (1993) Calcium-restricted ovariectomized Sinclair S-1 minipigs: an animal model
of osteopenia and trabecular plate perforation. Bone, 14, 379-382.
Müller, R., Van Campenhout, H., Van Damme, B., Van Der Perre, G., Dequeker, J., Hildebrand,
T., & Rüegsegger, P. (1998). Morphometric analysis of human bone biopsies: a
quantitative structural comparison of histological sections and micro-computed
tomography. Bone; 23, 59–66.
Nazarian, A., Hermannsson, B. J., Muller, J., Zurakowski, D., & Snyder, B. D. (2009). Effects
of tissue preservation on murine bone mechanical properties. Journal of Biomechanics,
42(1), 82-86.
Okutomi, T., Whittington, R. A., Stein, D. J., & Morishima, H. O. (2009). Comparison of the
effects of sevoflurane and isoflurane anesthesia on the maternal-fetal unit in sheep.
Journal of anesthesia, 23(3), 392-398.
Ozkan, F., Cakir-Ozkan, N., Eyibilen, A., Yener, T., & Erkorkmaz, U. (2010). Comparison of
Discussion
140
ketamine-diazepam with ketamine-xylazine anesthetic combinations in sheep
spontaneously breathing and undergoing maxillofacial surgery. Bosnian journal of basic
medical sciences/Udruzenje basicnih mediciniskih znanosti= Association of Basic.
Journal of Medical Sciences, 10(4), 297-302.
Panjabi, M. M., Krag, M., Summers, D., & Videman, T. (1985). Biomechanical time‐tolerance
of fresh cadaveric human spine specimens. Journal of Orthopaedic Research, 3(3), 292-
300.
Park, S. Y., Kim, K. H., Koo, K. T., Lee, K. W., Lee, Y. M., Chung, C. P., & Seol, Y. J. (2011).
The evaluation of the correlation between histomorphometric analysis and micro-
computed tomography analysis in AdBMP-2 induced bone regeneration in rat calvarial
defects. Journal of periodontal & implant science, 41(5), 218-226.
Pautke, C., Vogt, S., Tischer, T., Wexel, G., Deppe, H., Milz, S., ... & Kolk, A. (2005).
Polychrome labeling of bone with seven different fluorochromes: enhancing
fluorochrome discrimination by spectral image analysis. Bone, 37(4), 441-445.
Pearce, A. I., Richards, R. G., Milz, S., Schneider, E., & Pearce, S. G. (2007). Animal models
for implant biomaterial research in bone: a review. European Cells & Materials, 13(1),
1-10.
Plummer, P. J., & Schleining, J. A. (2013). Assessment and management of pain in small
ruminants and camelids. Veterinary Clinics of North America: Food Animal Practice,
29(1), 185-208.
Pyörälä, S., Laurila, T., Lehtonen, S., Leppä, S., & Kaartinen, L. (1999). Local Tissue Damage
in Cows after Intramuscular Administration of Preparations Containing Phenyl. Acta
veterinaria scandinavica, 40(2), 145-150.
Rajagopalan, S., Lu, L., Yaszemski, M. J., & Robb, R. A. (2005). Optimal segmentation of
microcomputed tomographic images of porous tissue‐engineering scaffolds. Journal of
Biomedical Materials Research Part A, 75(4), 877-887.
Rauschmann, M., Vogl, T., Verheyden, A., Pflugmacher, R., Werba, T., Schmidt, S., &
Hierholzer, J. (2010). Bioceramic vertebral augmentation with a calcium
sulphate/hydroxyapatite composite (Cerament™ SpineSupport) in vertebral compression
Discussion
141
fractures due to osteoporosis. European Spine Journal, 19(6), 887-892.
Reinwald, S., & Burr, D. (2008). Review of nonprimate, large animal models for osteoporosis
research. Journal of Bone and Mineral Research, 23(9), 1353-1368.
Rühli, F. J., Kuhn, G., Evison, R., Müller, R., & Schultz, M. (2007). Diagnostic value of micro‐
CT in comparison with histology in the qualitative assessment of historical human skull
bone pathologies. American journal of physical anthropology, 133(4), 1099-1111.
Saracen, A., & Kotwica, Z. (2016). Complications of percutaneous vertebroplasty: An analysis
of 1100 procedures performed in 616 patients. Medicine, 95(24), e3850.
Schlegel, K. A., Lang, F. J., Donath, K., Kulow, J. T., & Wiltfang, J. (2006). The monocortical
critical size bone defect as an alternative experimental model in testing bone substitute
materials. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and
Endodontology, 102(1), 7-13.
Seddighi, R., & Doherty, T. J. (2016). Field Sedation and Anesthesia of Ruminants. Veterinary
Clinics of North America: Food Animal Practice, 32(3), 553-570.
Stefan, U., Michael, B., & Werner, S. (2010). Effects of three different preservation methods
on the mechanical properties of human and bovine cortical bone. Bone, 47(6), 1048-1053.
Tamminen, I. S., Isaksson, H., Aula, A. S., Honkanen, E., Jurvelin, J. S., & Kröger, H. (2011).
Reproducibility and agreement of micro-CT and histomorphometry in human trabecular
bone with different metabolic status. Journal of bone and mineral metabolism, 29(4),
442-448.
Tarsuslugil, S. M., O’Hara, R. M., Dunne, N. J., Buchanan, F. J., Orr, J. F., Barton, D. C., &
Wilcox, R. K. (2013). Development of calcium phosphate cement for the augmentation
of traumatically fractured porcine specimens using vertebroplasty. Journal of
biomechanics, 46(4), 711-715.
Teo, J., Wang, S. C., & Teoh, S. H. (2007). Preliminary study on biomechanics of
vertebroplasty: a computational fluid dynamics and solid mechanics combined approach.
Spine, 32(12), 1320-1328.
Thomsen, J. S., Laib, A., Koller, B., Prohaska, S., Mosekilde, L. I., & Gowin, W. (2005).
Discussion
142
Stereological measures of trabecular bone structure: comparison of 3D micro computed
tomography with 2D histological sections in human proximal tibial bone biopsies.
Journal of Microscopy, 218(2), 171-179.
Thorwarth, M., Schultze-Mosgau, S., Kessler, P., Wiltfang, J., & Schlegel, K. A. (2005). Bone
regeneration in osseous defects using a resorbable nanoparticular hydroxyapatite. Journal
of oral and maxillofacial surgery, 63(11), 1626-1633.
Turner, A. S. (2002). The sheep as a model for osteoporosis in humans. The Veterinary Journal,
163(3), 232-239.
Turner, A. S. (2007). Experiences with sheep as an animal model for shoulder surgery: strengths
and shortcomings. Journal of shoulder and elbow surgery, 16(5), S158-S163.
van Gaalen, S. M., Kruyt, M. C., Geuze, R. E., de Bruijn, J. D., Alblas, J., & Dhert, W. J. (2010).
Use of fluorochrome labels in in vivo bone tissue engineering research. Tissue
engineering Part B: Reviews, 16(2), 209-217.
Voss, L. J., Ludbrook, G., Grant, C., Sleigh, J. W., & Barnard, J. P. M. (2006). Cerebral cortical
effects of desflurane in sheep: comparison with isoflurane, sevoflurane and enflurane.
Acta anaesthesiologica scandinavica, 50(3), 313-319.
Walkowiak, K. J., & Graham, M. L. (2015). Pharmacokinetics and Antinociceptive Activity of
Sustained-Release Buprenorphine in Sheep. Journal of the American Association for
Laboratory Animal Science, 54(6), 763-768.
Waterman, A. E., Livingston, A., & Amin, A. (1991). Analgesic activity and respiratory effects
of butorphanol in sheep. Research in veterinary science, 51(1), 19-23.
Welsh, E. M., Baxter, P., & Nolan, A. M. (1992). Pharmacokinetics of carprofen administered
intravenously to sheep. Research in veterinary science, 53(2), 264-266.
Welsh, E. M., & Nolan, A. M. (1995). Effect of flunixin meglumine on the thresholds to
mechanical stimulation in healthy and lame sheep. Research in Veterinary Science, 58(1),
61-66.
Discussion
143
Wieding, J., Mick, E., Wree, A., & Bader, R. (2015). Influence of three different preservative
techniques on the mechanical properties of the ovine cortical bone. Acta of
Bioengineering and Biomechanics, 17(1), 137-146.
Wilke, H. J., Kettler, A., Wenger, K. H., & Claes, L. E. (1997). Anatomy of the sheep spine
and its comparison to the human spine. The Anatomical Record, 247(4), 542-555.
Zullian, C., Lema, P., Lavoie, M., Dodelet-Devillers, A., Beaudry, F., & Vachon, P. (2016).
Plasma concentrations of buprenorphine following a single subcutaneous administration
of a sustained release formulation of buprenorphine in sheep. Canadian Journal of
Veterinary Research, 80(3), 250-253.
Chapter 8
Conclusions and
future perspectives
Conclusions and future perspectives
147
8.1. Conclusions
Multimodal analgesia, with low doses of multiple agents, like sedatives, NSAIDs, and
opioids, seems to provide sufficient postoperative pain relief with minimal adverse effects. The
advocated protocol was considered suitable – regarding the described surgical techniques – for
controlling orthopaedic and neuropathic pain, as demonstrated by rapid animal recovery, with
almost immediate food demand and herd behaviour. Nevertheless, other protocols may be
adequate.
The developed PVP model, using a bilateral modified parapedicular approach, was
considered appropriate for preclinical studies; still, it requires expertise and training. The
designed defect is innovative regarding the approach. Ex vivo training revealed to be essential,
as it allowed the surgeon to feel comfortable with the technique, and so to avoid the use of more
living, sentient animals. In vivo procedures were successful with a high survival rate (100%)
obtained.
Ancillary imaging – fluoroscopy and micro-CT – were crucial both in developing and
applying the model and, regarding micro-CT, in further assessing the obtained samples. Micro-
CT is a powerful tool that enables the analysis of the bone structure without destroying the
sample, complementing histology and other means. Moreover, micro-CT gives the researcher
the opportunity of predicting the bone behaviour, through the calculation of the structural
parameters and mechanical strength and stiffness prediction. Researchers should always look
for the best ancillary means (within reasonable economical limits) and techniques that provide
as much information as possible without increasing the number of experimental units.
Spine-Ghost was successfully created as an injectable composite cement, presenting high
bioresorbability and high bioactivity. It is particularly suited for vertebroplasty, since it is
radiopaque, easily injected, it has a reduced setting time, and, once set, showed a mechanical
strength comparable to the compressive strength of healthy vertebral trabecular bone.
Moreover, in vivo it presented a biological response identical, if not superior, to the one elicited
by the available commercial control, after a 6-month implantation time.
Conclusions and future perspectives
148
8.2. Future perspectives
In the line of the experimental work developed for this project several other ideas
emerged.
Concerning the developed model, besides the obvious utility of testing other materials, it
also should be of interest considerer the modified parapedicular approach for testing other
surgical techniques like, for instance, kyphoplasty. Moreover, considering the well-known
setbacks of using a sheep model – the hard cortical and trabecular bone –, but acknowledging
the surplus benefits, in a next occasion the same model could be tested on long-term steroid-
induced or ovariectomy-induced osteoporotic sheep, eventually fed with calcium-restricted
diets, like preconized by several authors (Aldini et al., 2002; Turner, 2002; Wu et al., 2008,
Ding et al., 2010; Oheim et al., 2012; Verron et al., 2014). The major disadvantage of these
animals is the time-consuming process to obtain them.
It would be interesting to further investigate, at different implantation times, the potential
of the experimental material in promoting new bone formation. To do so, other imaging
techniques could be use, like for instance, in vivo computer tomography or magnetic resonance
imaging. Other alternative would be to alter the experimental design and choose different time
intervals to sacrifice different animals, keeping in mind that this option must also comply with
the 3R’s concept and be very well justified.
Likewise it would be beneficial to predict – through the correlation with the 3D structural
parameters – the mechanical strength and stiffness of the filled vertebral body defect, both post-
mortem – which would require the animal sacrifice at different time intervals, if the model was
the sheep – and in vivo – through an in vivo computer tomography; or, less factual but even so
very accurate, through a micro-CT based finite element modelling (Jaecques et al., 2004; Wirth
et al., 2010; Watson et al., 2014).
Another technique that could have been explored to further assess the biological response
of sheep vertebrae to the biomaterial was the reverse transcription-polymerase chain reaction
(rt-PCR). An essential key for long-term survival and function of biomaterials is their
bioactivity and the fact that they do not elicit a negative immune response. After a biomaterial
is implanted into the body, the immune system initiates an immune response sequence, largely
mediated by the local inflammatory microenvironment. Rt-PCR would allow to access this
inflammatory response. This is of utmost interest regarding the developing of future
Conclusions and future perspectives
149
biomaterials, as it allows to improve biomaterials’ integration and diminish the risk of chronic
inflammation and/ or foreign body reaction, and ultimately to create biomaterials that are able
to trigger the desired immunological outcomes and thus support the healing processes (Franz et
al., 2011; Olivares-Navarrete et al., 2015).
Likewise, the measurement of serum, urine and saliva biomarkers is a non-invasive
technique that can be used to complement imaging and histological analyses to assess the bone
turnover, wherein specific antibodies are used to detect proteins (biomarkers) in cells within a
chosen tissue. For that reason, it should be considered an asset when developing research
projects involving animal models, as it allows the researcher to obtain more information from
a given animal, at different time points, without sacrificing the same. According to Leeming et
al. (2006) bone biomarkers can be divided in three groups: 1) bone formation markers; 2) bone
resorption markers; and 3) osteoclast regulatory proteins. They are considered particularly
useful in medicine to assess metabolic skeletal diseases, such as Paget's disease, osteoporosis,
and other types of bone disorders, such as metastatic bone cancer (Leeming et al., 2006). The
main limitation of biomarkers to measure bone metabolism is their biological variability,
dependent on numerous factors like age, gender, and disease, which hinders the establishment
of reference values for serum and urine biomarkers levels (Seibel et al., 2005); nevertheless, a
recent study by Sousa et al. (2013) support the use of bone biomarkers to provide information
regarding bone cellular activity in real time.
Finally, Spine-Ghost would benefit to be tested in different bone defect animal models or
sites, thus extending its use to other applications. For instance, currently calcium sulphate
injectable cements are described as good alternatives for vertebral compression fractures
(Masala et al., 2012) and augmentation around pedicle screws in the osteoporotic spine (Yi et
al., 2008), femoral neck fractures (Patel & Kamath, 2016) and femoral head osteonecrosis
(Civinini et al., 2012), tibial plateau fractures (Iundusi et al., 2015), calcaneal fractures (Bibbo
et al., 2006; Chen et al., 2011), distal radial fractures (Abramo et al., 2010), proximal humerus
fractures (Somasundaram et al., 2013) and osteomyelitis (Karr et al., 2011). These would
possibly be good alternative applications to test the novel composite since favourable outcomes
are predictable.
Conclusions and future perspectives
150
8.3. References
Abramo, A., Geijer, M., Kopylov, P., & Tägil, M. (2010). Osteotomy of distal radius fracture
malunion using a fast remodeling bone substitute consisting of calcium sulphate and
calcium phosphate. Journal of Biomedical Materials Research Part B: Applied
Biomaterials, 92(1), 281-286.
Aldini, N. N., Fini, M., Giavaresi, G., Giardino, R., Greggi, T., & Parisini, P. (2002). Pedicular
fixation in the osteoporotic spine: a pilot in vivo study on long‐term ovariectomized sheep.
Journal of orthopaedic research, 20(6), 1217-1224.
Bibbo, C., & Patel, D. V. (2006). The effect of demineralized bone matrix-calcium sulfate with
vancomycin on calcaneal fracture healing and infection rates: a prospective study. Foot
& ankle international, 27(7), 487-493.
Chen, L., Zhang, G., Hong, J., Lu, X., & Yuan, W. (2011). Comparison of percutaneous screw
fixation and calcium sulfate cement grafting versus open treatment of displaced intra-
articular calcaneal fractures. Foot & ankle international, 32(10), 979-985.
Civinini, R., De Biase, P., Carulli, C., Matassi, F., Nistri, L., Capanna, R., & Innocenti, M.
(2012). The use of an injectable calcium sulphate/calcium phosphate bioceramic in the
treatment of osteonecrosis of the femoral head. International orthopaedics, 36(8), 1583-
1588.
Ding, M., Cheng, L., Bollen, P., Schwarz, P., & Overgaard, S. (2010). Glucocorticoid induced
osteopenia in cancellous bone of sheep: validation of large animal model for spine fusion
and biomaterial research. Spine, 35(4), 363-370.
Franz, S., Rammelt, S., Scharnweber, D., & Simon, J. C. (2011). Immune responses to
implants–a review of the implications for the design of immunomodulatory biomaterials.
Biomaterials, 32(28), 6692-6709.
Iundusi, R., Gasbarra, E., D’Arienzo, M., Piccioli, A., & Tarantino, U. (2015). Augmentation
of tibial plateau fractures with an injectable bone substitute: CERAMENT™. Three-year
follow-up from a prospective study. BMC musculoskeletal disorders, 16(1), 1-5.
Jaecques, S. V. N., Van Oosterwyck, H., Muraru, L., Van Cleynenbreugel, T., De Smet, E.,
Conclusions and future perspectives
151
Wevers, M., Naert, J., & Vander Sloten, J. (2004). Individualised, micro CT-based finite
element modelling as a tool for biomechanical analysis related to tissue engineering of
bone. Biomaterials, 25(9), 1683-1696.
Karr, J. C. (2011). Management in the wound-care center outpatient setting of a diabetic patient
with forefoot osteomyelitis using Cerament Bone Void Filler impregnated with
vancomycin: off-label use. Journal of the American Podiatric Medical Association,
101(3), 259-264.
Leeming, D. J., Alexandersen, P., Karsdal, M. A., Qvist, P., Schaller, S., & Tanko, L. B. (2006).
An update on biomarkers of bone turnover and their utility in biomedical research and
clinical practice. European Journal of Clinical Pharmacology, 62(10), 781–792.
Lewis, G. (2006). Injectable bone cements for use in vertebroplasty and kyphoplasty: State‐of‐
the‐art review. Journal of Biomedical Materials Research Part B: Applied Biomaterials,
76(2), 456-468.
Masala, S., Nano, G., Marcia, S., Muto, M., Fucci, F. P. M., & Simonetti, G. (2012).
Osteoporotic vertebral compression fractures augmentation by injectable partly
resorbable ceramic bone substitute (Cerament™| SPINE SUPPORT): a prospective
nonrandomized study. Neuroradiology, 54(6), 589-596.
Olivares-Navarrete, R., Hyzy, S. L., Slosar, P. J., Schneider, J. M., Schwartz, Z., & Boyan, B.
D. (2015). Implant materials generate different peri-implant inflammatory factors: poly-
ether-ether-ketone promotes fibrosis and microtextured titanium promotes osteogenic
factors. Spine, 40(6), 399-404.
Oheim, R., Amling, M., Ignatius, A., & Pogoda, P. (2012). Large animal model for osteoporosis
in humans: the ewe. European Cells & Materials, 24, 372-385.
Patel, H. M., & Kamath, A. F. (2016). Subchondral Insufficiency Fracture of the Femoral Head
treated with Core Decompression and Bone Void Filler Support. The Archives of Bone
and Joint Surgery, 4(3), 264-268.
Seibel, M. J. (2005). Biochemical markers of bone turnover part I: biochemistry and variability.
The Clinical biochemist. Reviews/Australian Association of Clinical Biochemists., 26(4),
97-122.
Conclusions and future perspectives
152
Somasundaram, K., Huber, C. P., Babu, V., & Zadeh, H. (2013). Proximal humeral fractures:
the role of calcium sulphate augmentation and extended deltoid splitting approach in
internal fixation using locking plates. Injury, 44(4), 481-487.
Sousa, C. P., De Azevedo, J. T., Reis, R. L., Gomes, M. E., & Dias, I. R. (2013). Short-term
variability in biomarkers of bone metabolism in sheep. Lab animal, 43(1), 21-26.
Verron, E., Pissonnier, M. L., Lesoeur, J., Schnitzler, V., Fellah, B. H., Pascal-Moussellard, H.,
Pilet, P., Gaulthier, O., & Bouler, J. M. (2014). Vertebroplasty using bisphosphonate-
loaded calcium phosphate cement in a standardized vertebral body bone defect in an
osteoporotic sheep model. Acta biomaterialia, 10(11), 4887-4895.
Turner, A. S. (2002). The sheep as a model for osteoporosis in humans. The Veterinary Journal,
163(3), 232-239.
Watson, N. A. D., Gandhi, A. A., Fredericks, D. C., Smucker, J. D., & Grosland, N. M. (2014).
Sheep cervical spine biomechanics: A finite element study. The Iowa orthopaedic
journal, 34, 137-143.
Wirth, A. J., Mueller, T. L., Vereecken, W., Flaig, C., Arbenz, P., Müller, R., & Van Lenthe,
G. H. (2010). Mechanical competence of bone-implant systems can accurately be
determined by image-based micro-finite element analyses. Archive of applied mechanics,
80(5), 513-525.
Wu, Z. X., Lei, W., Hu, Y. Y., Wang, H. Q., Wan, S. Y., Ma, Z. S., Sang, H. X., Fu, S. C., &
Han, Y. S. (2008). Effect of ovariectomy on BMD, micro-architecture and biomechanics
of cortical and cancellous bones in a sheep model. Medical engineering & physics, 30(9),
1112-1118.
Yi, X., Wang, Y., Lu, H., Li, C., & Zhu, T. (2008). Augmentation of pedicle screw fixation
strength using an injectable calcium sulfate cement: an in vivo study. Spine, 33(23), 2503-
2509.